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Abstract 
Lanthanide based probes and sensors have been widely utilised over the past few 
decades, particularly in the study of biological processes. The favourable 
photoluminescent properties of the lanthanide ions and the use of functionalised 
macrocyclic ligands that permit tuneable excitation means there is now a plethora of 
examples, across the scientific literature. 
An azaxanthone-based chromophore has been incorporated into a cyclen ligand, and the 
ability of this complex to bind to proteins has been studied further, examining the 
possibility of personalised medicine. The complex competes with selectively chosen 
pharmaceutical compound in binding to the acute phase serum protein α1-AGP. This 
complex is one of the first examples which uses CPL to monitor a binding event. 
The same chromophore, as well as the azathioxanthone analogue, have been utilised 
further in cyclen based complexes, with the aim of binding the controversial herbicide, 
glyphosate. Selectivity for glyphosate against other potential competitors has been 
studied, testing the ability of a series of structurally related complexes to operate in a 
variety of media. 
The final chapter looks at a new family of compounds, which bear an extended 
chromophore and a tripicolylamine based arm. Again, these were tested for their ability 
to bind glyphosate selectively, in a range of media. Time-gated methodology was used 
to allow any unwanted organic auto-fluorescence to be removed, particularly in samples 
which may contain a lot of biological compounds. Following these studies, one complex 
was selected, testing whether the complex can be used to calculate the concentration of 
glyphosate in extract from spiked wheat and oat grains. This complex was able to be 
used over the range 0.5 to 60 micromolar of glyphosate with a limit of around 4 
micromolar. 
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1. Introduction 
1.1 Overview 
Luminescence in its various forms has been known for centuries through 
chemiluminescence, bioluminescence and photoluminescence, defined by their mode of 
excitation. Bioluminescence is the oldest known form, with references made by Pliny 
the elder, and described by Aristotle after his observations of ‘cold light’ in animals and 
fungi.
1
 An early mention of chemiluminescence was made by Vincenzo Cascariolo, in 
the early 17
th
 century, who observed a purple-blue light from impure barium sulfide.
2
 
However, the work in this thesis will focus on photoluminescence; the spontaneous 
emission of light following the absorption of photons. 
Lanthanide photoluminescence has been used in a plethora of scientific and 
technological fields, including the authentication of documents and bank notes, to cell 
imaging and assays. 
3–6
 In this work, the use of lanthanide complexes as a probe for 
different analytes is discussed and developed, exploiting their unusual properties.  
One of the key advantages is the long-lived luminescent lifetime of terbium and 
europium complexes in particular. The lifetime of these being in the millisecond 
domain, compared to nanoseconds for most organic and transition metal complexes, 
which permit time-gated emission spectra to be acquired. This allows the unwanted 
organic luminescence to be eliminated. This is particularly useful if investigating 
biological media, where auto-fluorescence can interfere with results. For example, 
lanthanide complexes have been used to probe biologically relevant anionic species, 
such as phosphates or bicarbonate as these species are involved in a diverse range of 
metabolic pathways.
7–10
 Upon binding the analyte there is a dramatic change in spectral 
form and emission intensity. The sharp and unique emission lines from lanthanide 
spectra allow small changes in the spectral form to be discerned, as well as having the 
potential to probe the structure of the complex and the competitive binding of analytes.  
All of these properties have been well researched and discussed particularly over the 
past two decades.
11,12
 The more recent development of circularly polarised 
luminescence (CPL) is also starting to gain traction in the lanthanide community.
13,14
 
The potential to gain more information about the chiral structure of a complex, as well 
the binding mode or coordination environment, is being investigated, partially driven by 
the ubiquitous nature of chirality within biology. 
 2 
 
This thesis will explore the use of lanthanide complexes in both CPL and time-gated 
experiments to study the use of these compounds in ‘real-life’ situations. Reversible 
binding will be monitored through changes in emission, as well as addressing any 
sampling problems which arise in the process. 
1.2 Luminescent Lanthanide Complexes 
1.2.1 Photoluminescence 
The term photoluminescence is inclusive of both fluorescence and phosphorescence, the 
radiative decay from a spin allowed and spin forbidden transition respectively. The 
‘allowed’ or ‘forbidden’ aspect of the transition stems from the Laporte rule which 
states that a transition must include a change in parity.
15
 This obviously assumes perfect 
quantum numbers which is rarely the case, so even with a forbidden transition, emission 
is often observed, albeit with a much weaker intensity coupled with a longer lifetime 
than those seen with an allowed transition. The relaxation of the Laporte rule comes 
through the coupling of vibrational and electronic states, which distorts the symmetry 
around the metal ion sufficiently to allow the transition. 
1.2.2 Lanthanide Luminescence 
The unusual luminescent properties of lanthanide complexes mostly stem from the 
forbidden nature of the f-f transition. As it is disallowed, once the lanthanide is in an 
excited state, it takes time for relaxation to occur via radiative decay, hence the long 
lifetime. However, this is often seen as a positive and is a well utilised property, with 
the negative aspect being that it is often paired with a small extinction coefficient and 
therefore, a low quantum yield. These features create a potential problem when 
designing a complex, as the emission must be sufficiently intense to be observable 
quickly. 
Furthermore, owing to the lanthanide contraction, there is little overlap of orbitals 
between the lanthanide and any ligand, so the ligand has less influence on the form of 
the emission spectrum, in comparison to transition metal coordination complexes. 
Hence, lanthanide complexes tend to have distinct emission with sharp bands. However, 
the nature of the ligand has a measureable effect on lanthanide spectra. Indeed, variation 
in the ligand field determines the crystal field parameter, 𝐵0
2, which can be calculated 
from the change in the ΔJ = 1 band in europium emission, for example.16  
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The distinct emission bands from the lowest energy excited states, range in energy 
through the lanthanide series. Each lanthanide emits in its own distinct region. For 
example, europium and terbium emit in the visible region, giving rise to red and green 
light respectively. Others emit in the near IR (NIR), such as neodymium, ytterbium and 
erbium. Figure 1.1 shows the relevant energy levels of the lanthanides.  
 
Figure 1.1- Energy level diagram for lanthanides with the ground state (blue) and the excited states from 
which radiative decay can be observed (red)
17 
The energy gap between the first excited state and the ground state should be considered 
in terms of what the lanthanide complex will be used for. For example, if the energy gap 
is too small, the number of viable non-radiative pathways increase and hence lanthanide 
emission intensity decreases. Europium, terbium and gadolinium all have large energy 
gaps, with gadolinium in the UV region. This is important to note, as gadolinium 
complexes are not appropriate for use in biological media, due to the potential of UV 
damage. Consequently, it is predominantly europium and terbium which have been 
investigated. Furthermore, uses in displays for example, are normally limited to 
europium and terbium. 
Europium is more commonly used in emission studies, compared to terbium, partially 
due to the lowest level excited state, 
5
D0 being non-degenerate. The effect of this on the 
spectra is that fine structure in each band arises due to the degeneracy of the ground 
states, 
7
Fn (n=0-7). Hence, europium spectra are not only the simplest to interpret, but 
are also those from which information is most easily extracted.  
Additionally, the long-lived luminescent lifetimes of the lanthanide metals allows for 
time-gated experiments to be achieved. Particularly in biological media, there is a level 
 4 
 
of short-lived organic fluorescence, which could mask or interfere with the lanthanide 
emission. Up to a 10 microsecond delay after excitation could be used, for example, 
before emission is collected, to remove any competing fluorescence.  
1.2.3 Sensitising Ligands 
Due to the forbidden nature of the f-f transition, not only is the emission lifetime long, 
but it is also difficult to excite the lanthanide directly with their low (5 dm
3
 mol
−1
 cm
−1
) 
molar extinction coefficient. Although possible using certain lasers, it is inefficient, so 
most researchers utilise sensitising ligands. These are often conjugated organic 
chromophores which when excited, transfer energy to the lanthanide excited state, from 
which it can relax. The first report was published in the 1940s by Weissman, focussing 
mainly on europium but stating it was also observed for terbium and samarium.
18
 In the 
paper, he also discussed the effect of solvent and temperature in the process, which later 
was referred to as the ‘antenna effect’.  
 
Figure 1.2 - A simplified sketch to illustrate the antenna effect 
The chromophore can be designed specifically for the lanthanide and for the final use of 
the complex. For example, solubility, charge, and sample uptake in biological systems 
can be varied through modification of the chromophore. There are a number of probes 
which are designed to investigate a biological process that are not soluble in water, and 
therefore require the use of DMSO.
19–21
 The chromophore, as well as the rest of the 
ligand, should be designed in such a way that it can be used directly, according to its 
original intended use. As such, a wide range of chromophores has been used to sensitise 
lanthanide emission.
22–26
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Figure 1.3 - The structures of a number of chromophore that have been used to excite lanthanides
22–26
 
Excitation of the antenna preferably occurs at a wavelength close to the maximum 
absorbance of the chromophore. Ideally, this would also be at an excitation wavelength 
that aligns with laser or LED excitation sources, e.g. at 365 nm or 380 nm, which are 
commercially available LED wavelengths. Once the chromophore is excited, it relaxes 
very quickly via vibronic relaxation to the lowest lying S1 state, as described by Kasha’s 
rules.
27
 This process occurs on the timescale of 10
-13
 to 10
–11
 seconds. From the S1 state 
there are three main pathways the process can follow. The first is non-radiative decay 
back down to the S0 state. The second is a radiative process down to S0 giving 
fluorescence, which takes 10
–9
 to 10
–7
 seconds. The third option is to undergo 
intersystem crossing (ISC) to the excited T1 state, which is the most common pathway 
in lanthanide luminescence.  
 
Figure 1.4 - Schematic showing some potential pathways of relaxation when utilising the antenna effect
28 
From the triplet state, there are a number of options. Again the option of a non-radiative 
pathway back to S0 is a possibility, as well as a radiative option, phosphorescence. This 
can occur over a timescale of 10
–4
 seconds to hours, which is how ‘glow-in-the-dark’ 
objects work. The third option in lanthanide complexes is energy transfer from the 
chromophore’s T1 state to a lanthanide excited state. Similar pathways are available for 
the lanthanide excited states as the chromophore T1, including back transfer to the 
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chromophore T1 state. When the lanthanide excited state luminesces, it is typically on 
the micro- to millisecond timescale. 
The transfer of energy between the chromophore and the lanthanide can go through two 
potential pathways, Förster or Dexter which are through space and bonds respectively. 
Due to the lanthanide contraction, the lanthanide 4f orbitals provide poor overlap with 
those of the ligand and as such, it is unlikely that this transfer occurs via a Dexter 
mechanism. It is therefore assumed in most cases to be a Förster mechanism, and this 
pathway displays an r
–6
 dependency. Therefore, when designing an antenna ligand, it 
must lie sufficiently close in space to the lanthanide to allow efficient energy transfer. 
The energy transfer actually takes place through a dipole-dipole interaction between the 
orbitals of the organic chromophore and the 4f orbitals of the lanthanide ion. 
Although this is the most common pathway to achieve maximum lanthanide 
luminescence, there are various points in which non-radiative decay can occur. For 
example, the triplet excited state can be quenched by triplet oxygen. In the design of the 
chromophore, these and other pathways should be considered to maximise lanthanide 
luminescence. 
An alternative method to lanthanide excitation is through an ICT (internal charge 
transfer) state on the chromophore.
29–31
 These states exist where there is an electron 
withdrawing and electron donating group that are linked via π-conjugation.32 The 
greater the charge difference between the groups, the larger the bathochromic shift. The 
same effect can also be induced by increasing the length of the conjugated chain, and 
these states often correspond to the visible region.  The large Stokes shift which is often 
observed in this system is due to the reorganisation of the excited state which has a 
different dipole moment to the ground state. Therefore, the relaxation is highly 
dependent on the donor/acceptor pair as well as solvent polarity due to differential 
stabilisation of the excited state. The states are also thermally activated, resulting in a 
temperature dependence. 
 7 
 
 
Figure 1.5 – The structures of [Eu.La]29 (left) and [Eu.Lb1-3]31 (right), that are excited through ICT states 
Significantly fewer examples are seen of singlet excited state sensitisation. It was first 
proposed in 1969 by Kleinerman who proved it was a viable process.
33
 However, 
transfer from the triplet state can still occur, if this energy transfer is faster than the 
singlet state. The first confirmed case wasn’t reported until 2004 by Yang et al.34  
 
Figure 1.6 – The structure of [Eu.Lc]34  
Using time-resolved experiments, they showed that the decay of the singlet excited state 
of [Eu.L
c
] matched the rise time of the 
5
D1 excited state of 1.8 ns; the triplet excited 
state was proven to have a lifetime of 3.9 s, through low temperature measurements. 
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However, examples of singlet sensitisation are still much rarer, with most examples 
using the triplet excited state. This can be depicted more simply on a Jablonski diagram. 
 
Figure 1.7 - A Jablonski diagram displaying possible ways to sensitise the lanthanide excited state using 
a sensitising chromophore 
One of the main points to ensure efficient phosphorescence via the T1 state of the 
chromophore is that it should be higher in energy than the excited state of the 
lanthanide, but be close enough in energy to allow efficient transfer. If the difference in 
energy is too great, the brightness (Equation 1.1) of the probe is compromised. 
However, the energy of the chromophore T1 should be more than 19,000 cm
–1
 in 
europium or 22,000 cm
–1
 in terbium, to allow an energy gap greater than 1,700 cm
–1
. 
This situation ensures back transfer from the lanthanide to the chromophore does not 
occur quickly. These points need to be balanced to optimise efficient lanthanide 
luminescence. 
One comprehensive study saw 41 compounds synthesised which were used to compare 
the lanthanide luminescent quantum yield and the triplet excited state.
35
 A clear 
correlation between the two was observed for both europium and terbium. They also 
found that quantum yields decreased due to back transfer to terbium when the ligand 
triplet state was below 22, 300 cm
–1
. For europium, the precise numbers were more 
difficult due to multiple excited states, but again, it was found that the best sensitisation 
was close to the 
5
D0 excited state, but when the gap was too close, a large decrease in 
luminescence was observed. 
A high quantum yield is an essential feature of a good luminescent probe to ensure a 
good signal-to-noise ratio in both total luminescence and CPL. It can be related to many 
aspects of ligand design, including those discussed above. Essentially, the quantum 
 9 
 
yield is the ratio of the number of photons emitted compared to the number absorbed. 
The quantum yield (ϕ) and the molar extinction coefficient (ε(λ)) of a ligand determines 
the brightness 𝐵(λ) of a probe. 
 𝐵(λ) =  𝜀(λ)ϕ𝑒𝑚 (1.1) 
The molar extinction coefficient is a constant that is described by the Beer-Lambert 
Law; 
 𝐴(λ) =  𝜀(λ)𝑐𝐿 (1.2) 
The molar extinction coefficient is proportional to concentration (c) and is constant for a 
compound in a given solvent and wavelength. It is therefore regularly used to calculate 
the concentration of compounds at the micro-molar level.  
1.2.4 Ligands for Ln(III) Complexes 
A plethora of chromophores and ligands exist that have been used to sensitise 
lanthanide ions. This section will focus on europium and terbium complexes as these 
are the main two metal ions which emit in the visible spectrum and therefore are most 
commonly used in luminescence studies.  
Thus far, the focus has been on good chromophores which have high brightness, but the 
stability of the coordination complex is also imperative. Going back to uses in 
biological systems, lanthanide metals are toxic if not encapsulated in a kinetically and 
thermodynamically inert complex as they may replace Ca
2+
. The similar sized radius 
and high charge means lanthanides can bind to the same binding sites as calcium, as 
well as being taken up into bone tissue, which can affect biological pathways, altering 
physiological processes.
36
 For a stable complex, a high coordination number is 
necessary (preferably 8- or 9-) with hard donor ligands such as nitrogen and oxygen, 
which bind strongly to lanthanide ions.  
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and related ligands 
have been used widely as MRI contrast agents as they have good kinetic stability. 
Commercially known as Dotarem, [Gd(DOTA)(H2O)]
 –
, was first used in vivo in 1986 
as an alternative to [Gd(DTPA)(H2O)]
2–
 (Magnevist) (Figure 1.8).
37
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Figure 1.8 - DPTA (left) and DOTA (right) 
[Gd(DOTA)(H2O)]
–
 possess more favourable relaxation properties compared to 
[Gd(DTPA)(H2O)]
2–
, and has the added benefit that the logKML values are higher, with 
24.7 compared to 22.3 respectively for the gadolinium complexes.
38
 The reason for the 
favourable binding constants in each case is due to the ‘chelate effect’, which reduces 
the entropic contribution of chelation of the lanthanide metal ion compared to complex 
formation with multiple mono-dentate ligands. The stability of the lanthanide DOTA 
complexes is greater than those of DPTA due to the ‘macrocyclic effect’. It is similar in 
nature to the chelate effect, but as the macrocycle is already formed before 
complexation, it reduces the entropic penalty compared to the open chain analogue and 
gives rise to higher logK values. 
The ligand cyclen and the octadentate derivative DOTA form the basis of a number of 
ligands which have been used as multimodal contrast agents as well as for luminescence 
studies.
39,40
 Modifications to both the cyclen ring itself or the N-substituents can alter 
the ligand properties, allowing the synthesis of a range of complexes for a variety of 
uses. 
The hexadentate 9-N3 equivalent is called NOTA, where similar modifications to the 
parent ring aids the creation of a library of NOTA derivatives. Groups such as pyridines 
with a carboxylate group in the 6-position allow for three additional coordination sites, 
taking the coordination number up to nine, and is therefore suitable for stable lanthanide 
complex formation.
41
 The possibility of substituting the carboxylate group for a 
phosphinate group has also been explored, (Figure 1.9).
42
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Figure 1.9 - Structure of NOTA (left), H3tpatcn (centre), and the phosphinate analogue (right)
42 
The use of the pyridine group serves two purposes, as it can act as a sensitiser for the 
lanthanide ion, in addition to coordinating to the metal centre. However, simple 
pyridines with either phosphate or carboxylate groups absorb at or close to 280 nm 
which is not an appropriate wavelength for use in biological media for example. 
43,44
   
To rectify this, an extended chromophore can be utilised. With the addition of an 
electron rich aryl group connected through an alkyne linker, a charge separation along 
the axis of the chromophore is created. This creates an internal charge transfer (ICT) 
absorption band, which has a much higher molar extinction coefficient, compared to a 
pyridine group alone. It’s first use as a lanthanide chromophore was in the 1990s as a 
label in immunohistochemistry.
45
 It has since been engineered in 9-N3 complexes and 
used with EDTA complexes with improved quantum yields. Use of [EuEDTA-L
d-i
] 
(Figure 1.10) gave quantum yields of over 20% with one being three times higher than 
previously reported ligands in this class.
46
 
             
Figure 1.10 - (Left) Structure of [EuEDTA-L
d-i
], (right) structure of L
d-i
, with quantum yields (H2O, 295 
K) in brackets
46 
A series of 9-N3 based complexes exist in which the use of these ligands to sensitise 
europium has been reported.
47,48
 Many, but not all, use all three arms to ensure a nine 
coordinate environment. The pyridine is generally adorned with a carboxylate or 
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phosphinate group, with a variety of substituents on the aryl ring, most commonly 
substituted in the para position.  
Work in 2008 looked at the possibility of sensitising a number of lanthanide ions, 
including near-infrared emitters such as neodymium and ytterbium.
30
 The most efficient 
behaviour was found with europium complexes; quantum yields of about 40% in DCM 
were measured in this study and the authors predicted that further development of these 
brighter complexes would be very efficient for bio-probes. Following on from this 
work, both quantum yields and water solubility was improved. One complex in water 
gave a quantum yield of 32%, one of the highest reported in this solvent.
49
  
 
Figure 1.11 - The structure of europium complexes which utilise the extended chromophore
32,49,50 
More practical uses for these complexes have developed over time. For example, 
[Eu.L
k
]
 
(Figure 1.11) was used to monitor the pH in the endoplasmic reticulum (ER) of 
living cells.
50
 The complex localised selectively in the ER. On protonation, the nitrogen 
in the sulphonamide arm detached from the europium, and was replaced with an inner 
sphere water. This process led to a decrease in emission intensity, as well as a change in 
the spectral form, allowing for ratiometric measurements. The change in pH could also 
be tracked using the change in lifetime. This emission behaviour is associated with the 
quenching effect of the bound water, at lower pH, and the reduction in intensity is not 
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ideal. The broad absorption maximum of the ICT transition in the complex is at 322 nm, 
and excitation at 355 and 365 nm is possible, so it can be safely used in cells without 
killing them. The use of time-gated acquisition allowed removal of organic auto-
fluorescence, which could have otherwise obscured the europium emission. 
Azaxanthones and azathioxanthones (Figure 1.12) have also been investigated as 
potential ligands for europium in biological media. The triplet state energy level was 
measured to lie at 24, 800 cm
-1
, which is sufficiently high in energy to ensure minimal 
back donation from terbium, successfully sensitising both terbium and europium.
51
 
There are relatively few examples of its use in the literature thus far.  
 
Figure 1.12 - Structure of axathiozanthone (left) and axazanthone (right) 
An example of a europium cyclen based complex, [EuDAPA2], was found to 
successfully allow measurement of citrate and lactate in various biological media.
52
 The 
380 nm excitation for the azathioxanthone, and 336 nm for azaxanthone means that 
variety of excitation sources can be used.
53
 Usefully, the aforementioned long 
fluorescence lifetimes of europium and terbium complexes allow the use of time-gated 
experiments to remove organic fluorescence interference.  
 14 
 
 
 
 
Figure 1.13 - Mechanism of how citrate binds to [EuDAPA2]
52
 (top) and the change in the emission 
spectrum upon addition of citrate (bottom) with the calculated binding curve (inset) 
Citrate binds reversibly to the complex in a bidentate fashion, through the hydroxyl and 
the α-carboxylate groups, replacing two inner sphere waters. This binding event results 
in an increase in emission intensity, a change in spectral form and the lengthening of the 
luminescence lifetime. The ‘switch-on’ effect is another advantage for this complex. 
The importance of this probe’s development is due to the fact that irregularities in low 
level of citrate can be indicative of prostate cancer.
54
 Lactate can also bind to the 
complex in an analogous manner, but with a smaller binding constant. Therefore, a 
known excess of lactate was used to make up part of the assay to saturate lactate 
binding, and thereby ensure any change in emission spectral form was purely due to 
citrate. 
The related azaxanthone chromophore, has been used in conjunction with terbium 
(Figure 1.14) to detect potassium.
55
 K
+
 is commonly found in biological systems, where 
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it influences a number of physiological processes. Selective binding over sodium, 
another common ion used in biological systems, is highly sought after due to the 
similarity of the two ions and their differing relative concentrations, making 
discrimination difficult. However, the toxicity of the complex was highlighted in the 
cell studies so further use of the compound in biological systems would not be advised.  
 
Figure 1.14 - Structure of the [Tb.L
o
]
55
 
This complex is designed slightly differently with the chromophore being separated 
from terbium by a diaza-18-crown-6 moiety. In the absence of the potassium ion, little 
terbium emission is observed. Upon binding of the ion in the crown, there is a 
preference for π-bonding between the crown and the aryl ether and hence the 
chromophore is brought significantly closer to the terbium ion, leading to enhanced 
emission. 
A further example of an azaxanthone chromophore being used in the detection of 
biologically relevant compounds involved a dynamically racemic complex that binds 
alpha-1-acid glycoprotein (α1-AGP) and alpha-1-antitrypsin (α1-ATT).
56
 These are both 
proteins found in the blood whose concentration changes dramatically in response to 
inflammation. Both were found to have an increase in emission intensity upon binding 
to the complex. Again, it is likely due to the replacement of a bound water with a 
glutamate side chain carboxylate. Binding was signalled by induced CPL, the concept 
of which will be discussed in the following section.  
1.3 Circularly Polarised Luminescence 
Circularly polarised luminescence (CPL) has been known since the 1940s but the 
method for the detection of this type of luminescence was developed decades later.
57
 
CPL is now a relatively well known technique, often used in conjunction with CD 
(circular dichroism). CPL is the emissive analogue of CD and gives information about 
the excited state of a compound based on the differential emission of left and right 
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circularly polarised light. It is inherently more sensitive than CD and is less affected by 
background luminescence.  
1.3.1 Background and Theory 
Light is classically known to be made of two main components, the magnetic and 
electric field vectors. CPL occurs because two components of the electric field vector 
are out of sync by a quarter of a wavelength. Depending on which of the two 
components are first, you can get left- or right- handed CP light (Figure 1.15). 
 
Figure 1.15 - Left and right circularly polarised light. The two perpendicular components of the electric 
field vector are depicted in blue and green 
In CPL a measurement is made of the left versus right circularly polarised spontaneous 
emission, ΔI.  
 ∆𝐼 = 𝐼𝐿(𝜆)  −  𝐼𝑅(𝜆) (1.3) 
However, measuring absolute emission values can be difficult. CPL is most commonly 
reported as the dissymmetry value (gem), defined in Equation 1.4. 
 
𝑔𝑒𝑚 =
2(𝐼𝐿(𝜆) − 𝐼𝑅(𝜆))
(𝐼𝐿(𝜆) + 𝐼𝑅(𝜆))
 
  (1.4) 
Here, IL(λ) and IR(λ) are the intensities of left and right polarised emission respectively. 
It follows that the maximum values of gem are ±2 and the absence of any circularly 
polarised luminescence gives a value of zero.  
Alternatively, you can link the dissymmetry factor to the rotatory and dipole strength of 
the relevant transitions. A study by Emeis and Oosterhoff showed that these transitions 
can be linked to the electric dipole moment and the magnetic dipole moment.
58
 
Simplified, you can write the dissymmetry factor as: 
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𝑔𝑒𝑚 =  
4𝑅𝑎𝑏
𝐷𝑎𝑏
 
(1.5) 
Rab is the rotatory strength of the transition. It influences the sign and magnitude of the 
CPL signal. It can also be written as Equation 1.6: 
 𝑅𝑎𝑏 = |𝜇||𝑚|𝑐𝑜𝑠𝜏 (1.6) 
Where μ is the electric and m is the magnetic transition dipole, and τ is the angle 
between the two transition dipole moments. The dipole strength (Dab) of the transition 
also plays an important role in the dissymmetry factor, contributing to the total 
emission. 
 𝐷𝑎𝑏 = |𝜇|
2 + |𝑚|2 (1.7) 
Substituting these two parameters into the equation for gem gives: 
 
𝑔𝑒𝑚 =
4|𝜇||𝑚|𝑐𝑜𝑠𝜏
|𝜇|2 + |𝑚|2
 
(1.8) 
As the magnitude of the electric transition dipole moment is typically much greater than 
the magnetic transition dipole moment, we can assume the contribution of m
2
 is 
negligible, and this can be simplified to give the equation: 
 
𝑔𝑒𝑚 =
4|𝒎|
|𝝁|
𝑐𝑜𝑠𝜏 
(1.9) 
The difference in electronic and magnetic dipole moments can be important in CPL 
detection. For example, in europium emission, the ΔJ = 1 transition is magnetic dipole 
allowed and electric dipole forbidden. Hence the ΔJ = 1 band typically gives large gem 
values. 
However, any chiroptical transition requires a non-vanishing rotational strength and for 
f-f transitions, such as those observed in lanthanide complexes, a vanishing rotational 
strength is expected. There are two mechanism that allow this for lanthanide species, 
static and dynamic coupling.
14
 In static coupling, mixing of 4f and 5d orbitals may 
provide the odd parity necessary for the non-vanishing rotational strength. However, 
this can only happen if the coordination sphere is chiral so covalent contribution to the 
bonds between the lanthanide and the donor atoms must invoke such hybrids. However, 
lanthanide interactions with donor atoms are not known to be strongly covalent, and 
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therefore only weakly effect the metal ion. This mechanism varies with the twist angle 
of the ligand, and a maximum is reached when ϕ = 22.5⁰ . For complex with much 
larger twist angles, static coupling is low and therefore, a second mechanism comes into 
play. It is possible to observe dynamic coupling between lanthanide and nearby ligand 
transitions, which have non-zero electric dipole allowed character. If the lanthanide is 
excited, its associated electric quadrupole induces an electric dipole moment on the 
ligand, which provides the necessary dissymmetry for a transition to be observed. For 
this mechanism to work, the metal centre and the ligand must be spatially close.    
1.3.2 Instrumentation 
Only in recent years has a commercially available spectrometer been marketed, the 
JASCO CPL-200.
59
 A consequence of this is that there remain a number of ‘in-house’ 
spectrometers that were custom built in different departments which are fairly sensitive 
to CPL detection.
60
  As there are a number of differences between each instrument, 
standardisation of measurements can be problematic. However, the essential 
components of the spectrometer set up are comparable. 
 
Figure 1.16 - A typical set up of a CPL spectrometer
61 
The incident light used to excite the sample, usually a laser driven light source, is 
typically linearly polarised or unpolarised. The high intensity increases the likelihood of 
photochemical degradation, but gives rise to a brighter CPL signal.  The light is 
detected and modulated at 90° to the direction of this light (to stop saturation of the 
detector) by the photoelastic modulator (PEM). This is usually some form of 
isotropically clear optical material that becomes anisotropic on application of a stress 
period. The PEM is driven by AC light at a frequency of approximately 50 kHz and 
therefore acts as an oscillating quarter-wave plate. The consequence of which is the 
deceleration of light, which transforms left and right polarised light into linearly 
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polarised light. The light passes through a linear polariser, tilted to 45˚ and directed to 
the monochromator. It then goes through a photomultiplier tube (PMT) before 
detection. Early instrument designs, such as the one set up in Figure 1.16, used a lock in 
amplifiers to detect the difference in AC and DC current which is converted into the 
CPL and total luminescence signals respectively. Photon counting detectors are more 
commonly used now, which are both more reliable and easier to calibrate. 
1.3.3 CPL Probes  
The first set of chiral probes studied were small organic molecules (SOMs) which were 
examined during the discovery of CPL. Emeis and Oosterhof used bicyclic chiral 
ketones and studied the n→π* transition.58 These compounds generally had weak 
fluorescence, and π conjugation was extended in an attempted to improve their 
oscillator and rotatory strengths. Other organic molecules which have been investigated 
include helicenes, and various twisted polycyclics.
62,63
  
1.3.3.1 CPL of Small Organic Molecules 
High dissymmetry is achieved when you have a transition that is magnetic dipole 
allowed and electric dipole disallowed, as highlighted in Equation 1.9. Unlike 
lanthanide complexes, organic compounds do not usually have such a transition leading 
to difficulties when attempting to increase gem. Despite the poor dissymmetry factor, a 
lot of research has sought to develop organic molecules that exhibit CPL activity, and 
seek a wide range of applications including sensors, displays and dyes.
64–66
  
Due to the poor gem values, the use of organic compounds as CPL emissive biological 
probes has not been deeply investigated. Dipyrrolyldiketone boron complexes are linear 
motifs and their luminescence properties arise following binding with anions, such as 
halides or amino acids.
67
 A dimer of two of these complexes with a phenylene bridge 
can bind to halide ions resulting in an induced CPL response due to ion pairing between 
the chiral cations and the anion.
65
 To bind bigger anions, a longer spacer group is 
necessary to form a large enough cavity. With a terphenyl linker, which can either be 
meta-meta-meta or para-ortho-para, it is possible to bind amino acids to these π-
conjugated moieties and induce a CPL signal which is dependent on the chirality of the 
anion binding.
68
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Figure 1.17 - (Left) A dimer binding a small anion [L
p1
-X] (X = halide). (Right) A terphenyl bridged 
complex capable of binding L-amino acids [L
p2
]
68
 
However, the complex only gives rise to small induced gem values, with a maximum of 
7x10
-4
 at 553 nm.
68
  The experiments were repeated at -50 ˚C as it was hypothesised this 
would more tightly curl the helices around the anion and change the ratios of the two 
diastereoisomers. Even at these temperatures, the gem values were in the region of 10
–3
; 
although this is an improvement by a factor of 10, the values themselves are still very 
small.  
More recently a CPL-SOMs based on bis(haloBODIPY) have been studied.
69
 One such 
example adopted a helical conformation in chloroform which gave rise to gem values of 
±0.001.
70
 It was also found that with a small structural change in the compounds, 
opposite CPL signals were observed. Thus, upon replacing the nitrogen in RR-L
q1
 for 
oxygen (RR-L
q2
), the CPL signal goes preferentially from left-handed light to right. 
Such a small modification in the compound leading to opposite chirality is an exciting 
piece of research. 
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Figure 1.18 - RR- enantiomer of two chiral CPL-SOMs based on haloBODIPY moieties
70 
All SOM probes investigated so far have very small gem values, in the region of 10
–4
. 
However, whilst these values are still too low to be of use as CPL emissive biological 
probes, this research is good ground work for their longer term use, such as in 3D 
displays, security and informational storage. 
1.3.3.2 CPL in Transition Metal Complexes 
The use of heavy metals can offer an advantage in helicene chemistry in particular. For 
example, it can act as a template, as is well known through coordination chemistry of 
transition metals. Furthermore, as it is possible to vary the metal centre or the 
coordination sphere geometry, it offers a method to tune the chiroptical and electronic 
properties of the complexes. A number of metal complexes have been investigated, 
including those of platinum and rhenium.
71
 There are fewer examples of rhenium 
complexes owing to the poorer overlap of rhenium d orbitals with the conjugated 
system. Hence, the gem values for rhenium are smaller (gem~10
-3
) than have been found 
with platinum (gem~10
-2
).
72
 Iridium complexes have also been investigated, but show 
smaller gem values than with platinum, for similar reasons (gem~10
-3
).
73
  
An example of the use of an organometallic helicene has been reported as a pH probe.
74
 
The study looked at the comparison of an organic and organometallic system. The 
change of pH in the organic helicene resulted in no change in the gem values. However, 
in the organometallic system upon protonation, the gem value doubled.  
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Figure 1.19 - Organic and organometallic helicenes M-(–)-Ls with potential as a CPL probe74 
Both enantiomers of this helical structure P-(+)- and M-(–)- were made, confirmed by 
their mirror image CPL spectra, with the pronated ligand giving gem values of +3.2 x 10
–
3
 and -2.5 x 10
–3
 at 590 nm respectively. For Pt[P-(-)-L
r
] and Pt[M-(-)-L
r
], gem values of 
+1 x 10
–3
 and -1.1 x 10
–3
 were found. Upon protonation of the platinum complexes, the 
CPL activity is approximately doubled giving gem values of +1.8 x 10
–3
 and -2.2 x 10
–3
 
for P and M isomers respectively, where λmax = 590 nm. By comparing the response of 
the organic and organometallic helicenes, using various techniques, the compounds can 
be considered as multi-modal probes. However, these values are still an order of 
magnitude lower than those previously found in platinum complexes and there are other 
ways in which the probe works in a more effective manner (CD and UV/vis) which 
means it is unlikely to be used purely as a CPL probe. 
The highest known gem value for a platinum helicene was publish in 2014, where 
enantiopure complexes were obtained following column chromatography and 
recrystallization (Figure 1.20).
72
  All complexes gave gem values in the expected region 
of transition metals of 10
-3/-4
, with the exception of L
s6
. This gave a value of 10
-2
, which 
is the highest value obtained for a molecular helicene. Of note in this paper, is that upon 
the addition of the metal ion, the gem value increases the CPL signal by approximately 
100-fold. 
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Figure 1.20 - Structure of L
s1-6 
Another point to note is that previously reported helicenes have all been fluorescent 
systems. The spin-orbit coupling of the platinum(II) valence orbitals promotes rapid 
ISC to the T1 state, which diminishes the fluorescence intensity and is accompanied by 
phosphorescence. 
Even though transition metal complexes do give gem values which are an order or two 
higher than SOMs, these values are still very small and liable to error. Further 
improvement in the size of the CPL signal is needed before these complexes can be 
considered for biological systems in particular.  
1.3.3.3 CPL Studies of Lanthanide Complexes 
Lanthanides, particularly europium and terbium are useful optical probes, and are used 
in a number of other luminescent studies due to their attractive photophysical properties 
including their narrow emission bands and long luminescence lifetimes. With CPL, they 
have a further advantage of large emission dissymmetry factors.
75
 They act as pure 
spherical emitters, which negates the problem of anisotropy. 
There is a wide range of europium complexes that are CPL active, with an intense ΔJ = 
1 band. This transition has purely magnetic dipole character which is a requirement for 
large dissymmetry factors. Although terbium’s transitions are not as favourable, it 
generally has higher luminescence intensity which can be useful in obtaining a signal. 
There are relatively few other examples of reported CPL active lanthanide complexes. 
However, Richardson’s classification, which identified which transitions have expected 
high dissymmetry factors, suggests that samarium’s 4G5/2 to 
6
H5/2 transition should be as 
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favourable as terbium’s main transition.76 Unfortunately, due to multiphoton quenching, 
samarium complexes are often weakly luminescent, and there are very few reported 
CPL active complexes.
77,78
 However, one example, Cs[Sm((+)hfbc)4], gives a gem value 
of -1.15 and +1.15.
79
 
The highest ever recorded gem value is a europium complex with a value of +1.38. The 
complex studied was a tetrakis((+)-3-heptafluorobutylyrylcamphorato) (hfbc) 
lanthanide(III) complex with a caesium counterion.
80
 The nature of the alkali metal 
counterion was important with a 9-fold increase in gem between Na and Cs, and a 
significantly smaller gem value in the absence of an alkali metal cation.  
 
Figure 1.21 - (Left) A crystal structure of Na[Eu((+)-hfbc4].CH3CN.
81
 (Right) The structure of one ligand 
and how it is predicted to interact with both the lanthanide ion and alkali metal 
Further studies changing the alkali metal ion were conducted.
79
 An increase in CPL 
intensity with increasing ionic radius of the metallic ion was observed in chloroform. In 
acetonitrile, the effect was not observed to the same extent, with much less variation in 
the gem value. Therefore, the authors declared that solvent does play a significant role in 
the intensity of the emission. However, they did not consider a possible role of 
aggregation in rationalising this behaviour, nor any shift in the orientation of the main 
component of the magnetic susceptibility tensor with solvent or cation variation in the 
ion-pair. 
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Figure 1.22 - The CPL (top) and total emission (bottom) signals of the (left) ΔJ = 2 transition from (left to 
right) Na-Eu, K-Eu, Rb-Eu and Cs-Eu, and (right) the  ΔJ = 3 transition in (left to right) EtOH, CH3CN 
and CHCl3
79 
Due to the high gem value, further work has examined potential uses. After mixing the 
europium complex with polyvinylcarbazole (PVK) and 1,3-bis[2-(4-tert-butylphenyl)-
1,3,4-oxadiazo-5-yl]benzene (OXD7) a doped thin film was formed for use as a 
circularly polarised LED. A gem value of +0.75 in the film was measured, which 
although is far below the complex in solution, it is the highest ever measured for a CP 
LED.
82
 
One of the few examples of stable and enantiomerically pure f-helicates that display 
europium centred CPL was reported by the Gunnlaugsson group.
83
 A dimetallic 
europium structure with three identical helicate ligands was investigated. Excitation of 
the naphthalene antenna at 340 nm gave rise to relatively large dissymmetry factors of -
0.23 for the 593 nm transition (ΔJ = 1). However, all of these examples were examined 
in acetonitrile and methanol and are not applicable to more competitive media. 
 
Figure 1.23 - (Left) Structure of L
u
 used in complex. (Right) 3-D structure of the europium complex
83 
In other work, changes in the CPL fingerprint upon binding to different proteins has 
been investigated. It was found that the CPL of one enantiomer of a lanthanide complex 
changed upon binding to human and bovine serum albumin.
84
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Figure 1.24 - The racemic structure of [Ln.L
u1,2
] 
The complex, [Ln.L
u1
], for example, was found to bind to ‘drug site II’ reversibly, 
inverting the CPL signal, suggesting that there is a radical change in complex helicity 
upon binding. The effect was only seen with the (SSS)-Δ complex, and only with serum 
albumin. The only change in the CPL spectrum for the (RRR)-Λ complex upon binding 
was a decreased signal. The lack of change in only one enantiomer makes the complex a 
unique chiroptical probe, specific to reversible albumin binding. 
 
Figure 1.25 - The CPL spectra of (SSS)-Δ –[Eu.Lu1]3+ (left, black) with BSA (blue/green) and (SSS)-Δ-
[Tb.L
u2
]
3+
 (right, black) and in the presence of BSA (pink)
84
 
Other responsive probes include those that induce a CPL signal upon anion binding. 
One such example is a set of dynamically racemic europium complexes (Figure 1.26) 
with which induced CPL spectra are observed upon binding to certain phosphorylated 
amino acids, e.g.  O-phosphono-Ser and Thr.
85
 Chemoselective binding of the 
phosphate oxygen to the lanthanide centre occurs in this case. 
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Figure 1.26 - Structures of [Eu.L
v1
] and [Eu.L
v2
]
85
 
In a control experiment, it was shown that the CPL response did not occur for the non-
phosphorylated peptide. It is also interesting to note that there is no CPL response when 
O-P-Tyr itself was added. The O-P-Tyr residue must be part of the peptide chain for a 
CPL response to be induced. Upon binding to a phosphorylated peptide chain, a gem 
value of +0.10 were observed, one of the highest induced CPL values observed with a 
dynamically racemic europium complex in purely aqueous media.  
It was also possible to see a change in sign of the CPL signal when different peptides 
were used; suggesting the chiral response of the bound species is associated with the 
particular peptide rather than just the presence of one amino acid. The solubility of these 
complexes was their downfall, with 50% MeOH being necessary. The issue needs to be 
addressed, perhaps with analogues bearing peripheral sulfonate groups to allow more 
extensive studies. 
The complexes, [Eu.L
v1-2
] are not the only examples of dynamically racemic complexes 
exhibiting chiral properties upon binding to biologically important proteins. Other 
europium and terbium complexes have also been explored, examining their use in 
binding lactate and malate.
61
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Figure 1.27 - Two complexes, [Ln.L
1
]
+
 (Ln = Eu, Tb) (left) and [Eu.L
w
]
 
(right,) which were found to bind 
bioactive anions to give a chiroptical response
61 
For each of these complexes, binding of lactate was associated with an induced CPL 
signal. It was found in the ΔJ = 2 manifold, that [Eu.L1]+ had a gem value (+0.04) almost 
an order of magnitude greater than that of [Eu.L
w
] (+0.006). It is thought the difference 
in gem values stem from the different ways that lactate binds. For [Eu.L
1
]
+
, dissociation 
of one azaxanthone nitrogen is followed by formation of a five-membered chelate 
involving the hydroxyl and acid groups of the lactate. However, when [Eu.L
w] binds to 
lactate, it does so in a bidentate fashion through the carboxylate group alone.
86
 The 
helicity of the complex was determined by the nature of the enantiomer bound, with the 
gem values being equal and opposite for addition of R- and S- enantiomers. Furthermore, 
the binding constants for the two enantiomers to [Eu.L
w
] were identical (logK = 2.41 
(±0.05)). The strong binding behaviour coupled with the strong CPL signal means these 
complexes offer a good basis for further development, allowing CPL to be used to track 
changes in helicity of such lanthanide ternary complexes. 
Although CPL has been known to exist for nearly 40 years, taking information directly 
from experimental spectra is still difficult. For example, it is not usually possible to 
assign absolute configuration by inspection of the CPL spectrum. Work has been carried 
out into related structures to see if empirical rules can be determined, and it is thought 
that a stable range of helical complexes, including [Ln.L
x1
] and [Ln.L
x2
] could be used 
to achieve this.
87
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Figure 1.28 - Two ligands L
x1
 (left) and L
x2
 (centre) that could potentially be used to work out empirical 
rules for CPL and (right) crystal structure of Λ-[Eu.((R,R)-Lx1)3]
3+87
 
One such example of this approach involved the series of tetrakis((+)-3-hfbc) 
lanthanide(III) complexes which have a high symmetry, as previously mentioned [Page 
24].
79
 It was found that a positive CPL value in the ΔJ = 1 band was consistent with a Δ 
configuration of the ligand.  
Although this is true for these symmetric complexes, more general rules should be 
considered to help calculate the local configuration from the CPL data. To attempt this, 
studies have looked at the development of a series of cyclen based structures.
88
 One 
study concluded that there are three major factors that determine the CPL data; firstly 
the nature of the ligand, as the axial donor plays a large role in the hypersensitive 
transitions as well as magnetic dipole allowed transitions where it contributes to J-
mixing; the second is the helical twist of the complex which can be written as 
sin2θcos2θ for SAP (square anti-prismatic) complexes; thirdly, the angle between the 
electric and magnetic dipole moment transition vectors which determines the rotatory 
strength.
89
 
Work has also been carried out on several series of triazacyclonane compounds.
42
 It is 
easier to study structurally similar compounds and in one study, they all bore two 
aralkynyl pyridyl moieties allowing space for chiral carboxylates, which induced a CPL 
signal upon binding.
90
 It was found in all cases, that an R- chiral carboxylate gave rise 
to emission typical of a Δ complex. 
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Figure 1.29 - The structures of four triazacyclonane with arylkynyl pyridyl moieties used in a structural 
study
90 
Advancement in this field continues, and the configuration can be calculated for some 
complexes, particularly if it is structurally similar to complexes already studied. For a 
completely new complex however, this method may not be reliable. 
1.4 Alpha-1-acid Glycoprotein as a Chiral Protein 
A vast number of proteins exist within the blood stream for a variety of reasons, from 
transport such as haemoglobin, to immune response such as the immunoglobulins. 
Many also interact with drugs and can have an important effect on their bioavailability. 
Serum albumin, exists in high concentration, with levels of approximately 30-50 g/L 
(0.4-0.7 mM) as quoted by Weaving.
91
 However, this protein does not seem to have 
such an effect on changes in drug bioavailability as other proteins such as alpha-1-
glypcoprotein (α1-AGP). This is due to the fact that levels of HSA remain relatively 
constant in all conditions, whereas α1-AGP concentration can change dramatically in an 
inflammatory response. 
α1-AGP is a 183 chain amino acid, a 41-43 kDa glycoprotein, with a pI of 2.8-3.8.
92
 Its 
normal concentration is in the range 0.6-1.2 mg/mL (15-29 μM), which means it only 
contributes to 1-3% of the total plasma protein. It is also a positive acute phrase protein, 
meaning that its concentration increases several fold in response to inflammation or 
stress.
93
 The concentration of this protein is known to be affected by a wide range of 
situations. Men have slightly higher levels than women, and its levels have been 
reported to increase in females with age, but not males.
94
 This behaviour is important as 
it has a wide range of applications, some of which are known while others are still being 
investigated. For example, it is thought to play a key role in immune function and to 
have anti-neutrophil and anti-complement activity.
95
 It has also been found to bind to a 
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wide range of neutral and alkaloid drugs as well as steroids, having a serious 
consequence on their bioavailability.
96,97
 
α1-AGP has two main genetic polymorphs, A and F1*S.
98
 The genetic differences in the 
polymorphs mean that they do not have identical drug binding abilities. The level of 
glycosylation can also vary as quoted by Hochepied, and many studies thus far, 
concentrate on a mixture of these variants. 
92
 There are five N-linked glycosylation sites, 
and the level of glycosylation changes with varying conditions.
99,100
 It has been shown, 
that varying levels of glycosylation can have an effect on the biological properties of the 
protein. Furthermore, variation can occur within one person under a range of conditions. 
For example, if they get pregnant, or if they suffer from hepatitis.
101,102
 
 
 Figure 1.30 - The protein structure the F1*S (left) and A (right) variant of α1-AGP
103 
HSA is well known to bind a wide range of acidic drugs, whereas α1-AGP binds 
predominantly basic drugs, as well as some neutral drugs, both of endogenous and 
exogenous origin. Due to HSA’s binding preference and predominance, it has generally 
been assumed that α1-AGP does not affect the free concentration of acidic drugs. 
However, studies show that the association constants to α1-AGP are sufficiently high, 
particularly when concentrations are elevated, that variations in protein concentration 
may affect the bioavailability of some acidic drugs.
104
  
Up to seven sites on α1-AGP at 4 °C have been described for estradiol, an endogenous 
steroid, whereas only a single site has been found to bind acidic drugs.
105,106
 It is also 
believed that acidic drugs, which have an affinity for this site, also bind to site I on 
HSA, or the warfarin site. Drugs that contain a carboxylic acid group and bind to drug 
site II on HSA (diazepam site) generally have a poor affinity for α1-AGP.
107
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The difference in drug binding between genetic variants, F1*S and A has been partially 
investigated.
108,109
 In some cases, there is no selectivity between the two polymorphs, 
but in others there is total preference for one over the other.
110
 However, as stated 
before, most of the research in binding to α1-AGP has been undertaken using a mixture 
of polymorphs and there is not much reliable data detailing the differences between the 
two and why they bind so differently. 
1.5 Pharmaceuticals; Methadone, Imatinib, Disopyramide 
The pharmacological drugs being investigated within this thesis, in the context of 
competitive α1-AGP binding, are all basic drugs that are used in a wide range of 
treatments. Methadone, disopyramide and imatinib all work on the body in various 
ways, and each has been shown to bind strongly to the protein α1-AGP, with an affinity 
in the range of 10
5
 to 10
6
 M
–1
. These drugs were also specifically chosen due to their 
λmax being sufficiently low to avoid competitive absorption with the chromophore, with 
values of 270 nm, 254 nm, and 292 nm respectively.
111
 
Two of the three (methadone and disopyramide) are chiral compounds, which is 
important to note because of the potential for the two enantiomers to have different 
pharmacological effects. It is also important to note that for these drugs, increased levels 
of α1-AGP could limit the bioavailability of the drugs, which may have important 
ramifications on the physiological response. 
 
Figure 1.31 - Three drugs being investigated in this report, S-methadone (left), imatinib (middle) and S-
disopyramide (right) 
Methadone is used in pain medication, but is also used in maintenance therapy to treat 
morphine and heroin addiction. In the treatment of addiction, too low a dosage of 
methadone causes ‘cold turkey’ like symptoms which often leads to a relapse. However, 
too high a dose can lead to feelings of euphoria and overdose, so the concentration 
given to the patient is important. The binding of methadone to α1-AGP was interpreted 
in terms of two types of binding sites with the stronger one giving a Ka value of 4x10
5
 
M
-1
.
112
 It was also found that methadone could be displaced from these binding sites by 
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other drugs, such as chlorpromazine and imipramine. It has been hypothesised that the 
reason for the low percentage of complete abstinence from opioids from this particular 
treatment could be due to varying levels of α1-AGP.
113
 
The two enantiomers of methadone are known to elicit different clinical responses. 
Indeed, some maintenance treatment centres only prescribe (R)-methadone over the 
racemic due to fears of QT interval prolongation (Figure 1.32), which is linked to (S)-
methadone, as well as being able to give a lower dose.
114
 However, the single 
enantiomer is more expensive, and it is not currently widespread practice to prescribe 
solely (R)-methadone. 
  
Figure 1.32 - An ECG diagram highlighting the PR interval, the QRS complex and the QT interval 
Thus far, no experiments have been done specifically on the binding of the two 
enantiomers of methadone with α1-AGP. However, due to the different properties, their 
efficacy and differences in how they act in the body have been studied. (R)-methadone 
is a μ-opioid receptor agonist (MOR), which mimics endogenous compounds such as 
endorphins and enkephalins. Hence, at high enough concentrations, a euphoric high is 
achieved. (S)-Methadone is a poor MOR agonist, but can block hERG (human Ether-à-
go-go-Related Gene) channels which has been postulated to be the reason behind the 
problems with arrhythmia and sudden death that have been found in some patients 
taking methadone.
115,116
 
Racemic disopyramide is used in the treatment of ventricular tachycardia. This illness is 
defined as a regular and fast heart rate, which can potentially lead to cardiac arrest if 
untreated.
117,118
 It occurs due to improper electrical signals in the ventricles of the heart. 
Symptoms can go unnoticed if it occurs for only a small amount of time, or can cause 
dizziness and chest pain. It can be diagnosed through an electrocardiogram (ECG) 
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which shows a heartbeat faster than 120 beats per minute and at least three wide QRS 
complexes in a row.
119
 
Disopyramide is a ‘class 1a’ antiarrhythmic agent meaning it works as a sodium channel 
blocker. It decreases the uptake of sodium during the initial stages of the heart beat that 
prolongs the PR interval, slowing down propagation of the action potential from the 
atria to the ventricles. It has been found that levels of α1-AGP increase two-fold when 
acute myocardial infarction (AMI) occurs, which has implications for the efficacy of 
disopyramide.
120
 
In one study, the two enantiomers of disopyramide were separated by chiral HPLC and 
the individual binding constants to α1-AGP were calculated. The binding constants were 
found to be logK = 3.20 and 3.47 (303 K).
121
 Clearly, there is a small difference in 
binding between the two enantiomers but what the research did not report, is the 
configuration assignment of the enantiomers. It was shown that the enantiomer which 
eluted second had a higher binding constant compared to the first, for α1-AGP. 
However, both of these values are two orders of magnitude smaller than with the A 
variant of α1-AGP, suggesting that the genetic variation may play a hugely different 
role.  
Imatinib, sold commercially as Gleevec, is used in the treatment of multiple cancers, 
including chronic myelogenous leukemia (CML).
122
 CML is associated with the 
Philadelphia chromosome, which leads to the formation of BRC-ABL gene fusion.
123,124
 
It translates into an enzyme, BRC-Abl, a tyrosine kinase, which is stuck in the ‘on’ 
position. Therefore, the addition of phosphate groups to tyrosine becomes unregulated, 
activating a cascade of proteins leading to rapid cell division. Imatinib targets tyrosine 
kinase to slow the growth of this cancer. Up until the 1980s, this form of cancer was 
thought to be untreatable, but now there is complete or nearly complete cytogenetic 
remission in up to 80% of patients.
122
 However, studies have shown that imatinib binds 
to α1-AGP, but the level of available drug could increase in the presence of other drugs 
which bind to α1-AGP, such as clindamycin.
125
 
The three drugs discussed above have each been shown to bind with varying degrees of 
affinity to α1-AGP. Although direct comparisons cannot be made between the drugs, the 
literature binding constants do give a good idea on their relative free energies of 
binding. The reason they cannot be compared directly is due to the fact that different 
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research groups have explored the area using a variety of experimental conditions, with 
different pH, temperature and solvent conditions. These can each lead to variations in 
the binding affinity to α1-AGP. Furthermore, some studies examined particular variants 
of the protein, e.g. comparing A and F1*S, while others examine a mixture of these 
polymorphs. 
Table 1.1 - Literature binding constants of the pharmaceuticals to α1-AGP. (298 K, pH 7.4 in buffer 
unless stated otherwise, where not stated in the literature, these conditions are assumed.) (–) Values not 
documented in the literature 
 
Methadone and disopyramide have been shown to bind to the A variant of α1-AGP with 
logK values of 6.00 (±0.05) and 6.40 (±0.02) respectively.
127
 These numbers suggest 
disopyramide binds more strongly than methadone, but it is possible that binding to the 
second variant of α1-AGP could be very different. The value for methadone is similar to 
the value reported for unfractionated α1-AGP, suggesting that the variants give similar 
values of binding.  
There are a number of different binding studies reported on imatinib. Again, they were 
undertaken with different conditions and the method used to calculate the binding 
constant is different in each case. They do, however, all give values of the same order 
i.e. approximately 10
6
. The binding of imatinib to F1*S was also investigated, and a 
binding constant of 1.7 (±0.2) x 10
6
 was found at 37 °C. The A variant on the other 
hand was found not only to bind more weakly to α1-AGP but also was less specific.
126
 
1.6 Glyphosate as a Herbicide 
Glyphosate (N-(phosphonomethyl)glycine) is a broad-spectrum, post-emergence, 
systemic herbicide which is popular due to the increasing demands of intensive farming. 
It was first discovered to have herbicidal properties by Monsanto in the early 1970s, 
was patented in 1974 as the active ingredient in Roundup and by 1980 was already one 
                                                 
a
 37˚C 
b
 pH 4.0 
Drug 
logK - 
unfractionated  
α1-AGP (M
–1
) 
logK - A 
variant 
logK - F1*S 
variant 
Absorption 
maximum 
(nm) 
Imatinib 6.38 (±0.2)
126
 – 6.23 (±0.05)126 292 
Methadone 5.60 (±0.08)
112a
 6.00 (±0.05)
127
 – 270 
Disopyramide 3.20, 3.47
121b
 6.40 (±0.02)
127
 – 254 
 36 
 
of the fastest selling herbicides.
128
 Since the patent expired in 2000, it has become the 
most widely used herbicide by volume, being manufactured and sold by various 
companies around the globe.
129
 The popularity of glyphosate was firmly established as 
Monsanto developed ‘Roundup Ready’ crops, such as cotton, corn and soybean which 
were resistant to the herbicide and are now widely grown.
130
 
 
Figure 1.33 - Structure of glyphosate 
However, over the past few years, increasing concern over the safety of the chemical led 
to thorough investigations into the possibility of its potential carcinogenic properties.
131
 
Thus far the IARC (International Agency for Research on Cancer) in 2015 is the only 
international organisation to label glyphosate as potentially carcinogenic to humans. In 
the same year the EFSA (European Food Safety Authority) found that it was ‘unlikely 
to pose any carcinogenic hazard to humans’.132 These opposing views led the EU to ask 
for an independent study to be completed by the European Chemicals Agency (ECHA). 
In June 2017, they declared that there was not sufficient scientific evidence to classify 
glyphosate as carcinogenic.
133
 Nevertheless, wide-spread concerns with the herbicide 
has led to a shorter renewal period of five years rather than the standard 15 by the 
European Commission in December 2017. The use of glyphosate was banned in the 
state of California in July 2017, who proclaimed that the herbicide is carcinogenic.
134,135
 
The following year, a court case in the same state found that glyphosate was the cause 
of a former groundskeepers cancer.
136
 
It was initially thought to be one of the safest herbicides in existence, as it works via 
disruption of the Shikimate biosynthetic pathway that does not exist in mammals.
137,138
 
Specifically, glyphosate is absorbed through the foliage and minimally through the 
roots, where it then migrates to the tips of the plant. Here, it inhibits the enzyme EPSP 
synthase, which is necessary for growth. EPSP synthase catalyses the reaction between 
shikimate-3-phosphate and phosphoenolpyruvate, to form 5-enolpyruvylshikimate-3-
phosphate (EPSP) (Figure 1.34). The Shikimate pathway synthesises aromatic amino 
acids: phenylalanine, tryptophan and tyrosine.
139
 Without these essential amino acids, 
the plant cannot survive. 
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Figure 1.34 - The reaction between shikimate-3-phosphate and phosphoenolpyruvate to form EPSP 
Owing to its controversial nature, limits on the presence of glyphosate in food and water 
have been set by a number of agencies around the world. It is generally considered that 
current levels in drinking water are well below dangerous concentrations and as such, 
neither the WHO, the EU, nor the UK regulatory authorities have set an MRL (minimal 
residual level). However, the US EPA has set a precautionary limit of 0.7 mg/L  (4.1 
μM) although levels this high have never been detected in drinking water.140 Glyphosate 
has also been found to decompose relatively rapidly in chlorinated water, into 
phosphate, carbon dioxide, methanediol and nitrate, and so it is unlikely large 
concentrations will be found in tap water.
141
  
It is generally accepted that the main source of glyphosate for the general populous is 
through diet, and therefore, limits have been set by a number of organisations across the 
world to ensure that food contains low levels of glyphosate.
142–145
 Grain, fruit and 
vegetables have all been given MRLs to ensure the level of glyphosate consumed is 
well below ‘dangerous levels’. For the EU, the MRL for oat is 20 mg/kg (0.1 mM) and 
for wheat grains is 10 mg/kg (59 μM). 
There is a need to monitor glyphosate concentrations in food produce to ensure levels 
remain below the MRLs set by regulatory bodies. As most of these MRLs are in the 
millimolar or even micromolar range, there is a need to be able to detect glyphosate 
accurately at low concentrations. There are currently a wide range of techniques which 
that can be used, but most require either a professional skill set, or expensive 
equipment, which limit widespread usage. An ideal detection method should be simple 
and portable.  
1.6.1 Current Methods of Detection 
The initial analysis for glyphosate in the late 1970s involved HPLC.
146
 However, since 
glyphosate has neither a chromophore nor fluorophore, it can be difficult to detect as it 
elutes from the column. A way round this is a derivatisation step e.g., with Fmoc-Cl 
which allows glyphosate to be more sensitively detected.
147
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Figure 1.35 - The reaction of glyphosate with Fmoc-Cl to allow glyphosate to be detected by 
fluorescence, and the formation of a GMC 
The need for this specialised step, as well as the need for expensive equipment, means 
this procedure is neither quick nor cheap. It does, however, give a good limit of 
detection (LOD) of 2.5 μg/mL (15 μM). Techniques have been derived for a range of 
samples, including palm oil, breast milk, and soil samples.
148–150
 Some of these 
techniques have a limit for detection of less than 1 ng/mL (6.0 nM) and are very 
specific. Different columns and changes in techniques may be required depending on 
the sample, whether solid, liquid or contaminated with other analytes that may interfere 
with accurately measuring the concentrations of glyphosate. 
Mass spectrometry can also be used to detect glyphosate
151
 and is often used in tandem 
with other techniques. One such example examined the effect that salt matrices have on 
RP-LC-HESI-MS/MS (reverse phase liquid chromatography heated electrospray 
ionisation tandem mass spectrometry).
152
 Such an approach is necessary for 
environmental samples such as seawater, in which a number of different metal ions are 
present that can be problematic due to the formation of glyphosate metal complexes 
(GMC). Fmoc-Cl was used for the derivatisation of the target, before the use of mass 
spectrometry.  
 
Figure 1.36 - The structures of glufosinate (left), AMPA (middle) and 2-AEP (right) 
Glyphosate was tested along with glufosinate, its metabolite AMPA 
(aminomethylphosphonic acid), and 2-AEP (2-aminoethylphosphate). Glyphosate was 
the only compound to form the metal complex that led to a change in the retention time 
by approximately seven minutes. However, the presence of some cations, for example, 
Cu
2+
, Co
2+
, Zn
2+
 and Mn
2+
 prevented glyphosate detection whereas Ca
2+
, Mg
2+
, and Sr
2+
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contributed to altering the retention time. Hence, the different retention times for 
glyphosate in numerous samples can be ascribed to the varying concentration of these 
metal ions and hence the formation of GMC. Such behaviour needs to be taken into 
account when developing techniques with water samples using mass spectrometry. 
However, both of these techniques can be expensive and alternatives have been sought. 
In the last decade with the growing level of interest in glyphosate analysis, the number 
of techniques used to detect it has also increased. These techniques revolve around a 
few basic ideas. Better HPLC and MS techniques are constantly being developed, and 
colormetric, luminescence procedures or electrochemiluminescence (ECL) methods are 
also being studied.  
1.6.2 Electrochemical Analysis Methods for Detecting Glyphosate 
Electrochemical luminescence (ECL) may occur during an electrochemical reaction in 
solution. It is found when an electrochemically generated species undergoes electron-
transfer reactions to an excited state that emits light. It was first discovered in the 
1960s,
153
 but the use of [Ru(bpy)3]
2+  
as a luminophore didn’t occur until the 1970s, and 
is now the most commonly used.
154
 In this example, glyphosate acts as the co-reactant, 
which produces strongly reducing intermediates, with which the luminophore reacts, to 
generate the excited states.
155
 It is the secondary alkyl amine which gives it its co-
reactant properties.  
 
Figure 1.37 - The electronic process in which [Ru(bpy)3]
2+
 is used to detect glyphosate 
The above equations show that glyphosate (Gly) can be detected via this technique. It 
has a detection limit of 1.7 ng/mL (0.01 μM) with a linear range of five orders of 
magnitude. It utilises Ru(bpy)3
2+
 deposited on gold electrodes modified with self-
assembled monolayers (SAM) of alkanethiol derivatives. The use of SAM allows for 
careful design of the electrode surface, and hence its properties, through the choice of 
terminal functional groups. A bare gold surface, an ionisable terminal group (-COOH) 
and as a control, a non-ionisable terminal methyl group was tested, with the carboxylic 
acid group giving the lowest limit of quantification (LOQ) of 6.4 μM.  
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Figure 1.38 - ECL intensity vs. time for a potential jump between 0 vs 1.25 V to a bare Au electrode (left), 
to an Au/SAM-CH3 electrode (right) and to an Au/SAM-COOH electrode (bottom). Electrolyte: 0.1 mM 
Ru(bpy)3
2+
 in a pH 8 phosphate buffer. (a) with no glyphosate, (b) 0.25 μM glyphosate, (c) 100 μM 
glyphosate, and (d) calibration curve for glyphosate
155 
Such a level is sufficiently low to detect glyphosate in water at the limit set by the EPA. 
However, other examples of herbicides with secondary alkyl-amines were not tested and 
the work was done only in pure water, under argon. The technique allows for detection 
of glyphosate without derivatisation of the target and may result in a cheaper alternative 
to either HPLC or MS. However, the lack of testing in real samples, and the sensitivity 
of these electrodes to outside influences would limit its use in the field. 
Another group has used ECL in a similar [Ru(bpy)3]
2+
-based system using screen-
printed electrodes with multi-walled carbon nanotubes (MWCNT) as well as testing the 
use of a gold surface.
156
 It was found that MWCNT decorated with ZnO gave the best 
results, with a limit of detection of 1 μM for both glyphosate and its metabolite AMPA.  
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Figure 1.39- (Left) ECL signal of 1 μM/L glyphosate (solid line) as a function of electrical excitation 
pulse (pulse width 0.5 s; dotted line) with (right four signals) and without nano-ZnO (left four signals). 
(Right) Chemiluminescence spectrum of [Ru(bpy)3]
2+
 (100 μM/L) with glyphosate (10 μM/L) as 
coreactant, with (0.1 mg) and without nano-ZnO. The chemiluminescence spectrum was recorded as 
follows: wavelength scan 450–700 nm; scan speed 300 nm/min; electrical excitation pulse width 0.1 s; 
frequency 0.5 s−1; pulse height 1– 3.54 V156 
Fast amperometry has also been investigated as a method of detecting glyphosate.
156
 
However, neither glyphosate nor AMPA are electroactive, and so must be complexed 
with copper, which yields similar detection limits as those found with ECL. Again, the 
lack of testing of multiple analytes, and the need to prepare an electrode for the fast 
amperometry method increases cost and decreases speed; the MWCNT electrode could 
not be cleaned and therefore a new electrode had to be used every time, which can result 
in slight variations in current. The LOD is also higher than the previous study and hence 
is not as useful.  
An electrochemical sensor has been developed based on molecularly imprinted 
polypyrrole (MIPPy).
157
 These sensors were fabricated on gold electrodes with pyrrole 
and glyphosate as a template. Cyclic voltammetry (CV) was used to monitor the 
irreversible oxidation of pyrrole at 1.0 V.  Glyphosate was then removed from the 
electrode through an over-oxidation process, involving scanning between –1.3 V and 
+1.2 V for 20 cycles in 0.1 M NaOH solution.  
To investigate the efficiency of these electrodes, varying levels of glyphosate were 
incubated under optimised conditions. A linear relationship was discovered between 5 
and 800 ng/mL (30 nM - 4.7 μM), with a LOD of 0.27 ng/mL (1.6 nM). The selectivity 
was tested with AMPA, chlorpyrifos and aldicarbs which all show little change in 
current with a MIPPy electrode. The recovery of glyphosate in tap water and cucumber 
was found to be 73-99% between 10-50 ng/mL (60-300 nM) and gave approximately 
the same values as those derived from LC-MS/MS. This technique therefore showed 
good selectivity and sensitivity over a large linear range.  
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1.6.3 Colorimetry, Fluorescence and Absorbance Methods of Glyphosate Detection 
Chang et al. investigated the use of CuO doped MWCNT to detect the concentration of 
glyphosate.
158
 The MWCNT/CuO nanomaterial was seen to catalyse H2O2 to H2O and 
the oxidation of Amplex Red to resorforin. However, this effect was diminished in the 
presence of glyphosate, which disrupts the catalytic activity of the nanotube. This 
results in decreased fluorescence intensity at 590 nm compared to that observed in the 
absence of glyphosate. This wavelength could be monitored to give a limit of detection 
0.67 ng/mL (4 nM) and a linear range of 0.002-0.01 ng/mL (0.01-0.06 nM). 
 
Figure 1.40 - A simplified diagram signalling how glyphosate inhibits the catalytic activity (left) and the 
change in colour and fluorescence intensity (right)
158
 
A small number of other potentially interfering pesticides were also tested. No large 
change in emission intensity occurred, suggesting high selectivity. The method was also 
successfully tested with a number of ‘real-life’ samples, including lake water and tap 
water. However, this is a ‘turn-off sensor’, and ideally, a ‘turn-on’ sensor is preferred, 
as with the former, high concentrations of analyte can lead to poor signal-to-noise ratios 
and inaccurate readings. 
This system is not the only example of glyphosate inhibiting the catalytic ability of a 
compound. It was found that Cu
2+
 could catalyse the reaction of 3,3,5,5 – 
tetramethylbenzidine (TMB) to oxTMB with hydrogen peroxide, which results in a 
colour change.
159
 Glyphosate inhibits this process by binding to the copper and hence 
the absorbance change could be used to monitor the reaction. However, this approach 
was far less successful, as the limit of detection was only 0.17 g/mL (1 M). 
An example of a sensor array has been described that is designed to detect a range of 
organophosphates through enhancement of fluorescence intensity. The array was 
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prepared through the macromolecular self-assembly of two sensing elements, (G5.F) 
and (G5.MUPm),
160
 where G5 is a generation 5 PAMAM dendrimer, F is fluorescein 
and MUP is 4-methylumbelliferyl phosphate. The latter two compounds were chosen as 
they are highly fluorescent dianions in aqueous solutions, whose emission is quenched 
upon binding to the dendrimer.  
 
Figure 1.41 - The 2D PCA plot with 500μM of anaylte (right) the LDA score plot for the quantitative 
analysis of glyphosate (left) and the response of the sensor array to phosphoate, glyphosate and MPA 
from 10 μM to 2 mM (bottom)160 
Following addition of a range of organophosphates, the fluorescence of F and MUP is 
restored as displacement occurs, and usefully each organophosphate displays different 
displacement behaviour. The absorbance, fluorescence intensity, and anisotropy at 
different wavelengths were studied in a multimodal microwell plate reader. The spectral 
data was evaluated using the statistical methods, principle component analysis (PCA) 
and linear discriminant analysis (LDA). The resulting 2-D PCA plot for five different 
phosphates at 0.1 mg/mL (0.8 mM), show clear clustering with definite discriminatory 
capacity. At lower concentrations 0.08 mg/mL (0.5 mM) discrimination is less clear, 
particularly between methylphosphonate (MPA) and glyphosate.   
The LDA score plot, as well as the PCA data, were drawn up for glyphosate, with 
concentrations ranging from 1.7 μg/mL (10 μM) to 0.3 mg/mL (2 mM), and showed 
good qualitative analysis. The limit of detection of this method was 0.5 μg/mL (3.0 μM) 
which is sufficient for the US EPA MRL in drinking water. However, it is good enough 
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to be able to recognise different organophosphates at neutral pH and the starting 
materials are both cheap and commercially available. 
Indicator displacement methods which use intramolecular interactions have also been 
explored. Such methods were hoped to overcome the low sensitivity of other dye 
displacement assays due to low dye-receptor affinity.
161
 Typically the sensor exhibits a 
change in fluorescence when the chromophore is displaced by anions in the receptor. A 
number of compounds were synthesised, in particular, compound L
y1
 which features 
thiourea and amide groups as anion recognition moieties and a naphthyl carboxylate 
moiety as a chromophore. It was found upon addition of anions to L
y1
 that fluorescence 
quenching was seen, but with compound L
y2
 an increase in emission was observed. 
Compound L
y2
 is similar to L
y1
, and incorporates two naphthalimide moieties to 
generate fluorescence. L
y1
 is switch off as in the ground state, the naphthyl carboxylate 
is fixed in position from hydrogen bonding. However, displacement upon addition of a 
guest increases the degrees of freedom of the carboxylate and therefore deactivation 
through rotation and vibration is possible. The paper rationalises the increase in 
emission upon addition of a guest with L
y2
 due to the increased rigidity of the host, 
which limits rotation and vibration and therefore fewer paths for non-radiative decay. 
 
Figure 1.42 - Structure of L
y1
(left) and L
y2
 (right)
161 
These compounds were embedded into a hydrophilic polyurethane matrix which could 
be cast onto plates with a 200 nL volume containing different anions, including 
glyphosate. Using LDA, discrimination between different anions could be made. The 
quantification of glyphosate was also investigated, and a LOD of 0.2 mg/L (1.2 μM) 
was determined, again well below the US EPA limit for drinking water.  
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There are a number of other examples that use colorimetric methods of analysis to 
detect glyphosate. One example involved 2-mercapto-5-nitrobenzimidazole capped 
silver nanoparticles (MNBZ-Ag NPs) using Mg
2+
 as a trigger and tuner.
162
 Various 
metal ions were tested with the nanoparticles and glyphosate as tuners, and it was found 
Mg
2+
 was superior.  
 
Figure 1.43 - (Left)UV-visible absorption spectra of MNBZ-Ag NPs in the presence of glyphosate (10 
μM) with various metal ions (Ca2+,Cd2+,Co2+,Cu2+,Hg2+,Ni2+ and Mg2+,50 μM) as tuners. (Inset) 
Photographic images illustrating the corresponding colorimetric response. (Right) Absorption spectra of 
MNBZ-Ag NPs with Mg
2+
 ion in the presence of different organophosphorus pesticides (acephate, 
chlorpyriphos, dichlorvos, monocrotophos, profenophos, quinalphos, triazophos, 1.0 mM) and glyphosate 
(10 mM). (Inset) Photographic image illustrating the corresponding colorimetric response. (Bottom) The 
SPR band spectral changes of MNBZ-Ag NPs with and without glyphosate (10 mM) and Mg
2+
 ion, 
glyphosate (without MNBZ-Ag NPs) with Mg
2+
 ion (50 μM)162 
Upon addition of glyphosate, complex formation of MNBZ-Ag NPs-Mg
2+
 occurred 
leading to a colour change from yellow to orange-red and a shift in the surface plasmon 
resonance (SPR) band from 399 to 517 nm was observed (Figure 1.43). The LOD was 
2.8 ng/mL (17 nM) and it showed good selectivity over other pesticides present at 1 
mM. Complex formation requires both the presence of glyphosate and the magnesium 
ion. Without Mg
2+
, the limit of detection is 5.4 mg/mL (32 mM), i.e. not sufficiently 
sensitive to detect glyphosate at its MRLs dictated by the US EPA and the EU. 
The use of a nanofiber based colorimetric sensor strip has also been developed. 
Derivatisation of glyphosate is required and must be reacted with carbon disulphide, 
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resulting in the formation of dithiocarboxy(phosphonomethyl) carbamic acid (Figure 
1.44).
163
 
 
Figure 1.44 - (Top) Derivatisation of glyphosate with carbon disulphide. (Bottom left) The colour change 
upon increasing percentage of carbon disulphide (0-7%) with 1000 μg/mL of glyphosate in 30 μL. 
(Bottom right) The calibration curve for glyphosate (0.1-500 μg/m) in a 30 μL sample size 
The dithiocarbamic acid interacts with copper on the poly(vinyl alcohol) (PVA) 
nanofibre sensor strip to give a colour change from blue to yellow. Although this system 
gives a fast response (1-3 s), has a low LOD 0.1 mg/L (0.6 μM) and was stable for up to 
20 days at 23 ˚C, studies found the response was pH dependent.  The colour change was 
only observed at pH 11 and 12 which the paper claimed was due to the deprotonation of 
the amine group on glyphosate. The deprotonation allowed the formation of the 
dithiocarbamic acid intermediate which subsequently allowed the formation of the metal 
complex, hence pH 12 was chosen as the optimum pH. Further experiments confirmed 
that this technique was also susceptible to interference from other analytes found in 
environmental water samples, particularly at low glyphosate concentration. It led to 
recovery of 128% at lower concentrations of glyphosate which meant pre-treatment of 
water samples were required before testing. The requirement for pre-treatment of the 
water sample means it is unlikely to be a cost-effective method. Furthermore, both 
carbon disulphide and the resulting glyphosate derivative are potentially toxic. Hence, 
the disposal of the assay kit could also be costly.  
Other reported examples have explored the use of lanthanide doped nano-particles 
(NPs) and a TR-FRET-IDA (time resolved Förster resonance energy transfer indicator 
displacement assay) to detect glyphosate and similar herbicides.
164
 The TR-FRET of the 
LiYF4:Ce/Tb NPs was used to ensure any organic short-lived luminescence would not 
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affect the indicator. This is another example of a ‘switch-off’ sensor, where glyphosate 
displaced indicators from the nano-particle, causing emission to decrease.  
 
Figure 1.45 -  (Top) Normalised at 622 nm time resolved titrations of NPs and fluorescein sodium (FI)  
with (left) glyphosate and (right) AMPA in Tris buffer (pH 7.0). (Bottom) Displacement curve of NPs and 
FI with (left) glyphosate and (right) AMPA
164
 
Studies revealed that this technique could distinguish between 11 different anions, 
although this experiment was only carried out in aqueous buffer and not tested on any 
environmental samples. For glyphosate, a LOD of 0.13 μg/mL (0.78 μM) was found 
which is well below the EPA drinking water limit.  
Another example of FRET based detection utilised thioglycolic acid capped CdTe 
quantum dots and cysteamine stabilised gold NPs. Together they form a FRET donor-
acceptor system.
165
 The NPs quench the quantum dot emission, but in the presence of 
glyphosate, aggregation of the NPs leads to recovery of the emission.  
 
Figure 1.46 - Emission spectra of CdTe QDs-AuNPs with increasing concentrations of glyphosate in 
apple matrix
151 
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Again, the system showed good sensitivity with a LOD of 9.8 ng/kg (0.06 nM) and a 
linear range of 0.02-2.0 μg/kg, which is well below the limit set by China where this 
study was conducted.
151
 The method was successfully able to detect low levels of 
glyphosate in apples. However, no real competition studies were carried out allowing a 
comparison of glyphosate against other herbicides or biologically relevant compounds.  
A more selective method using ‘switch-on’ luminescence uses carbon dots (CD) tagged 
to glyphosate antibodies and has been tested with other herbicides.
166
 In solution, 
Fe3O4-glyposate was added to the luminescent CD-antibody where glyphosate bound to 
the antibody. Applying a magnet to the bottom of the cell pulled the fluorescence CDs 
down due to the magnetic iron, showing little fluorescence. However, in the presence of 
free glyphosate, the antibodies bind to this competitively with the iron compound. 
Therefore, upon application of the magnet, the fluorescent CDs are not attracted to the 
bottom of the cell and therefore are observed in the general solution. Selectivity came 
from the presence of the glyphosate specific antibodies.  
 
Figure 1.47 - The detection scheme of CD with glyphosate antibodies, which shows the increase in 
emission intensity upon glyphosate
166 
A detection limit of 0.8 ng/mL (4.7 nM) was found for glyphosate, with a linear 
response region for glyphosate concentrations between 0.01 and 80 μg/mL (59 nM – 0.5 
mM). The system was tested in a number of different sample types including soil, tea 
and in cells where recovery ranged from 87-104%.  It is a simple, selective and sensitive 
technique that operates over a range of concentrations.  
Tripier et al. synthesised a glyphosate, and ATP (adenosine triphosphate) sensor, which 
could be used via NMR, absorbance, fluorescence, and potentiometric methods.
167
 They 
studied two similar compounds, L
z1
 and L
z2
 (Figure 1.48). L
z1
 possesses an anthracenyl 
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fluorophore on the 4-position of the pyridine ring which allows the compound to be 
used as a fluorescence probe. 
 
Figure 1.48 - The structure of L
z1
 (left) and L
z2
 (right) as their free amines
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The protonation behaviour and anion complexation studies were carried out with L
z1
 
and L
z2
 and showed similar behaviour, in terms of protonation and the binding affinity 
for glyphosate and ATP. Both ligands at pH 7 predominately have a charge of +4, but 
upon addition of ATP or glyphosate becomes +6, and either analyte effects the emission 
in L
z1
.The binding constants for glyphosate and ATP for L
z1
 were measured using 
absorbance, fluorescence and potentiometric data with logK values of 4.7, 4.8 and 4.2 
determined respectively. Although this is a promising result, the logK values for ATP 
were 5.2, 4.6 and 4.9 showing similar binding constants, raising concerns over any 
selectivity for phosphorus oxyanions. No other biologically relevant anions were tested 
and since the binding is electrostatic, it is likely there would be a number of other 
anions which would interfere with results in biologically relevant samples, for both 
glyphosate and ATP. 
Another technique which has a low LOD is an enzyme-linked immunosorbent assay 
(ELISA) which was initially developed in the 1970s.
168
 One such example developed by 
Hall et. al. has a detection limit of  7.6 μg/mL (45 μM) and a linear range of 10-1000 
μg/mL (59 μM – 5.9 mM).169 This method was tested in the presence of the metabolite 
AMPA, glufosinate and other structurally similar compounds. There appeared to be no 
cross-reactivity with the assay with the exception of glyphosine (Figure 1.49). The 
results from this paper were comparable with the results found from HPLC with 
reduced cost, sample preparation time and solvent use. 
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Figure 1.49 - The structure of glyphosine 
However, a report in 2017 suggested that the commercially available ELISA test may 
not be as accurate as originally claimed. Ultra-high performance liquid chromatography 
in tandem with mass spectral (UHPLC-MS/MS) techniques stated that around the limit 
of detection 0.075 mg/mL (0.4 mM), ELISA’s accuracy and precision are low.170 
However, at 0.30 mg/mL (1.8 mM) and around MRLs, ELISA performed much better. 
In general, the results from the commercial ELISA and UHPLC-MS/MS linearly 
correlated, but the differences ranged from 1% for oats to 40% in barley. It was 
suggested that this ELISA may not be as accurate as believed, but is a complementary 
technique to more accurate and precise techniques. 
Whilst, both mass spectrometry and HPLC techniques are very accurate they have the 
disadvantage that they require derivatisation of glyphosate, e.g. with Fmoc-Cl, as well 
as being expensive and requiring the user to have specialist technical knowledge. 
However, the selectivity and sensitivity of these techniques mean they remain the 
chosen methods to measure the glyphosate concentration accurately. The US EPA for 
example uses ‘Method 547’ in which HPLC, post-column derivatisation and 
fluorescence are used to detect glyphosate in drinking water.
171
 This classic method uses 
o-phthalaldehyde-2-mercaptoethanol as the fluorophore rather than Fmoc-Cl. 
1.7 Project Aims 
The aims of this project are two-fold, and involve predominately europium (III) 
complexes to determine the concentration of target species at low concentrations. 
The first part will look at the competitive binding of pharmaceuticals to α1-AGP, 
displacing the europium complex from the protein binding site. The binding constant of 
the complex to α1-AGP has been used to select certain pharmaceuticals, which are 
known to have similar binding constants to ensure competitive binding. Predominately, 
changes in lanthanide luminescence have been followed monitoring total emission 
intensity. However, the development of CPL has allowed this technique to be used for 
the first time in such analysis.  
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Furthermore, as a number of drugs are chiral, with some being supplied as a single 
enantiomer, research into how each enantiomer may react differently with α1-AGP has 
been examined. A secondary aspect of this study relates to using the information from 
these experiments to make detailed analysis, in keeping with the desire to develop 
personalised medicines.  
The second part of this thesis looks at the selective binding of a number of europium 
complexes to glyphosate. Glyphosate is the most commonly used herbicide and current 
methods of detection, although accurate, can be slow and costly.  
There are potentially many problems with the detection of glyphosate. Firstly, its 
selective detection as similar biological structures, either derived from glycine or 
inorganic phosphate, may also bind to the complexes. The metabolites of glyphosate 
and other herbicides with a similar structure, such as glufosinate, could also be potential 
competitors in detection. Secondly, glyphosate is not commonly found in tap water 
owing to the decomposition of glyphosate in the presence of chlorine, so the detection 
of glyphosate in more relevant media should be studied. The complexes are first to be 
tested in a buffer solution in water. However, more complicated media, such as river 
water and grain extracts are also tested. The challenge is to make a complex that does 
not bind to other common species found in river water, nor to any biological 
macromolecules. It must also work well in a range of environments to maximize its 
scope and utility. 
The binding of glyphosate to the europium complex is to be examined using the 
intensity ratio of europium emission bands, to allow effective use of small, portable 
instruments that are already in existence. 
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2. α1-AGP Binding Drugs 
In previous studies, [Eu.L
1
]
+
 was found to bind to α1-AGP with a logK value of 5.73 
(±0.06).
56
 The binding event could be tracked through the induction of a CPL signal, 
which was coupled to an increase in total europium emission intensity. Upon binding to 
the protein, a nitrogen atom from one azaxanthone chromophore, dissociates from the 
metal, allowing α1-AGP to bind through a carboxylate oxygen atom of the Glu-64 
amino acid (Figure 2.1). It also loses an inner sphere bound water molecule in the 
process. The loss of this water is evident through the change in emission lifetime, and 
hence, the increase in emission intensity. Drugs with similar binding constants to α1-
AGP as [Eu.L
1
]
+
 could induce competitive binding that could be tracked by monitoring 
changes in both total emission and CPL intensity. 
 
Figure 2.1 - A schematic of how [Eu.L
1
]
+
 binds to α1-AGP
56
 
2.1 Synthesis and characterisation of ligands and complexes 
The synthesis (Scheme 2.1) of the ligand, L
1
,  began by reacting cyclen with benzyl 
chloroformate at pH 2.5 to facilitate trans-disubstution.
172
 The product mixture was 
recrystallized from diethyl ether and DCM to remove any mono- or tri-substituted by-
products. The desired trans-dicarbamate, 1, was subsequently reacted with tert-
butylbromoacetate to give the ester 2, before deprotection by means of catalytic 
hydrogenation to afford the amine 3.  
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Scheme 2.1 - Synthesis of 3 
The chromophore was synthesised in three steps following a previously published 
procedure (Scheme 2.2).
173
  The initial step involved the reaction of sodium phenolate 
with 2-chloro-6-methylnicotinic acid. The product of this reaction, 4, was stirred in 
polyphosphoric acid (PPA) for 24 h at 120 ˚C to yield 5 as a crystalline solid. In the 
final step of chromophore synthesis, radical bromination of 2-methyl-1-azaxanthone 
was achieved with N-bromosuccinimide (NBS), using benzoyl peroxide as the initiator. 
The desired mono-bromo derivative, 6, was separated by column chromatography 
before being used in the alkylation of cyclen (Scheme 2.4). 
  
Scheme 2.2 - Synthesis of the chromophore, 6 
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The final bromination step gave a maximum yield of 30%, with two by-products of 
similar yield, the starting material and the di-brominated compound. However, both 
were still useful if collected through column chromatography. The starting material 
could be recycled into the same reaction once again. In the case of the di-brominated 
compound, selective removal of a single bromine is possible with diethylphosphite and 
diisopropylamine, reacting for 10 minutes at 0 ˚C before quenching the reaction in iced 
water (Scheme 2.3). 
 
Scheme 2.3 - Debromination of 2,2-dibromomethyl-1-azaxanthone 
The alkylation of the two chromophores onto 3, gave 7 (Scheme 2.4). The t-butyl 
groups were removed under acidic conditions, before complexation with Ln(OAc)3 (Ln 
= Eu, Tb) yielded the final complex which was purified by reverse phase HPLC. 
 
Scheme 2.4 - Synthesis of [Ln.L
1
]
+
 
The final reaction was monitored by emission spectroscopic analysis of the reaction 
mixture, by excitation at 336 nm. As the energy transfer from the two chromophores to 
the lanthanide ion is very efficient, with little back transfer, there should be no ligand 
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fluorescence in the final complex, in accordance with completion of the complexation 
reaction. The presence of any unreacted ligand can be seen through a broad organic 
fluorescence emission band around 400 nm. Only strong emission was found in the 
relevant regions for the lanthanide being probed.  
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Figure 2.2 - The excitation and emission of [Eu.L
1
]
+
(red) and [Tb.L
1
]
+
(green) 
2.2 Binding Studies of [Ln.L
1
]
+
 with Selected Pharmaceuticals 
Initial binding studies were carried out with [Eu.L
1
]
+
 and [Tb.L
1
]
+ 
in a similar manner 
to those conducted by Carr et. al. in 2012.
56
 The complexes were dissolved in a 1 mL 
solution of 0.1 M NaCl, to ensure that the ionic strength remains constant throughout 
the titration. Physiological pH, 7.4, was maintained using NaOH(aq) and HCl(aq) to 
ensure that the human protein, α1-AGP did not denature. However, errors could 
potentially come in at this point with the lack of buffer. Changes in bicarbonate in 
solution could change the pH and as such effect the results obtained. Furthermore, with 
such strong acid and bases, it is possible to overshoot and large swings in pH could have 
a detrimental effect on the protein. 
α1-AGP was added incrementally to the complex solution, and binding events were 
tracked using changes in emission intensity and spectral form, in both total emission 
and CPL. The lifetimes at the start and end of the titration were also recorded. 
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Figure 2.3 - Changes in the emission spectrum of [Eu.L
1
]
+ 
with increasing concentrations of α1-AGP up 
to 50μM (30 μM complex, 0.1 M NaCl, pH = 7.4, 295 K). (Inset) The ratio of 615-620 nm / 595-600 nm 
as a function of increasing concentrations of α1-AGP 
As expected, upon addition of α1-AGP to [Eu.L
1
]
+
, an increase in total emission 
intensity was observed. There was also a change in spectral form, particularly in two of 
the bands in the ΔJ = 2 transition, whose intensity changed relative to one another. A 
more dramatic change also occurred in the ΔJ = 4 manifold. By plotting the ratio of ΔJ 
= 2 / ΔJ = 1 (615-620 nm / 595-600 nm) emission intensities as a function of α1-AGP, a 
binding constant of logK = 5.65 (±0.03) was calculated, which is within error of the 
previously stated literature value of 5.73 (±0.06).
56
 The logK value was calculated using 
Equation 5.2 and the errors in the parenthesis are due to statistical error in the fit of the 
line to the raw data. All logK values throughout the thesis were calculated in this 
manner. 
Other experimental errors which could come into play include the concentrations of all 
solutions, change in temperature and slight changes in pH. Repetitions of titrations were 
carried out to minimise the effect of any random errors. There could also be slight error 
in the ratio of the luminescent studies, but this is less likely with strong luminescence. 
Experiments were carried out in a temperature controlled room, with the pH being 
checked before and after each scan was carried out. 
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The initial observation of an increase in emission intensity was expected to be the result 
of the loss of an inner sphere water molecule. The O-H oscillators in water are well-
known non-radiative quenchers of the europium excited state, so a loss of water would 
be expected to be coupled with greater emission intensity and a longer lifetime of the 
emission.  
The lifetime of the complex was measured by analysis of europium emission decay 
profiles. Information from these profiles were recorded for the complex and the adduct 
in H2O and D2O. The inner sphere water number (q) can be obtained using Equation 
2.1.
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𝑞 = 𝐴 (
1
𝜏𝐻2𝑂
−
1
𝜏𝐷2𝑂
− 0.25 − 0.075𝑥) 
(2.1) 
In this equation, A is a proportionality constant, which for europium is 1.2 ms, and x is 
the number of coordinated amide N-H bonds, which in this complex, is zero. It is also 
important to note that the error in q is ±0.3, which is significant, when the values are 
generally between 0-2. The lifetimes in H2O and D2O of the complex and the adduct 
formed with α1-AGP are listed in Table 2.1. As expected, the complex has a q value of 
approximately one suggesting the presence of a single water molecule in the inner 
coordination sphere. Upon forming the adduct, the q value drops to approximately zero, 
consistent with the expulsion of water from the inner coordination sphere.  
Table 2.1 - Lifetimes and calculated q value of [Eu.L
1
]
+
 and the adduct formed with α1-AGP 
Complex 
Lifetime in H2O 
(τ1) (ms) 
Lifetime in D2O 
(τ1) (ms) 
q value 
[Eu.L
1
]
+
 0.50 1.69 1.4 
[Eu.L
1]:α1-AGP 0.96 1.47 0.1 
 
An analogous experiment, with the addition of α1-AGP to [Tb.L
1
 ]
+ 
was also carried out. 
Although very similar results would be expected, the overall emission intensity was 
significantly quenched. Owing to this decrease, the planned experiments designed for 
this complex with different pharmaceuticals were very difficult, as emission has 
significantly decreased. Furthermore, the binding curve of [Tb.L
1
]
+
 to α1-AGP was not 
simple to analyse, implying that more than one binding event was taking place. 
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Figure 2.4 - Changes in the emission spectrum of [Tb.L
1
]
+
 (black) with increasing concentration of α1-
AGP up to 40μM (red) (30 μM  complex, 0.1 M NaCl, pH = 7.4, 295 K). (Inset) The intensity ratio of 
532.5-562 nm / 498-510 nm as a function of increasing α1-AGP concentration 
It is thought the reason for the marked decrease in emission is related to the sensitivity 
of certain Tb
3+
 complexes to undergo charge transfer quenching.
175
 In α1-AGP, there is 
an electron rich tyrosine-37 residue which may lie close to the opening of the binding 
site.
56
 This amino acid could form an exciplex with the electron deficient Tb-
coordinated azaxanthone which may explain the significant quenching that is observed 
upon the complex binding with α1-AGP.  
A trial titration of [Tb.L
1
]
+
:α1-AGP (1:1) with increasing concentration of a drug was 
conducted to see if it would be possible to use this complex as a probe nonetheless. 
Incremental additions of imatinib (Figure 2.8) were tracked through total emission 
alone, and the same intensity ratio (532.5-562 nm / 497-510 nm) that was used in the 
titration of α1-AGP was utilised again (Figure 2.5).  
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Figure 2.5 - Changes in the emission spectrum of [Tb.L
1
]
+:α1-AGP (black) (30 μM, 1:1, 0.1 M NaCl, pH 
= 7.4, 295 K) with increasing imatinib concentration up to 50 μM (red). (Inset) The intensity ratio of 
532.5-562 nm / 479-510 nm as a function of increasing imatinib concentration 
Upon increasing the concentration of imatinib, there was an overall decrease in 
emission intensity, and the signal-to-noise ratio continued to deteriorate. Furthermore, 
the ratio that could have potentially been used, did not divulge any useful information. 
Due to these initial poor results, it was decided that further tests were to be carried out 
using [Eu.L
1
]
+
alone. 
For the titration of α1-AGP into [Eu.L
1
]
+
, CPL spectra were also collected. In solution, 
there is a dynamic equilibrium between the enantiomers of the complex. Hence, there is 
a racemic mixture, and no observable CPL signal. To explain the modes of chirality 
possible in this complex, it is easiest to consider a C4 symmetric complex such as 
[Ln.DOTA]
–
. [Ln.DOTA]
–
 can exist in four different isomers, with two pairs of 
enantiomers.  
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Figure 2.6 - The schematic representation of the four isomers of [Ln.DOTA]
 –176 
The δ and λ chirality element arises from the cyclen ring chelate. The N-C-C-N dihedral 
angle in each chelate ring can either be at an angle of +60° or -60° respectively, and the 
system can interconvert between the two states through cooperative ring inversion. The 
second type of chirality comes from the dihedral angle of the N-C-C-O chelate. These 
angles are the same sign in relation to each other, and give rise to either Δ or Λ. Again 
these can interconvert through cooperative arm rotation. In solution, all of these 
stereoisomers of DOTA can interconvert rapidly on the emission timescale at room 
temperature so if examined by CPL, no signal is observed. However, this is not the case 
in all complexes. 
The complex, [Eu.L
1
]
+
, is only C2 symmetric, and therefore the isomers in solution are 
slightly different, but the same basic principles apply. In solution, the complex rapidly 
converts between the isomers, but upon binding to α1-AGP, [Eu.L
1
]
+
 preferentially 
forms one preferred chiral diasteroisomeric complex, and a CPL signal can now be 
observed. 
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Figure 2.7 - The CPL spectra of [Eu.L
1
]
+
 (black) and the 1:1 adduct of [Eu.L
1
]
+
 with α1-AGP (red) (30 
μM, 0.1 M NaCl, pH 7.4, 295 K) 
Two large signals of opposite helicity are observed within the ΔJ = 2 band, which have 
potential to be used to investigate the system without large errors originating from poor 
signal-to-noise ratios. As the selected pharmaceuticals bind to the same site on α1-AGP 
as the complex, it is expected that upon addition of a drug, a decrease in the intensity of 
the CPL signal will be observed. This is due to the drug displacing the complex bound 
to the protein, so free [Eu.L
1
]
+ 
will return to its dynamic equilibrium with no preference 
for a particular enantiomer. 
Following initial investigations with α1-AGP, binding studies with the three selected 
pharmaceuticals were undertaken. The three chosen are imatinib, disopyramide and 
methadone. Each was found in the literature to bind to α1-AGP at the same site as the 
complex, with binding constants of similar magnitudes, as well as having absorbance 
maxima far from the 336 nm excitation wavelength of the complex.
56,110,112,177
 
 
Figure 2.8 - The structures of S-methadone (left), imatinib (middle) and S-disopyramide (right) 
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In each titration, the conditions were identical. The complex and protein were in a 1:1 
ratio (30 μM), in a 1 mL aqueous solution of 0.1 M NaCl at pH 7.4 and 295 K. Again, 
the pH was maintained with NaOH(aq) and HCl(aq) when appropriate. The concentration 
of the complex was calculated by measuring the absorbance at 336 nm and using the 
Beer-Lambert law. Incremental addition of the drugs was carried out, and the binding 
event was followed using total luminescence emission and CPL spectroscopy. In 
addition, emission lifetimes were recorded at the beginning and end of each titration. 
2.2.1 Total Emission Spectroscopy Analysis 
Total emission spectroscopy is widely used to follow binding events over a wide range 
of applications. In lanthanides in particular, the sharp emission bands, some of which 
are hypersensitive to coordination perturbation, can give a lot of information about a 
binding event. Information can be extracted from both the overall emission intensity and 
the change in shape of the spectral form. Although the drug is not thought to bind 
directly to the complex, it will change the coordination around it, as it replaces the 
complex in the binding site of α1-AGP. 
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Figure 2.9 - Changes in the emission spectra of [Eu.L
1
]
+:α1-AGP (black) (30 μM, 1:1, 0.1 M NaCl, pH 
7.4, 295 K) with increasing concentrations of imatinib up to 12.5 μM (red) 
As predicted, there was a clear and distinct decrease in emission intensity for each of the 
three drugs studied. Moreover, there is a change in the spectral form, particularly in the 
ΔJ = 2 manifold where the two major bands are of approximately the same intensity 
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after the addition of the pharmaceuticals. This change is compared to the fingerprint of 
the complex adduct with α1-AGP, where the intensity at 610 nm is stronger than that of 
620 nm. Similarly to the studies with α1-AGP binding, it is possible to follow the 
competitive binding, by examining the intensity ratio of the 615-620 nm / 595-600 nm 
bands. 
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Figure 2.10 - The binding curves of [Eu.L
1
]
+: α1-AGP (30 μM, 1:1, 0.1 M NaCl, pH = 7.4, 295 K) with 
increasing concentrations of methadone (left), disopyramide (right), and imatinib (bottom) 
LogK values were determined as for the complex with α1-AGP. The ratio of intensity of 
sections of the ΔJ = 2 / ΔJ = 1 manifolds (615-620 nm / 595-600 nm) were plotted 
against increasing drug concentration. These bands in particular are regularly chosen, 
due to the large change observed in the co-ordinately hypersensitive ΔJ = 2 band 
compared to the absence of significant change in the electronic dipole forbidden ΔJ = 1 
transition.  
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Table 2.2 - The experimental and literature logK values of the three drugs investigated. Unless stated 
otherwise, conditions from the literature values are assumed to be the same as the experimental 
conditions (0.1 M NaCl, pH 7.4, 295 K) 
Pharmaceutical Total emission logK Literature logK values 
Methadone 4.96 (±0.02) 5.60 (±0.08)
112,c
 
Disopyramide 4.59 (±0.01) 3.47
121,d 
, 5.87 (±0.09)
178,c
 
Imatinib 5.54 (±0.02) 6.38 (±0.2)
126
 
 
The logK values that were determined in these experiments (Table 2.2) clearly differ 
from those found in literature, by approximately an order of magnitude. In the cases of 
disopyramide and methadone, this can be explained by the varying conditions in the 
experiments. For example, the first disopyramide value reported in the literature (logK = 
3.47) was calculated at pH = 4.0, where binding to the complex may be significantly 
different depending on the levels of protonation of both the complex and the drug. The 
logK values for methadone, and the second disopyramide value quoted, were calculated 
at 37 °C, which may also explain why the literature values were different than those 
found in this experiment. 
However, it does not explain the difference in logK values in imatinib. As imatinib 
replaces the complex in the binding site, it is in competitive equilibrium. Hence, the 
value calculated from total emission experiments, where imatinib replaces the complex 
in the binding site of the protein maybe smaller than if there was nothing bound to α1-
AGP already. Furthermore, in the same paper that found a logK value of 6.38 (±0.2), 
when calculating via displacement of imipramine, an apparent logK value of 5.30 was 
found, which is much closer to the value calculated from total emission.
126
 
2.2.2 CPL Studies of Drug Binding 
Circularly polarised luminescence is rarely used to monitor changes in europium 
emission. However, it is slowly gaining popularity as more CPL spectrometers are 
being built and bought, allowing greater advancement in its understanding. In this 
example, the drugs compete with the complex to bind to α1-AGP. [Eu.L
1
]
+ 
returns back 
into the bulk solution, with no preference for either enantiomer which causes the CPL 
signal of the complex to decrease with increasing concentration of drug. 
                                                 
c
 37 ˚C 
d
 pH 4.0 
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Figure 2.11 - CPL spectrum of [Eu.L
1
]
+
:α1-AGP (black) (30 μM, 1:1, 0.1 M NaCl, pH = 7.4, 295 K) with 
increasing concentrations of methadone, up to 0.3 mM (red), showing a decrease in CPL signal 
The two largest CPL signals, and hence the easiest to follow, are found in the ΔJ = 2 
transition at 613 and 621 nm. The strong signal is not unsurprising as to attain 
maximum intensity in CPL, both the magnetic and electric dipole transition should be 
allowed, which is the case for this transition.  
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Figure 2.12 - The change in intensity of the CPL signal of [Eu.L
1
]
+
:α1-AGP (30 μM, 1:1, 0.1 M NaCl, pH 
= 7.4, 295 K) at 613 nm (left) and 621 nm (right) with added methadone (top), disopyramide (middle) 
and imatinib (bottom) 
In each case, the pharmaceutical was added to a [Eu.L
1
]
+:α1-AGP solution until the CPL 
signal had been completely lost. Hence, the binding curve reaches a limit. Both CPL 
signals at 613 and 621 nm were used, (Figure 2.12) and iterative least square fitting to a 
1:1 binding model was used to determine an apparent logK value. 
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Table 2.3 - The logK values calculated for the binding of each pharmaceutical to [Eu.L
1
]
+:α1-AGP (30 
μM, 1:1, 0.1 M NaCl, pH = 7.4, 295 K) at 613 and 621 nm with total emission and literature values for 
reference 
Pharmaceutical 
logK at 613 
nm 
logK at 621 
nm 
Total 
emission 
logK 
Literature 
logK value 
Methadone 5.66 (±0.07) 5.88 (±0.06) 4.96 (±0.02) 
5.60 
(±0.08)
112,e
 
Disopyramide 5.27 (±0.04) 5.12 (±0.06) 4.59 (±0.01) 
3.47
121,f 
, 5.87 
(±0.09)
178,e
 
Imatinib 5.63 (±0.01) 5.63 (±0.04) 5.54 (±0.02) 6.38 (±0.2)
126
 
 
For methadone, the CPL derived values were significantly closer to the literature values, 
compared to the logK values calculated from analysis of total emission changes. Indeed, 
the binding constant calculated from data at 613 nm is the same as the literature value 
within the statistical error of the fit. However, as the experiments were performed under 
different experimental conditions, more specifically, at different temperatures, these 
logK values should not be the same. A binding constant calculated at the same 
temperature would be more useful. 
There is a similar story for disopyramide. The two literature binding constants are very 
different, due to the differing conditions used in each. For example, at pH 4.0, the logK 
value is significantly smaller, but the one calculated at physiological temperature is 
slightly higher. Although the two binding constant from the CPL are not within the 
stated error, they are more similar compared to the binding constant of 4.59 (±0.01) 
derived from total emission data. Again, although it is difficult to compare due to the 
variation in conditions, the CPL binding constants are more in agreement with literature 
values than the total emission constants. 
Lastly, imatinib still gives logK values that are almost an order of magnitude different 
from the literature value, and is only a little higher than the value 5.54 (±0.02), 
calculated from total emission. The CPL values are in agreement with each other, but 
they should be within error of both the total emission and literature. Evidently, this is 
not the case. 
                                                 
e
 37 ˚C 
f
 pH 4.0 
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2.2.3 Emission Lifetime Analysis 
The lifetime of europium was measured at the end of each titration. Using analogous 
methods to gain the lifetimes after α1-AGP titrations, the readings were initially taken in 
H2O, the solution lyophilised and subsequently re-dissolved in D2O. The removal of 
solvent was repeated three times to ensure complete removal of H2O as residual levels 
could affect the emission decay data. The sample was dissolved again in D2O, to obtain 
the second lifetime necessary for the calculation of the q value. 
Table 2.4 - Lifetimes of [Eu.L
1
]
+
:α1-AGP (1:1) with methadone, disopyramide, and imatinib in H2O and 
D2O and the relevant q value 
Pharmaceutical 
Lifetime in H2O (τ1) 
(ms) 
Lifetime in D2O (τ1) 
(ms) 
q value 
Methadone 0.45 1.46 1.5 
Disopyramide 0.45 1.48 1.5 
Imatinib 0.40 1.39 1.8 
 
In all three cases, the lifetimes were extracted, and using Equation 2.1 the q values were 
calculated. The q values increase back to levels similar to those seen with the complex 
in the absence of α1-AGP. Again, this behaviour suggests that the pharmaceutical binds 
to the protein, displacing the complex. When this process occurs, the glutamate arm 
from the binding site of α1-AGP is no longer bound and the complex is removed from 
the hydrophobic pocket of the protein. This allows for a solvent water to bind directly to 
the metal ion, which decreases the lifetime as water promotes a pathway for non-
radiative decay. Not only does this affect the lifetime, but also decreases the overall 
intensity of the europium spectrum. 
2.3 Enantiomer Resolution of the Drug 
Of the drugs chosen for this investigation, two are available as a racemic mixture. In 
many examples, pharmacological drugs existing as two enantiomers have very different 
effects on biological systems. The most famous example of this is thalidomide, a drug 
originally given to alleviate morning sickness during early pregnancy and thought to be 
safe.
179
 However, it was soon found to be the cause of phocomelia, the disfigurement in 
developing foetuses. Research later found that S-thalidomide is responsible for this 
effect, with R-thalidomide being the enantiomer with sedative properties.
180
 It has also 
been suggested that if only R-thalidomide was prescribed, then it would still be 
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effective. However, due to the acidic proton at the chiral carbon centre, enantiomeric 
interconversion occurs rapidly in the body. Although the drug is still used today in 
frontline cancer treatment, the risk associated with pregnancy means it is carefully 
controlled. 
 
Figure 2.13 - The structure of (R)- (left) and (S)-thalidomide (right) 
There are numerous other examples of one enantiomer working more efficiently, or one 
enantiomer being liable for certain side-effects. Methadone is no exception; the R- 
enantiomer being a better MOR (μ-opioid receptor) than S-, with the S- enantiomer 
thought to be responsible for the arrhythmia problems which are sometimes noted in 
methadone treatment.
181
 
It is possible that with both methadone and disopyramide, the two enantiomers interact 
differently with α1-AGP. This aspect is important, as if one enantiomer binds more 
strongly to the protein, it will be less bioavailable which could potentially affect the 
efficacy of the medicine. This situation is of particular note if the more strongly bound 
enantiomer is more active.  
 
Figure 2.14 - Structures of the two enantiomers of disopyramide (left) and methadone (right) 
Both disopyramide and methadone were obtained as racemic mixtures and their 
resolution was studied.  
2.3.1 Disopyramide Enantiomers 
Disopyramide was selected initially, and separation of its enantiomers was attempted on 
a series of chiral HPLC columns, with different solvent systems. Base line separation 
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was successfully achieved with a CHIRALPAK-IC analytical column in 
hexane:DCM:methanol (65:30:5) adding 0.05% diethylamine (DEA) to stop the tailing 
of the peaks, by inhibiting N-protonation. 
 
Figure 2.15 - Resolution of the two enantiomers of disopyramide (CHIRALPAK-IC, 
hexane:DCM:methanol (65:30:5) with 0.05% DEA, 295 K, λem = 260 nm) 
Once separated on a larger scale, using the same conditions, but with a semi-prep 
CHIRALPAK-IC column, the two enantiomers could be tested separately and the 
binding constants compared. However, once the two enantiomers were separated, there 
was no way of detecting which enantiomer was which. The amount obtained from 
HPLC were too low to use a polarimeter, and even after attempts at recrystallisation, 
only a powder was obtained and as such, the absolute configuration of the enantiomer 
could not be determined through crystallography. As such, they were labelled 
disopyramide one, which eluted from the column first, and the latter was named 
disopyramide two.  
As with all previous experiments, the complex was dissolved in purite water at pH 7.4, 
with 0.1 M NaCl, until a concentration of 30 μM was achieved. α1-AGP was then added 
to make a 1:1 solution with the complex. Disopyramide was sequentially added and the 
change in the europium emission spectrum was monitored. 
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Figure 2.16 - Change in the emission spectra of [Eu.L
1
]
+:α1-AGP (black) (30 μM, 1:1, 0.1 M NaCl, pH 
7.4, 295 K) with increasing concentration of disopyramide ‘one’, up to 0.3 mM (red), with 0.3 mM of 
racemate for comparison (blue) 
As expected, the change in emission intensity and spectral form of both disopyramide 
one and two are similar to those of the racemic mixture. 
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Figure 2.17 - The binding curves of [Eu.L
1
]
+
:α1-AGP (30 μM, 1:1, 0.1 M NaCl, pH = 7.4, 295 K) 
following the ratio 608-627 nm / 583-605 nm, with increasing concentrations of disopyramide ‘one’ (left ) 
and ‘two’ (right) 
After plotting the binding curve, the binding constants were estimated by non-linear 
regression analysis were smaller than expected with logK values of 4.80 (±0.01) and 
4.78 (±0.02) for ‘one’ and ‘two’ respectively. This is a magnitude lower than the quoted 
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literature value, and surprisingly, significantly smaller than the value calculated with the 
racemate.  
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Figure 2.18 - The fitted binding curved of [Eu.L
1
]
+
:α1-AGP (30 μM,1:1, 0.1 M NaCl, pH 7.4, 295 K) with 
increasing concentrations of disopyramide one (top) and two (bottom) following the intensity of the CPL 
signal at 613 nm (left) and 621 nm (right) 
 The analogous titration examined changes in CPL. As expected, there was a decrease in 
CPL signal, and the binding event was followed as in previous experiments, by 
analysing the changes in the two wavelengths that gave the strongest initial signal at 
613 and 621 nm.  
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Table 2.5 - The logK values of the two enantiomers of disopyramide with [Eu.L
1
]
+
:α1-AGP (30 μM, 1:1, 
0.1 M NaCl, pH 7.4, 295 K) using CPL and total emission 
 logK CPL 
(613 nm) 
logK CPL  
(621 nm) 
logK Total emission 
(608-627 nm / 583-
605 nm) 
Disopyramide ‘one’ 5.49 (±0.08) 5.09 (±0.01) 4.80 (±0.01) 
Disopyramide ‘two’ 5.24 (±0.04) 5.12 (±0.06) 4.78 (±0.02) 
 
For the first enantiomer, none of the three calculated logK values were within error, so it 
is impossible to determine the correct binding constant from these experiments. For 
disopyramide ‘two’ the range of logK values is not as broad, but again, they are not 
within the error of each other. Therefore, there is no definite conclusion to the correct 
binding constant of either enantiomer, and it cannot be confirmed if they have the same 
or different binding constants. However, they are sufficiently close that it suggests that 
each enantiomer binds with a similar affinity to α1-AGP. 
Again, experimental errors could play a part in these experiments, particularly in the 
readings from the CPL at high disopyramide concentration as there is poor signal to 
noise ratio and as such, liable to significant error. Other errors, such as change in pH 
could also play a role. 
2.3.2 Methadone Enantiomers 
To separate the two enantiomers of methadone, a different approach was necessary. 
Although it is possible to use chiral HPLC columns, the appropriate columns were not 
available. A classic way to differentiate between enantiomers is to recrystallise them. 
Louis Pasteur famously discovered molecular chirality after the discovery of mirror 
image forms of crystals in the sodium ammonium salt of paratartaric acid.
182
 With 
methadone, the addition of one enantiomer of tartaric acid allows the crystallisation of 
one diastereoisomeric salt, from which methadone can be subsequently released by 
addition of base.  
 
Figure 2.19 - The structure of D- or (S,S)-tartaric acid 
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Following the method of Larsen et al., a racemic mixture of methadone was dissolved 
in propanol with D-tartaric acid (Figure 2.19), and left in the fridge overnight.
183
 A 
white powdery solid was filtered off, which was recrystallised again to ensure sample 
purity. The powder was dissolved in water and a few drops of ammonia were added to 
remove the tartaric acid. Methadone precipitated out, and was filtered, before a few 
drops of conc. HCl were added to make the hydrochloride salt. The separation of the 
pure enantiomer was confirmed by melting point analysis at each point in the 
separation, following values recorded in the literature.
183
 
To retrieve the second enantiomer, the original solution was taken, and L-tartaric acid 
was added. Thus, following the same method as above, both enantiomers were 
successfully separated. 
Although purification was confirmed through melting point analysis, particularly at the 
point of formation of their tartrate diastereoisomers, further confirmation of 
enantiomeric purity was achieved using a chiral solvating agent (CSA), (R)-( ̶)-O-
acetylmandelic acid (Figure 2.20). This compound can be used to determine the 
enantiomeric purity of amines by 
1
H NMR analysis of the diastereoisomeric salts 
formed in situ.
184
 
 
Figure 2.20 - The structure of (R)-(–)-O-acetylmandelic acid184 
The amine in methadone interacts with the CSA in a non-polar solvent which causes 
1
H 
NMR resonances of the different enantiomers to shift. The CSA was first added to the 
racemic mixture to see which resonances were affected and therefore, which were best 
to monitor. 
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Figure 2.21 - Partial 
1
H NMR (400 MHz, CDCl3, 295 K, 2.39 – 2.57 ppm) spectrum of racemic 
methadone (red), (R)-methadone (green), (S)-methadone (blue) following the addition of (R)-(-)-O-
acetylmandelic acid 
The resonance at 2.15 ppm shifted to 2.48 ppm (Figure 2.21) and the splitting of this 
resonance from a singlet to a doublet for the two methyl groups attached to the nitrogen 
(H
6
) was the most promising, along with some smaller splitting of methyl resonances in 
the 0-1 ppm region.  
 
Figure 2.22 - The structure of racemic methadone 
Upon addition of the CSA to the separated enantiomers, the resonance at 2.15 ppm was 
shifted to either 2.45 (R-) or 2.52 ppm (S-) but remained as a single peak. The splitting 
of the resonance of the methyl group at 0.54 ppm (H
5
) also occurred. Two dimensional 
NMR methods, namely COSY, HSQC and HMBC were utilised to find out more about 
the full spectral assignment.  
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Figure 2.23 - 
1
H NMR COSY (500 MHz, 295 K, CDCl3) of (S)-Methadone in the presence of (R)-(−)-O-
Acetylmandelic acid 
From Figure 2.23, it is possible to see that the resonance at 0.54 ppm (H4) is coupled to 
two resonances at 2.83 and 2.93 ppm (H
3
). The two separate peaks for H
3 
highlights that 
two protons are diastereotopic, which can be seen on NMR due to the more rigid 
structure of methadone when interacting with (R)-( ̶ )-O-acetylmandelic acid. 
There are other slight changes including the shifting of the two diastereotopic CH2CO 
protons (H
2
) to 2.20 ppm and 2.37 ppm; it was proven that they were on the same 
carbon using HSQC. 
2.3.2.1 Binding studies of the enantiomers of methadone. 
Following successful separation of the two enantiomers of methadone, titrations with 
[Eu.L
1
]
+:α1-AGP were carried out at pH 7.4, with increasing concentration of the drug. 
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Figure 2.24 - The binding curves of [Eu.L
1
]
+:α1-AGP (30 μM, 1:1 ratio, 0.1 M NaCl, pH 7.4, 295 K) with 
increasing concentration of S-methadone (top) and R-methadone (bottom) using both CPL and total 
emission (middle) 
The experiments were followed by analysis of CPL and total emission data (Figure 
2.24), and the binding constants were calculated similarly to previous experiments. In 
the total emission experiments, the ratio of the bands at 608-627 nm / 583-605 nm were 
used, as it gave a slightly better data. 
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Table 2.6 - The logK values of [Eu.L
1
]
+
:α1-AGP (30 μM, 1:1 ratio, 0.1 M NaCl, pH 7.4, 295 K) with the 
two enantiomers of methadone, using CPL and total emission 
 logK CPL 613 nm logK CPL 621 nm logK total emission 
R-Methadone 5.58(±0.05) 5.40 (±0.07) 5.52 (±0.01) 
S-Methadone 5.42 (±0.09) 5.20 (±0.02) 5.41 (±0.13) 
 
For R-methadone, the binding constants, ranged from logK 5.40-5.58, with the higher 
values being close to the literature value of 5.60 (±0.08) However, none of the values 
are within error of each other. For S-methadone, two logK values are close to 5.42, but 
with relatively large errors. The relevance of this being that it is still close to the 
literature value, and again suggests that both enantiomers have similar binding constants 
to α1-AGP. However, the third logK value for S-methadone is smaller, with a value of 
5.20 (±0.02). For both enantiomers, the calculated logK value at 621 nm were smaller 
than those at 618 and those calculated from the total emission. This lower value could 
also be a product of the poor shape of the graph, and the subsequent poor fit of the data. 
Furthermore, it could be related to the poor signal to noise ratio as the CPL gets smaller 
as the complex is removed from the binding site of α1-AGP. More repetitions of this 
experiment could produce better results, with a smooth graph which could be fit to give 
a more accurate binding constant. 
2.4 Conclusions and Further Work 
The complex, [Eu.L
1
]
+
 was specifically selected because of previous reports detailing 
its ability to bind to α1-AGP. The pharmaceuticals were chosen as they have 
demonstrated similar binding constants as the complex to α1-AGP, which allows for 
competitive binding, as well as having a suitable absorption spectrum allowing selective 
excitation of the europium complex chromophore.  This chapter highlights the use of 
this complex as a ratiometric probe, to calculate the drug concentration in solution, 
using both total emission and CPL spectroscopy. A binding curve was obtained for the 
complex with α1-AGP, as well in the presence of the three competing drugs. 
There are a number of previous examples which highlight the importance of 
enantiomeric drugs in biological systems, so the racemic mixtures of methadone and 
disopyramide were separated using crystallisation and chiral HPLC respectively. The 
separate enantiomers were also titrated into a [Eu.L
1
]
+
: α1-AGP solution and the binding 
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constants determined to investigate whether they bound to the protein with different 
binding affinities.  
The next step would be to construct a calibration curve for each drug in the medium of 
interest. Following this, there is the potential to test ‘unknown’ concentrations to 
determine whether [Eu.L
1
]
+
 can be used analytically. Thus far, the complex has only 
been investigated in water. One of the next steps to take would be to look at how well 
the [Eu.L
1
]
+
 works in more competitive media, with the aim being to analyse samples of 
the complex in human serum.
 
Furthermore, as mentioned in Section 1.4, α1-AGP has a number of different 
polymorphs and previous research has shown that varying the polymorphs and levels of 
glycosylation can affect the binding behaviour of certain analytes. This is an important 
aspect for any type of personalised medicine, as concentrations of the polymorphs can 
differ from person to person.
185
 It is possible to separate polymorphs into A and F1*S 
by chromatography.
127
 Analogous binding experiments can be carried out on these two 
polymorphs to extract a binding constant to gather more information towards the main 
goal of creating a complex that may be suitable for more general use. 
The complex has the potential to be tested on a greater number of pharmaceuticals. 
Work within Durham has examined this aspect. Four other drugs were examined, the 
anaesthetics lidocaine and bupivacaine, as well as the antidepressants nortriptyline and 
imipramine. Using the same complex, Ryan Waters MChem. looked at the CPL and 
total emission changes to calculate the binding constants.
111
  
Table 2.7 - The logK values of [Eu.L
1
]
+
:α1-AGP (30 μM, 1:1, 0.1 M NaCl, pH = 7.4, 295 K) with four 
pharmaceuticals, from CPL, total emission, and quoted literature values
111
 
 
logK 
(Total emission) 
logK (CPL) logK (literature) 
Bupivacaine 4.77 (±0.05) 5.38 (±0.03) 5.5-5.7
186,187
 
Lidocaine 4.31 (±0.03) 4.38 (±0.04) 4.6-5.2
187,188,g
 
Nortriptyline 3.60 (±0.01) 4.44 (±0.04) 4.3-5.1
189
 
Imipramine 4.18 (±0.02) 4.90 (±0.04) 5.6
186
 
 
                                                 
g
 logK calculated at 37 °C 
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Again, promising results were obtained, both in analysing the total emission and CPL 
data. Any further work suggested for the three drugs in chapter two, can also be applied 
to these. Bupivacaine is another racemic drug so the separation of the two enantiomers 
and subsequent titrations was considered a logical next step. S-Bupivacaine is 
commercially available, and therefore, titrations were also performed with this 
enantiomer, to give logK values that are reported in the range 5.41 (±0.04) and 5.46 
(±0.01) for total emission and CPL respectively. This value was very close to the 
literature value of 5.4-5.8.
187,190
 However, the R- enantiomer was never isolated. 
Although this is the case, as S-bupivacaine has a very similar binding constant to α1-
AGP as the racemate, it is suggestive that R-bupivacaine would also have the same or a 
similar logK value. There is no reason however, to limit such analysis to these drugs. 
Any alkaline drugs with a known binding constant of approximately logK = 5 to α1-
AGP could be suitable for analysis provided they do not absorb strongly above 300nm.  
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3. Eu(III) Complexes for the Detection of Glyphosate 
Due to the popularity of glyphosate, and the ever growing resistance against its usage, 
the low cost ‘in-house’ detection of glyphosate is of increasing interest. The initial and 
current methods of detection are through HPLC and mass spectrometry, which requires 
derivatisation of glyphosate, adding time and money to the process.  
This chapter will consider a number of complexes that were selected base on their 
particular absorption and chemical properties.  It will examine complexes that upon 
binding to glyphosate, give rise to an emission spectral profile that allows ratiometric 
methods of analysis to be used. The ratio can be simply used by comparison to a 
calibration curve to calculate the concentration of the herbicide in a variety of solvent 
media, from experiments in water, to river water, and grain background. 
The first example is an azaxanthone based complex which has previously been reported 
to bind citrate selectively with a logK value of 4.36 (±0.01); citrate itself is unlikely to 
be a competitive interferent when looking at river water or drinking water samples.
52
 It 
is hypothesised that it would bind to glyphosate through the phosphate oxygen. 
3.1 Synthesis and Overview  
The synthesis of [Eu.L
2
]
+
 was undertaken following a previously published method.
52
 
The first step in the synthesis is the same as for [Eu.L
1
]
+
, i.e., the trans disubstitution of 
cyclen, 1 (Scheme 3.2). An alkylation step followed, involving addition of the α-
bromoamide, 8, to the remaining secondary amine sites on the ring to yield 9. The 
amino acid arm was synthesised in a single step involving the reaction of alanine ethyl 
ester with bromoacetyl bromide to yield a yellow oil which was crystallised from DCM 
and petroleum ether to give a white crystalline solid (Scheme 3.1). 
 
Scheme 3.1 - Synthesis of the α-bromo amide 
The protecting groups of 9 were selectively removed by hydrogenation to yield 10, 
before the addition of a single chromophore moiety. The separation of 11 from 
dialkylated material was achieved by column chromatography on alumina. The 
remaining secondary amine on cyclen was methylated, by boiling under reflux with 
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formic acid and formaldehyde to give 12. This step was followed by hydrolysis of the 
ester groups to give L
2
. The hydrolysis reaction was carried out using NaOD in D2O to 
allow the reaction to be tracked by 
1
H NMR. The ligand was then complexed with 
Eu(OAc)3, at pH 5.5 to yield the desired complex as a pale yellow solid.  
 
Scheme 3.2 - Synthesis of [Eu.L
2
]
+
 
The organic chromophore in this complex is the same as that used in [Eu.L
1
]
+
 (Scheme 
2.2). The synthesis of the complex was confirmed by mass spectrometry and 
characterised by its luminescence emission spectrum.  
3.2 Initial Tests of Glyphosate Detection in Buffer 
Titrations with glyphosate were undertaken. Initial tests were carried out in aqueous 
solution, as one of the key aims of this project is the ability to test for glyphosate in 
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water. An aqueous solution of 0.1 M NaCl was chosen to ensure constant ionic strength 
throughout the titrations. The pH of each titration was maintained at 5.9 with a 0.1 M 
MES buffer solution. The pH of 5.9 was specifically chosen due to the differing pKa 
values of glyphosate and one of its main interferents, inorganic phosphate. The pKa of 
dihydrogen phosphate is known to be 7.21,
191
  whereas the equivalent proton in 
glyphosate has a pKa of 5.58.
192
 Therefore, at 5.90, glyphosate is predominately a di-
anion, whereas phosphate is a mono-anion, and enhanced selectivity for the doubly 
charged species is expected, based on the primary electrostatic interaction.  
 
Figure 3.1 - The experimental pKas of glyphosate
193
 (0.1 M NaCl) and in parentheses, the corresponding 
calculated values
192
 (I = 0) 
The long lifetime of europium luminescence allows for time-gating to be utilised 
effectively. In ‘real world’ samples of grain extract, and even possibly river water, the 
presence of certain components may give rise to unwanted short lived auto-fluoresce, 
following excitation at 365 nm. In the instrumental set up used throughout this project, a 
365 nm LED, operating at 330 mW was used as the excitation source, and each sample 
was irradiated for 2 ms during excitation. The time-gated spectrometer then collected 
data 0.01 ms after the excitation pulse, to ensure it is solely the long-lived lanthanide 
luminescence that is being monitored, with a 7 ms intergration time. 
Throughout these titrations, a 2 mL solution of [Eu.L
2
]
+ 
was used and incremental 
additions of an analyte solution, were made which was also dissolved in solution 
containing 0.1 M NaCl and 0.1 M MES at pH 5.9. 
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Figure 3.2 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) (0.1 mM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of glyphosate up to 0.5 mM (red). (Inset) The binding curve of 
[Eu.L
2
]
+
 as a function of increasing glyphosate concentration following the intensity  ratio of 614 nm / 
618 nm 
Following the titration, an overall decrease in emission intensity was observed. Binding 
of glyphosate could be tracked by examining the ratio of emission intensity at 614 nm / 
618 nm in the hypersensitive ΔJ = 2 manifold, and could be used to calculate an 
apparent binding constant, following iterative least-squared fitting to a 1:1 binding 
model. A logK value of 4.02 (±0.02) was extracted, consistent with the relatively strong 
binding expected with a phosphate group to a europium complex. 
The logK value was calculated using Equation 5.2 and the error stated in parenthesis is 
the statistical error of the fit to the data. Other experimental errors could play a role, 
with slight changes in concentration of either the complex or glyphosate would effect 
this value. The pH was controlled using buffer, but the reading from a pH meter is 0.02, 
and although the experiments were conducted in a temperature controlled room, there 
was still some fluctuations throughout all the experiments. 
To test the efficiency of the complex, four samples (A-D) of ‘unknown’ concentration 
were made up by weighing out glyphosate, making a stock solution and then diluting 
further to get four samples of varying concentration. These were then analysed by the 
Durham University Geography Department, who from a stock solution of glyphosate 
were able to create a calibration curve of glyphosate using a Dionex LC system. From 
 85 
 
this calibration curve, the four unknown samples were examined and their concentration 
calculated. These values were then compared to the ‘weighed’ values and those deduced 
by emission spectroscopic analysis. 
Table 3.1 - Four samples of 'unknown' concentration, and the concentration calculated from Dionex LC, 
and via europium emission analysis. The values for Dionex LC are 95% confidence intervals. For the 
weighed complex there is 0.05% error and with the emission of the complex, there is a 10% error 
Sample Weighed conc. (μM) Dionex LC (μM) [Eu.L2]+ (μM) 
A 6.0 3.4 8.0 
B 12.0 11.6 11.1 
C 23.0 21.3 22.0 
D 44.0 44.6 40.2 
 
At lower concentrations, both the Dionex LC column and the complex are not the most 
accurate. Furthermore, at the highest concentration, the complex gives a smaller value 
compared to both the weight and LC column. The other two samples give values in a 
very similar range to the LC column which gives some confidence in the accuracy of 
the complex determination in this range. The USA is one of the only places to set an 
MRL in drinking water of 4.1 μM. This is slightly below sample ‘A’, but if the level of 
glyphosate was above this limit, the use of [Eu.L
2
]
+
 would allow its detection.   
3.3 Testing Competitive Analytes 
Although initial results are promising, in more complex media there are more likely to 
be analytes which compete in binding to the complex and therefore inhibit accurate 
detection of glyphosate. Therefore, potential competitors should be studied to note the 
effect on binding and minimise interference risks. 
3.3.1 Inorganic Phosphate 
The titration was repeated, this time with inorganic phosphate at pH 5.9, in place of 
glyphosate. This competitive binding study observed little change in the 614 nm / 618 
nm intensity ratio consistent with little or no interference. At the end of the titration, the 
pH was raised to 8.0 and a final emission spectrum was taken. 
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Figure 3.3 - The emission spectrum of [Eu.L
2
]
+
 (0.1 mM, 0.1 M NaCl, 0.1 M MES, 295 K) with (red) and 
without (black) phosphate at pH 5.9 and with phosphate (0.5 mM) at 8.00 (blue). (Inset) The intensity 
ratio of 614 nm / 618 nm of [Eu.L
2
]
+
 at pH 5.9 as a function of increasing phosphate concentration 
At pH 8.0, the phosphate di-anion was expected to bind to the complex in a similar way 
to glyphosate. Indeed, the intensity ratio of 614 nm / 618 nm showed a significant 
change from 1.05 at pH 5.9 to 0.63 to pH 8.0, suggesting that binding of inorganic 
phosphate indeed occurs under these conditions.  
The change in spectral form and intensity at pH 8.0 confirms that although phosphate 
has the potential for significant interference, the control of pH should minimize this 
effect. Phosphate is expected to bind in a monodentate fashion, with a water molecule 
still in the inner sphere, as deduced through lifetime measurements.
10
 This is in line 
with previously reported data that phosphate acts as a monodentate ligand to single 
metal centres, with the possibility of bridging to multiple centres.
194,195
 However, 
phosphate does still bind significantly better to the metal centre at pH 8.00, due to the 
stronger coulombic interactions. 
To show that phosphate binds as a monodentate ligand, lifetime measurements were 
taken for [Eu.L
2
]
+
 in D2O and H2O, at the beginning and end of the glyphosate titration. 
These measurements were input into Equation 2.1 to obtain the relevant q values. 
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Table 3.2 - The lifetimes and q values of [Eu.L
2
]
+
 with and without glyphosate in H2O and D2O 
 
Lifetime in H2O 
(τ1 ms) 
Lifetime in D2O 
(τ1 ms) 
q value 
[Eu.L
2
]
+
 0.58 1.42 0.9 
[Eu.L
2
]
+
 + Glyphosate 0.52 1.33 1.1 
 
Table 3.2 clearly shows little change in emission decay rates following the addition of 
glyphosate in both H2O and D2O. Both give a q value of one, within error, which proves 
that the inner sphere water in not lost upon glyphosate binding. If a chelate were 
formed, an inner sphere water would be lost to allow room for this type of binding. 
However, there is no evidence in the Cambridge Crystallography Database Centre for 
phosphate chelation to a lanthanide centre. 
3.3.2 N-Methyl Glyphosate 
To delve deeper into the type of binding that occurs, further tests with other analytes 
were considered useful. Through simple methylation of the glyphosate amine by 
refluxing with formic acid and formaldehyde, methyl glyphosate was synthesised. This 
can give a good indication as to whether the secondary amine plays a role in binding, or 
whether the binding is purely through the phosphate group.  
 
Scheme 3.3 - Synthesis of N-methyl Glyphosate 
A titration similar to glyphosates was carried out with N-methyl glyphosate. Increments 
of N-methyl glyphosate were added to a buffered solution of [Eu.L
2
]
+
 and the emission 
intensity ratio at 614 nm / 618 nm was monitored, as a function of added analyte. 
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Figure 3.4 - The emission spectrum of [Eu.L
2
]
+
 (57 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9) with 
(red) and without (black) N-methyl glyphosate. (Inset) The intensity ratio of 614 nm / 618 nm, as a 
function of increasing N-methyl glyphosate concentration 
Following addition of N-methyl glyphosate (0.5 mM), no major change in either 
spectral form or emission intensity was observed (Figure 3.4). This lack of change 
suggests that in this system, the central nitrogen plays a surprisingly significant role in 
the binding of glyphosate to the europium centre, and the absence of binding maybe 
steric in origin. 
3.3.3 Glufosinate 
Glufosinate is a naturally occurring broad-spectrum, systemic herbicide, which has a 
structure that is not dissimilar to that of glyphosate. It has a phosphinate group, an 
amine, and a carboxylate group. However, with a phosphinate rather than phosphonate 
group, it was predicted not to bind as well as glyphosate as phosphorus O atom is much 
less basic and a much poorer donor to a metal ion. However, glufosinate is an herbicide 
that is produced by some species of soil bacteria, and is a possible competitor of 
glyphosate, particularly in ‘real-world’ samples.196 
 
Figure 3.5 - Structure of glufosinate 
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Incremental additions of glufosinate were added to a buffer solution of [Eu.L
2
]
+
 and was 
monitored by observing total emission intensity ratio changes, at 614 nm / 618 nm.  
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Figure 3.6 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) (57 μM, 0.1 M NaCl, 0.1 M MES, 295 
K, pH 5.9) with increasing concentration of glufosinate, up to 0.5 mM (red). (Inset) The change in 
emission ratio of 614 nm / 618 nm as a function of increasing glufosinate concentration 
As is evident from the intensity ratio (inset, Figure 3.6), there was no significant change 
of spectral form upon increasing glufosinate concentration. It is therefore a clear 
indication that glufosinate does not bind to the complex in the same manner as 
glyphosate. However, there was an overall decrease in emission that was used to assess 
binding (Figure 3.7). 
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Figure 3.7 - The fitted binding curve following the total emission of [Eu.L
2
]
+
 (57 μM, 0.1 M NaCl, 0.1 M 
MES, 295 K, pH 5.9) as a function of increasing glufosinate concentration 
Following the change in total emission, an apparent logK value of 4.17 (±0.02) was 
extracted. Although this is roughly equivalent to glyphosate, the detection of glyphosate 
is through the change in ratio which glufosinate does not impact significantly. The 
issues could arise if there was a very low glyphosate concentration or an excess of 
glufosinate binds more strongly to the complex. However, the concentration of 
glufosinate is never likely to be high enough that it would affect the emission ratio 
hugely. 
3.3.4 Quenching Studies 
As well as competitive binding, there are other factors that can also affect the complex 
emission spectrum which need to be monitored. For example, as [Eu.L
2
]
+
 uses an 
electron-poor azaxanthone chromophore, it can be susceptible to quenching by electron 
rich species. The issue lies with the intermediate triplet state of the chromophore, which 
can undergo non-radiative decay when an exciplex is formed. As the goal of this 
research is to find uses in biological systems, this may be a problem as electron rich 
species are common. Uric acid and catechol were chosen, as they are readily found in 
these systems and are well known quenchers with such azaxanthone Eu complexes.
175
 
3.3.4.1 Uric Acid 
The first to be examined was uric acid, which is a natural component of urine, but is 
also found in the blood. It is the product of the metabolic breakdown of purine 
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nucleotides. Purine can be found in higher plants, and some are capable of this 
degradation step.
197
 Therefore, this may be found in some biological systems tested.  
 
Figure 3.8 - The breakdown of guanine into uric acid 
The concentration of uric acid in human blood is approximately 14 μM, and several 
plants can be found to contain 100-500 mg of uric acid per 100 g of food (6 - 30 μM). It 
is therefore possible that some uric acid could be present in food-stuff tested with the 
complex. Titrations were carried out starting at these levels and increasing to much 
higher concentrations. 
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Figure 3.9 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) with increasing concentrations of uric 
acid, up to 0.5 mM (red) (57 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9). (Inset) The intensity ratio of 
614 nm / 618 nm as a function of increasing uric acid concentration 
The ratio used to track the binding of glyphosate is devoid of any trend, so unlikely to 
compete directly (Figure 3.9, inset). There appears to be no other change in spectral 
form, suggesting that uric acid does not bind to the complex. However, there is a change 
in emission intensity. 
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Figure 3.10 - The change in total emission of [Eu.L
2
]
+
 (57 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9) 
as a function of increasing uric acid concentration, up to 0.5 mM 
Figure 3.10 highlights that there is a significant decrease in intensity upon addition of 
the first 0.05 mM of uric acid. This is suggestive that uric acid interacts strongly in a 1:1 
fashion with the complex, likely forming an exciplex to allow non-radiative decay. 
Hence, a much less intense europium signal is observed. This could be an issue as if 
there are relatively high levels of uric acid in samples being tested with [Eu.L
2
]
+
, 
quenching effects could decrease the europium signal sufficiently for the signal-to-noise 
ratio to effect accurate glyphosate detection.  
3.3.4.2 Catechol  
Another potential quencher is catechol, which occurs naturally in fruit and vegetables. 
Although catechol itself is usually only found in trace amounts, the catechol moiety is 
found widely in the natural world, as well as synthetic catechols being used in the 
production of pesticides, and pharmaceuticals.
198,199
 It is therefore likely that either 
catechol or more complex derivatives could be present in food samples. 
 
Figure 3.11 - The structure of catechol 
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Figure 3.12 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) with increasing concentrations of 
catechol, up to 0.3 mM (red) (57 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9). (Inset) The intensity ratio 
of 614 nm / 618 nm as a function of increasing catechol concentration 
The intensity ratio of 614 nm / 618 nm of [Eu.L
2
]
+
 shows a slight decrease (Figure 3.12, 
inset). However, there is no clear and smooth trend. Furthermore, the change in ratio is 
small in comparison to the change seen upon addition of glyphosate. However, if 
catechol or another compound which bound this moiety was present at 0.5 mM, the 
change seen in the emission would be significant enough to affect the glyphosate 
reading, likely suggesting that there was a lower concentration. This is obviously an 
issue, particularly if levels were close to MRLs.  
Although there is comparatively little change in spectral form in comparison to the 
addition of glyphosate, the change in emission intensity decreases upon addition of 
catechol. 
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Figure 3.13 - The change in total emission of [Eu.L
2
]
+
 (57 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9) 
as a function of increasing catechol concentration, up to 0.3 mM 
The emission intensity is more than halved upon addition of catechol. This decrease is 
problematic as the binding of glyphosate in biological systems is also expected to be 
coupled with a decrease in intensity. Hence, if there are high concentrations of both 
catechol and glyphosate, or perhaps another quencher, the europium emission intensity 
may be insufficient to extract a ratio, and therefore would not be able to detect an 
accurate level of glyphosate. 
3.4 Testing in River Water 
Due to its widespread use in agriculture, glyphosate has been found in river water.
200
 
Therefore, it was imperative to check whether the complex was viable for analysing 
samples in this background medium, or if there is interference from other species 
present in the water. To do this, a sample of river water was taken from the River Wear 
in January 2017. The level of glyphosate in the river was assumed to be minimal, if 
present at all, as the spraying of glyphosate generally stops over the winter months 
when fewer crops are grown. 
The Dionex LC medium of analysis was again used to investigate the river water 
sample. The water had to be filtered through 0.2 μM filters to remove any solids from 
the sample which could block the column. It was tested for a number of common anions 
such as chloride or nitrate. Bromide was also tested for, but none was detected. 
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Table 3.3 - Concentration of anions found in river water, with the detection limit from Dionex LC, with 
95% confidence intervals 
Anion Fluoride Chloride Sulfate Phosphate Nitrite Nitrate 
Concentration 
detected 
(mg/L) 
0.70 23.27 9.91 0.01 
0.03 
 
0.87 
Detection 
limit (mg/L) 
0.01 0.03 0.02 0.02 0.02 0.04 
 
The UV trace of the river water alone was taken to see if anything in the sample absorbs 
at, or close to, the complex excitation wavelength. There is a strong maximum 
absorbance at 228 nm (A228 = 0.558). The absorbance does decrease slowly, but by the 
time is reaches 365 nm (A365 = 0.137), where the complex will be excited, the 
absorbance has not yet reached zero. It is therefore clear that something else 
competitively absorbs at that wavelength. However, the complex should still be able to 
be excited sufficiently to see a spectrum. It is also clear that the use of a time-gated 
method is necessary as there is potentially a lot of background luminescence from 
fluorescent species present in the water.  
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Figure 3.14 - The absorption spectrum of the river water collected from the river Wear (295 K) 
The titrations carried out in river water were analogous to those in buffer. The 
difference stems only from the fact that the solvent changed from purite water to river 
water. Although a number of ions are clearly present in river water, 0.1 M NaCl was 
added, to ensure minimal change in ionic strength, and the pH was maintained at 5.9 
with 0.1 M MES.  
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Figure 3.15 - Changes in the europium spectrum of [Eu.L
2
]
+
 in river water (black) (1.1 mM, 0.1 M NaCl, 
0.1 M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 1 mM (red). (Inset) The 
binding curve, following the intensity ratio of 614 nm / 618 nm as a function of increasing glyphosate 
concentration 
The same intensity ratio of 614 nm / 618 nm was used and gave an apparent logK value 
of 3.81 (±0.02) which is below the binding constant found in purite water. It is 
suggestive of a more competitive media, but the logK value, and the change in spectral 
form implies it should still be able to act as ‘real-life’ probe in river water without 
significant interference from other analytes at pH 5.9. However, a problem arises with 
the significant decrease in overall emission intensity, leading to the observed signal 
being weaker, causing issues in getting accurate readings from the measured ratio.    
3.5 Testing in Rice Samples 
The next step of the investigation was to see if the level of glyphosate could be detected 
in biological samples, particularly plant extract. Rice was selected as a test grain due to 
its high absorbency, so it was thought likely to be able to absorb the water and 
glyphosate. The experiments were also used as a study to compare the speed and 
accuracy of different methods.  
The first step was to take 30 grains of long-grain rice and soak it in glyphosate. The 
herbicide selected was ‘Resolva’ which is commercially available, and therefore, likely 
to be widely used by the public. It contained 0.81% w/w glyphosate giving an 
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approximate aqueous concentration of 5 mM. The grains were split into three groups of 
ten and each group were soaked in 5 mL of glyphosate for 24 h before being dried. 
From this point, each group of grain samples were treated differently. While the rice had 
been soaking in glyphosate, three identical solutions of [Eu.L
2
]
+
 (2 mL, 50 μM) were 
made up, in 0.1 M NaCl and MES, pH 5.9 and then left to lyophilise overnight. 
The first set of ten (A) were washed with 2 mL of tap water and the water was 
immediately added to a cuvette with the complex, salt and buffer, and used to take an 
emission spectrum. Another set of ten (B) were soaked in 2 mL of water for 24 h, before  
this water was added to the second cuvette of complex and used to take an emission 
spectrum. The final ten grains (C) were frozen in liquid nitrogen and crushed using a 
mortar and pestle. The sample was then soaked for 24 h in water. To collect the water 
from group ‘C’, the mixture has to be filtered through a syringe filter before being 
added to a cuvette to take the final emission spectrum. This process ensured that all the 
pieces of floating rice had been removed which have the potential to affect the emission 
spectrum. 
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Figure 3.16 - The variation in the emission spectrum of [Eu.L
2
]
+
 (1.1 mM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) (green), with different treatments of rice, ‘A’ (red), ‘B’ (black) and ‘C’ (pink) 
It was found that the ratio of intensity at 614 nm / 618 nm decreased from 0.9 in the 
complex alone, to 0.76 (A), 0.74 (B), and 0.73 (C) for the three different rice treatments. 
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There is also an increase in emission intensity for ‘A’ and ‘B’. This behaviour is 
interesting, as an increase in emission intensity has not previously been seen for this 
complex upon binding glyphosate. Nevertheless, the binding event is tracked using the 
ratio of 614 nm / 618 nm. In each case, the ratio dropped, rather than increased as 
occurred in buffer solution and river water. Such behaviour is indicative of competition 
from another analyte, which may perturb the results. Sample set ‘B’ gives a lower ratio 
value than ‘A’ suggesting the addition of soaking time extracts other species from the 
grain, which may include glyphosate. 
Although set ‘C’ gave a lower ratio value than either ‘A’ or ‘B’, the additional steps in 
the protocol makes the system inaccessible to most people, who do not have access to 
liquid nitrogen, and adds time to the process. Furthermore, one issue with glyphosate in 
food is that it is sprayed during the drying process and unlikely to be taken up by fruit 
or grain. Indeed, the majority of glyphosate is expected to be on the outside of food. 
This step of crushing the sample also may add other competitive compounds, which 
could massively interfere with the complex binding glyphosate. 
Taking this into account, the next step of this study is testing for glyphosate in grains. 
This initial result in rice suggested that a calibration curve for grain extract was 
necessary as it appears as though there are other compounds that also bind to the 
complex. To take this into account, the binding curves in buffer solution or river water 
are not sufficient to also work in biological media. This work suggests that the best way, 
for the most accurate results, would be to leave the grains soaking in water for 24 hours 
to ensure all the glyphosate is extracted. If a rough calculation is needed, simple 
washing may be sufficient. However, as we strived to be rigorous, subsequent work was 
carried out after soaking for 24 hours before testing.  
3.6 Analysis of Grain Samples 
The next step to test whether complex [Eu.L
2
]
+
 was able to detect glyphosate in ‘real-
life’ samples, was to obtain grains which have been treated with different levels of 
glyphosate, to test whether it is possible to calculate the concentration using the 
methods described above. From the initial tests with rice, it was clear that a calibration 
curve using water that had soaked grains, which had not been treated with glyphosate, 
was necessary. 
 99 
 
To establish the calibration curve, untreated cordiale wheat grains were soaked in purite 
water for 24 h. The water was then lyophilised prior to regenerating in 2 mL solution of 
complex in 0.1 M MES and NaCl. Glyphosate (1mM solution) was added in 
incremental steps to the complex mixture to produce a calibration curve. 
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Figure 3.17 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) (51 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of glyphosate up to 0.5 mM (red) in grain extract. (Inset) The 
ratio of emission intensity at 614 nm / 618 nm as a function of increasing glyphosate concentration 
In previous experiments, there were several ratios which could have been chosen to 
track changes in spectral form as a function of the change in concentration of 
glyphosate. In Figure 3.17, it can be seen that the ratio used thus far with [Eu.L
2
]
+ 
clearly does not give rise to a smooth binding curve. Indeed, the ratio decreases which is 
unlike the analogous experiments in buffer and tap water. Other ratios that could have 
been used, such as comparing the ΔJ = 2 and the ΔJ = 1 manifolds were of similarly 
poor quality, and it was impossible to retrieve an apparent binding constant. The only 
spectral response change that gave a curve that could possibly be used was the total 
emission. 
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Figure 3.18 - The change in total emission of [Eu.L
2
]
+ (51 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
as a function of increasing glyphosate concentration, up to 0.5 mM  
In this grain extract experiment, the overall emission intensity decreased. However, 
using the total emission in place of a ratio to calculate a binding constant is not ideal. 
The advantage of a ratiometric method, rather than looking at change in the overall 
emission is that ratios are not as dependent on the concentration of the complex. 
Variations in total emission may also be subject to interference from unrelated signal 
quenching process. 
Following the addition of the first 50 μM of glyphosate, a significant amount of noise is 
present, as highlighted by the curve tracking overall intensity (Figure 3.18). As this is 
the region in which glyphosate is likely to be detected in grains, and the MRL in the EU 
is 59 μM, it constitutes a difficult problem. It appears as though the complex is bound to 
something other than glyphosate present in grains, which glyphosate is replacing. The 
unknown analyte is interfering with the results.  
There are two potential solutions to consider in an attempt to circumnavigate this 
problem. Firstly, something could be added to the initial solution which could bind to 
the chemical responsible for the loss of a ratiometric response. The second option was 
to consider the use of another complex that showed higher affinity yet maintained 
selectivity for glyphosate, and functioned in a range of media. 
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3.7 Removing the Quenching Species 
As this complex has already been synthesised and showed initial promise, the first 
choice of attack to overcome this problem was to attempt to remove the compound or 
compounds in the grain which causes the issues. However, grains are complex 
biological entities and therefore, it is difficult to predict exactly what is causing the 
effect. 
Therefore, instead of concentrating initially on the grains themselves, the complex was 
examined to determine possible interactions. As the chromophore is electron poor and 
π- conjugated and the problem is a decrease in intensity, there is a possibility of π- π 
stacking. This interaction would diminish the activity of the probe as instead of energy 
transfer to the europium, non-radiative decay is more likely occur. Polyphenols are 
regularly found in biological media, which would be prime candidates for π- π stacking 
with the chromophore, and a consequent of quenching of emission via charge transfer. 
The UV spectrum of the background grain showed a strong absorption band at around 
200 nm. However, the tail is long and there is still strong absorption at 336 nm, the 
wavelength at which the chromophore is excited. Even at 365 nm where the time-gated 
experiments are excited, there is still 0.5 abs, i.e. the light used to excite the complex is 
also being absorbed by the endogenous chromophore. 
3.7.1 Activated Charcoal 
The first attempt to remove the endogenous chromophores in the hope of returning to a 
ratiometric response of [Eu.L
2
]
+
 with varying concentrations of glyphosate, was to use 
activated charcoal which has been known for decades to remove impurities through 
chemical filtration.
201
 Charcoal (20 mg) was initially added to the solution extracted 
from the grain, before the complex was added. The mixture was stirred at room 
temperature for 2 h, the charcoal removed by centrifuge and the absorption spectrum 
was taken. The process was repeated multiple times, eventually stirring for 24 h when 
no further change was seen in the absorption spectrum. Although it was clear that the 
treatment reduced the absorption at 336 nm, it did not decrease to zero, only to 0.17 abs 
which is still more than half of the 0.30 abs which is the target of absorption for the 
complex. However, this is still a significant decrease from 0.71 abs.  
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Figure 3.19 - The absorbance spectrum of grain extract stirring in activated charcoal at 0 h (black),  2 h 
(red) and 24 h (blue) 
After this reduction in absorbance by grain extract, a titration was attempted to see if 
stirring with activated carbon had helped. The titration was performed, exciting at 336 
nm with [Eu.L
2
]
+
. 
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Figure 3.20 - Changes in the emission spectrum of [Eu.L
2
]
+
 (black) in grain extract that has been treated 
with activated carbon with increasing concentration of glyphosate up to 0.5 mM (red) (46 μM, 0.1 M 
NaCl, 0.1 M MES, pH 5.9, 295 K). (Inset) The intensity ratio of 614 nm / 618 nm as a function of 
increasing concentration of glyphosate 
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Following treatment with charcoal, there was still an overall decrease in emission 
intensity .The ratio used in buffer solution, 614 nm / 618 nm, increased upon addition of 
glyphosate (Figure 3.20). However, it was not a smooth increase, and still not one that 
would be suitable to be used to calculate either an apparent binding constant of 
glyphosate under these conditions, or the concentration of glyphosate in unknown 
samples. 
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Figure 3.21 - The change in total emission of [Eu.L
2
]
+
 (46 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
with increasing concentration of glyphosate 
Furthermore, looking at the changes in total emission of [Eu.L
2
]
+
 with increasing 
concentration of glyphosate, the start of the titration still has a lot of noise which has not 
been removed by treatment of activated carbon. The compound that binds to the 
complex which is replaced by glyphosate is clearly still present. Although activated 
carbon has helped to remove some compounds in the grain, not enough of the 
competitors have been removed to make this complex good enough to work in complex 
biological media. 
3.7.2 Silver Nitrate 
Another additive used was silver nitrate. It was theorised that a small amount of silver 
nitrate would interact with some biological molecules, especially proteins and cause 
them to precipitate out of solution and allow them to be easily filtered off. Solid was 
expected to form almost instantaneously but even after treating the solution and stirring 
for 24 h, no solid could be observed. 
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3.7.3 Acid Bath Treatment 
It was hypothesised that under acidic conditions many large biological molecules, 
including proteins, would denature and therefore no longer interact with the complex. 
Glyphosate has been detected in urine, meaning it has survived the rigour and pH 
swings of human digestion.
202,203
 As the stomach is approximately pH 2.0, glyphosate 
should be stable under these conditions. After stirring at room temperature for 24 h at 
pH 2.0, the pH of the background solution was raised back up to 5.9 followed by a 
titration which monitored europium emission as a function of glyphosate concentration.  
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Figure 3.22 - Changes in the emission intensity of [Eu.L
2
]
+
 (black) (46 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) in acid treated grain extract with increasing concentration of glyphosate, up to 0.5 mM (red). 
(Inset) The intensity ratio of 614 nm / 618 nm of [Eu.L
2
]
+
 as a function of increasing glyphosate 
concentration  
Upon addition of glyphosate, the emission intensity decreased, as expected, coupled 
with a change in spectral form (Figure 3.22). Using the ratio 614 nm / 618 nm there was 
an increase upon addition of glyphosate. However, there is a lack of a distinct curve to 
utilise. Following the changes in total emission, however, there is a decrease in 
intensity, which showed a comparatively smooth curve. 
 105 
 
0.0 0.1 0.2 0.3 0.4 0.5
8000
9000
10000
11000
12000
13000
14000
15000
16000
17000
T
o
ta
l 
E
m
is
s
io
n
[Glyphosate] / mM  
Figure 3.23 - The changes in total emission of [Eu.L
2
]
+
 (46 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
in acid treated grain extract following an increase in glyphosate concentration 
Despite the clear trend of decreasing intensity, there is still noise close to the beginning 
of the titration, suggestive that the compound that binds to the complex has not been 
removed by the treatment of acid. Outside of this initial range, the smooth curve 
suggests that the acid treatment of the grain extract has aided in removing some 
unwanted competition.  
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Figure 3.24 - Following the intensity ratio of ΔJ = 4 / ΔJ = 2 (681-704 nm / 608-629 nm) of [Eu.L2]+ (46 
μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) as a function of increasing glyphosate concentration 
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A better example highlighting the removal of some interference follows the ratio of ΔJ 
= 4 / ΔJ = 2 (681-704 nm / 608-629 nm), two hypersensitive transitions. The binding 
curve has little noise at the start with a steep response at low glyphosate concentrations, 
over the concentration range 0-50 µM. However, a 1:1 binding curve could not be fit, 
suggesting that glyphosate isn’t binding to [Eu.L2]+ as expected, particularly since the 
614 nm / 618 nm ratio also does not give a good curve.  
3.8 Other Azaxanthone Based Complexes Screened 
Although the acid digestion of the grains showed some promise, the problems which 
arose upon testing in grain extract were not overcome. Therefore, the second route using 
alternative complexes was taken to find a complex which would continue to work in 
biological media. 
3.8.1 The Tri-positive Complex [Eu.L
3
]
3+
 
The next complex examined was very similar in structure to [Eu.L
2
]
+
. The difference 
stems from the lack of the N-Me group on the cyclen ring and the ester group on the 
alanine arm, meaning the overall charge of the complex is now +3, rather than +1. 
Synthesis is analogous to [Eu.L
2
]
+
, up to compound 11 (Scheme 3.2). Then instead of 
methylation of the final nitrogen on the amine, and deprotection of the esters, the ligand 
is immediately complexed to give [Eu.L
3
]
3+
. The lifetimes in H2O and D2O were 
measured for this complex, giving values for τ1 of 0.27 and 0.63 ms respectively. 
Inserting these values into Equation 2.1, gave a q value of 2.3, which fits with the 
observation that the ligand is seven coordinate, leaving two spaces for solvent 
molecules. 
 
Figure 3.25 - The structure of [Eu.L
3
]Cl3 
 107 
 
Modification of the N-Me group in [Eu.L
2
]
+
 to N-H in [Eu.L
3
]
3+
 changes the steric 
demand around the europium centre. The ester groups protecting the carboxylic acid 
group of the alanine moiety means the overall charge of the complex has changed, as 
there is no negative charge on the ligand to balance the +3 charge from the europium 
ion. Each of these points was expected to influence binding and, as such, a different 
logK value needed to be determined experimentally. 
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Figure 3.26 - Changes in the emission spectrum of [Eu.L
3
]
3+
 ( 40 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 
295 K) upon addition of glyphosate, up to 0.5 mM. (Inset) The intensity ratio of 613 nm / 618 nm as a 
function of increasing glyphosate concentration 
The addition of glyphosate can be seen to decrease the overall total emission. However, 
no ratio could be found in which a smooth binding curve could be attained. Even 
following the total emission a curve could not be found. The lack of any useful spectral 
change makes it difficult to glean any information about binding constants. The absence 
of a useful ratio meant that this complex was not used in further experiments. 
3.8.2 Azathioxanthone Complex 
The complex, [Eu.L
4
]
3+
, (synthesised by R. Pal) utilises an azathioxanthone group 
rather than an azaxanthone as a sensitiser. It was used to see if [Eu.L
4
]
3+
 would still bind 
to glyphosate, as it is structurally similar to previous complexes, and whether the slight 
change in chromophore structure would have any effect on the quenching of the 
emission state in grain background.  
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Figure 3.27 - The structure of [Eu.L
4
]Cl3 
There is again no N-Me group on the cyclen ring and there is a change in the amide 
arm, from a methyl group to a phenyl moiety; i.e. the arm is derived from phenylalanine 
rather than alanine. The lifetimes in both H2O and D2O were calculated and gave values 
for τ1 of 0.30 and 0.45 ms respectively. Putting these values in Equation 2.1, a q value 
of 1.1 was obtained. This is slightly different from the value calculated in [Eu.L
3
]
3+
 
which had two inner sphere waters. The difference in q value could be to do with the 
more bulky arms, which increase steric hindrance sufficiently to stop the second water 
molecule binding, meaning this complex is eight coordinate. 
After seeing little binding in the grain extract, a change in chromophore was thought to 
be necessary, in order to permit longer wavelength excitation, where there is less 
absorbance by endogenous chromophores in grains. With azathioxanthone, excitation 
can occur at 385 nm. However, there is still the risk of quenching by electron-rich 
species in more complex media. Titrations were carried out in purite water, with the 
addition of 0.1 M NaCl and MES to maintain ionic strength and pH respectively. 
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Figure 3.28 - Change in the total emission of [Eu.L
4
]
3+
 (90 μM, 0.1 M NaCl, 0.1 M MES, pH = 5.9, 295 
K) (black) with increasing glyphosate concentration, up to 0.3 mM (red). (Inset) The intensity ratio of 615 
nm / 620 nm as a function of increasing glyphosate concentration 
From Figure 3.28, it is clear the complex has bound to glyphosate with a significant 
change in spectral form observed, revealed particularly in the ΔJ = 2 manifold around 
620 nm. From the fitted curve, an apparent logK value of 4.95 (±0.01) was determined 
which is greater by nearly a factor of 10 than [Eu.L
2
]
+
 (4.01). This greater logK value 
suggests from initial experiments that this complex is a better glyphosate probe. 
Lifetime experiments were also performed to see any change in lifetimes, and what this 
could tell us about binding. In H2O, the Eu emission lifetime was 0.39 ms, with D2O 
giving a slightly longer lifetime of 0.48 ms. These are both longer than found without 
glyphosate, and gave a q value of 0.30 suggesting the inner sphere water has been 
displaced. This behaviour is expected as it is theorised that glyphosate will bind to the 
metal directly, through its phosphate oxygen, and hence replace the most labile ligand, 
which in this case is the water molecule. 
3.8.2.1 Titration of [Eu.L
4
]
3+
 with Inorganic Phosphate 
It is likely that as this complex is highly charged, other analytes may interfere with 
glyphosate binding. As it again binds through the phosphate group, one of the main 
competitors was expected to be inorganic phosphate. A control experiment was 
undertaken to see if the complex binds phosphate in buffered solution.  
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Figure 3.29 - Changes in the emission spectrum of [Eu.L
4
]
3+
 (black) (90 μM, 0.1 M NaCl, 0.1 M MES, 
pH = 5.9, 295 K) following incremental additions of phosphate, up to 0.5 mM (red). (Inset) The intensity 
ratio of 615 nm / 620 nm as a function of increasing concentration of phosphate 
A decrease in emission intensity was observed and the change in spectral form appeared 
very similar to that seen with glyphosate. Indeed, following the ratio as before of 615 
nm / 620 nm, an apparent logK value of 4.26 (±0.02) was calculated, which is less than 
a factor of ten smaller than glyphosate. However, the fit is clearly not perfect. The 
conclusion which can be drawn from this is that although glyphosate has a higher 
binding constant, phosphate is likely to interfere with the intensity ratio and may be the 
reason why the complex is not suitable for use in river water samples. 
 3.8.2.2 Titration of [Eu.L
4
]
3+
 with AMPA 
AMPA (Figure 3.30) is a metabolite of glyphosate, which still contains the phosphonate 
group and hence it was theorised that it could still bind to the Eu complex. 
 
Figure 3.30 – The structure of AMPA 
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Figure 3.31 - Changes in the emission spectrum of [Eu.L
4
]
3+
 (black) (80 μM, 0.1 M NaCl, 0.1 M MES, 
pH = 5.9, 295 K) following incremental additions of AMPA, up to 1 mM (red). (Inset) The intensity ratio 
of ΔJ = 1 / ΔJ = 2 following increasing concentration of AMPA 
Unexpectedly, following the ratio of intensities of the manifolds ΔJ = 1 / ΔJ = 2, as well 
as the intensities at 615 nm / 620 nm, a distinct change upon addition of AMPA was not 
observed. Even after adding up to 1 mM, the changes in ratios were noisy and not easy 
to follow. However, there is a decrease in emission intensity. These results suggest that 
the complex may interact with AMPA, but not bind to the metal centre in the same 
manner as both glyphosate and phosphate.  
3.8.2.3 River Water 
Following on from the successful titration in buffer, the next step was to see how the 
complex functioned in the slightly more complex medium of river water, using the same 
sample introduced in Section 3.4.  
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Figure 3.32 - Changes in the emission spectrum of [Eu.L
4
]
3+
 (black) (90 μM, 0.1 M NaCl, 0.1 M MES, 
pH = 5.9, 295 K) with increasing levels of glyphosate in river water, up to 0.5 mM (red). (Inset) The 
intensity ratio of 615 nm / 620 nm as a function of increasing glyphosate concentration 
Initial results in river water were not promising, with Figure 3.32 showing little change 
in spectral form, and the intensity ratio originally used of 615 nm / 620 nm gave a poor 
correlation. There is also very little change in emission intensity.  
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Figure 3.33 - The change in the intensity ratio of ΔJ = 1 / ΔJ = 2 of [Eu.L4]3+ (90 μM, 0.1 M NaCl, 0.1 M 
MES, pH = 5.9, 295 K) following incremental additions of glyphosate in river water, up to 0.5 mM 
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However, different ratios were investigated and it was found that a ratio of bands, 
namely ΔJ = 1 / ΔJ = 2 was found to produce a more useful apparent binding curve 
(Figure 3.33). Although this provided a smooth curve, a 1:1 binding model did not give 
rise to a binding constant. As river water contains phosphate, it is possible this is 
interfering with glyphosate binding.  
3.8.2.4 Testing the Complex in Grain Extract 
The next step was to test how efficient [Eu.L
4
]
3+
 was at detecting glyphosate in ‘real-
life’ samples. Following the river water titration, the change in spectral form in the ΔJ = 
2 band itself was not as obvious, so the binding event was followed using two 
transitions, ΔJ = 1 and ΔJ = 2. 
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Figure 3.34 - Changes in the emission spectrum of [Eu.L
4
]
3+
 (black) (90 μM, 0.1 M NaCl, 0.1 M MES, 
pH = 5.9, 295 K) in grain extract with increasing glyphosate concentration, up to 0.5 mM (red). (Inset) 
The intensity ratio of ΔJ = 1 / ΔJ = 2 as a function of increasing glyphosate concentration 
Comparing the start of this titration in grain extract to that in buffer solution clearly 
highlights the difference in spectral form, particularly in the ΔJ = 2 band. The band in 
grain extract is already a single peak, compared to two distinct ones at the start of the 
buffer titration. This behaviour suggests that there is something in grain extract which 
has already bound to the complex to cause this change in form, perhaps something 
containing a phosphate group. An issue that arose from this conjecture is that the ratio 
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followed in the buffered solution, of 615 nm / 620 nm did not show any correlation, 
upon addition of glyphosate. 
A binding curve was found, however, by comparing the ΔJ = 1 and ΔJ = 2 transition 
intensities, giving an apparent logK value of 4.39 (±0.03). As can be seen in Figure 
3.34, the binding curve is not a perfect fit, and therefore, this value is subject to error, 
and the further use of this curve to calculate the concentration of glyphosate is not ideal. 
Furthermore, using this ratio is not as useful compared to the ratio 615 nm / 620 nm due 
to the significantly smaller change. The binding curve in the ratio of bands is in the 
range 0.208-0.234 compared to 3.4-6.3 as seen in 615 nm / 620 nm. The significantly 
smaller range with the bands could lead to much greater error, with any noise 
potentially having great effect on the reading of glyphosate concentration. 
In addition, the use of azathioxanthone as a chromophore has the significant 
disadvantage of having a smaller extinction coefficient than the azaxanthone, meaning 
more complex is needed to see change and the binding curve it is then more susceptible 
to noise fluctuations. 
3.8.3 Cationic Complex, [Eu.L
5
]
3+
 
The next complex (synthesised by S. Shuvaev) utilises a new chromophore used 
previously within the Parker group.
204
 It utilises an extended chromophore system as 
opposed to the fused ring moiety previously used. If the quenching arose in the 
aforementioned complexes from π-π stacking, it is less likely to affect [Eu.L5]3+. The 
use of the same phenylalanine based arm over the alanine arm was partly due to the 
higher logK value of [Eu.L
4
]
3+
 over [Eu.L
2
]
+
. It may encourage selective binding of 
glyphosate, but, for this to occur, disassociation of one pyridine nitrogen atom must take 
place. This process may lead to decreases in the overall emission intensity but may also 
give rise to a large change in spectral form.  
The extended chromophore with the push-pull system means europium is excited 
through the ICT state of the ligand. The extended conjugation shifts the excitation 
wavelength to 340 nm, but the broad absorption band means that there is still significant 
absorbance at the LED wavelength of 365 nm.  
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Figure 3.35 - The structure of [Eu.L
5
]
3+
 
As expected, there was a decrease in emission intensity. However, there is not the 
predicted change in spectral form, and as such, finding intensity ratios capable of 
following the binding event becomes increasingly difficult (Figure 3.36). 
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Figure 3.36 - Changes in the emission spectrum of [Eu.L
5
]
3+
 (black) (20 μM, 0.1 M NaCl, 0.1 M MES, 
pH 5.9) with increasing concentration of glyphosate, up to 0.5 mM (red).  (Inset) The intensity ratio of 
(1.8 - (ΔJ = 4 / ΔJ = 2)) with increasing glyphosate concentration 
The change in ratio that gave the most promising results involved the comparison of the 
ΔJ = 4 / ΔJ = 2 transition. A binding constant was calculated using an iterative least-
square fitting to a 1:1 binding model, giving an apparent logK value of 5.24 (±0.04), the 
highest value found thus far. 
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The titration was also carried out using a time-gated instrument, as the relatively high 
absorbance at 365 nm meant that the europium emission signal was sufficiently large to 
allow use of this method. It also means going forward, this technique can be used to 
remove fluorescence from the grain extract, as it removes the first 0.01 ms of emission. 
Following promising glyphosate results, the next step would be to look at the effect of 
possible interferents, such as phosphate. 
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Figure 3.37 - Changes in the emission of [Eu.L
5
]
3+
 (black) ( 20 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9) 
with increasing concentration of phosphate, up to 0.5 mM (red). (Inest) The intensity ratio of ΔJ = 4/ΔJ = 
2 as a function of increasing concentrations of phosphate 
A 15% decrease in emission intensity upon addition of phosphate was observed (Figure 
3.37). However, the intensity ratio did not produce any meaningful variation. 
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Figure 3.38 - The emission spectrum of [Eu.L
5
]
3+
(black) ( 20 μM, 0.1 M NaCl, 0.1 M MES, 295 K) with 
0.5 mM of glyphosate (red), 0.5 mM of phosphate at pH = 5.9 (blue) or pH 8.0 (green) 
The effect of pH on phosphate was also investigated. After altering the pH of the 
complex and phosphate (0.5 mM) to 8.0, there was no change in emission intensity or 
spectral form suggesting that the deprotonation of the second phosphate oxygen does 
not affect the binding. Furthermore, the overlaid emission spectrum of glyphosate, 
phosphate at pH 5.9 and 8.0, all showed almost exactly the same emission intensity and 
spectral form. This could potentially be a huge issue in ‘real-world’ samples as there 
would be no way to distinguish between a signal from phosphate and a signal from 
glyphosate. 
Testing in grain extract will give an indication of whether this complex will be able to 
function in more complex media. It may be possible that there is endogenous 
phosphate-bearing material in the group which could interfere with glyphosate binding 
to the complex.  
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Figure 3.39 - Changes in the emission spectrum of [Eu.L
5
]
3+
 (black) in grain extract (20 μM, 0.1 M NaCl, 
0.1 M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.5 mM (red). (Inset) The 
intensity ratio of ΔJ = 4 / ΔJ = 2 following incremental additions of glyphosate 
Again, a distinct lack of change in spectral form meant that no ratio was found which 
could be used to follow the binding event. To highlight this, the ratio of two bands in 
Figure 3.39 shows no correlation between ΔJ = 4 / ΔJ = 2 and glyphosate concentration. 
Furthermore, the unusual change in spectral form suggests that something is bound to 
the complex which competes with glyphosate which could explain why the emission 
intensity initially increases, and then decreases back to almost the original intensity. 
To further test this complex, the grains were treated with acid, as in Section 3.7.3. To 
see if this could improve the response of the complex with glyphosate.  
 119 
 
580 600 620 640 660 680 700 720
0.0
0.2
0.4
0.6
0.8
0.0 0.1 0.2 0.3 0.4 0.5
1.50
1.52
1.54
1.56
1.58

J
 =
 4
 /
 
J
 =
 2
[Glyphosate] / mM
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength / nm  
Figure 3.40 - Changes in the emission spectrum of [Eu.L
5
]
3+
 (black) (20 μM, 0.1 M NaCl, 0.1 M MES, 
pH 5.9, 295 K) in acid treated grain extract with increasing glyphosate concentrations, up to 0.5 mM 
(red). (Inset) The intensity ratio of ΔJ = 4/ ΔJ = 2 with incremental additions of glyphosate 
The treatment of acid appeared to help the change in emission intensity to return to a 
more typical trend of a decrease with increasing glyphosate concentrations. However, 
even at the beginning of the titration, the spectral form of ΔJ = 2 was still different from 
the titration which was performed in buffer solution. It suggests that even with the acid 
treatment, there is still something in the grain extract which binds to the complex.  
The complex binds to unwanted analytes, which may be due to the +3 charge. Hence, 
there is a suggestion that this would be less selective for glyphosate as other negatively 
charged compounds within biological media are likely to bind to the complex, through 
simple electrostatic interactions. Therefore, going forward, a complex that does not have 
such a large charge may be required to increase selectivity for glyphosate. 
3.9 Conclusion and Further Work 
The four compounds tested in this chapter utilised the alanine or phenylalanine arm in 
the detection of the herbicide, glyphosate. The complexes also differed through the 
variation of the chromophore structure, and systems with an azaxanthone, 
azathioxanthone and an extended chromophore were examined. 
With the exception of [Eu.L
3
]
3+
, all complexes were found to bind glyphosate in buffer 
solution, showing that in non-competitive media, the complexes have some merit, and 
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most bound at a rate that would be useful if looking at the detection limits set by the EU 
and US EPA of glyphosate in food. However, the complexes were often not selective 
for glyphosate, as seen in the titrations with phosphate in particular. The pH was 
specifically set at 5.9 to attempt to overcome this competition but this strategy did not 
seem to be successful in every case.  
Furthermore, once the titrations were carried out in more complex media, it became 
evident that the complexes were affected by the presence of other species which made 
the selective detection of glyphosate impossible.  
Both the azaxanthone and azathioxanthone systems are sensitive to quenching of the 
intermediate triplet state due to the electron deficient nature of the chromophores. This 
aspect was highlighted by the titrations run with [Eu.L
2
]
+
 and potential electron rich 
quenchers. They all showed a dramatic decrease in emission intensity upon addition of 
the quencher and as these were switch-off probes anyway, this behaviour only 
exacerbated the problems related to glyphosate binding. 
The complex, [Eu.L
5
]
3+
, binds glyphosate but the change in spectral form and indeed 
emission, was limited. Therefore, any interference from other species stopped efficient 
detection of glyphosate, as was seen in the grain extract. Although once the grains were 
treated with acid, the ability of the complex to detect glyphosate was enhanced, it was 
not sufficient for the complex to be useful. 
This chapter showed the types of system that would not work in ‘real-life’ samples. For 
example, no further work should be done in the detection of glyphosate in grain extract 
with azaxanthones or azathioxanthones lanthanide probes, as they are too easily 
quenched by electron-rich species. 
Although the use of the extended chromophore stopped this interference, [Eu.L
5
]
3+
 was 
not selective for glyphosate, perhaps due to the +3 charge associated with the complex. 
Therefore, by changing the charge of the complex, for example by the addition of a 
carboxylate group, phosphonate or phosphinate group on the 6-position of the pyridines 
which would decrease the positive charge to +1. Furthermore, the comparison between 
these groups could further develop the probe.  
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4. Further Development on Europium Sensors for Glyphosate 
Detection 
A series of complexes were synthesised, the first of which was originally designed as a 
zinc sensor, building on work by Pope et. al..
205
 The tripicolylamine group binds to a 
zinc ion through the four exocyclic nitrogen atoms. It was found more recently to bind 
strongly to ATP and ADP with the aid of zinc, which interestingly induced opposite 
chirality into the probe complex.
206
 It was therefore possible to distinguish between the 
nucleotides and allowed the determination of the relative concentrations in a mixture of 
the two. As it binds to ATP and ADP, it was hypothesised that the complex could 
potentially bind to glyphosate directly through the phosphonate group. 
4.1 Synthesis of [Eu.L
6
] 
The complex, [Eu.L
6
], was synthesised from cyclen, and follows Scheme 2.1 giving rise 
to the intermediate diester, 3. Preparation of the chromophore used in this complex 
required a six step synthesis (Scheme 4.1). Starting from chelidamic acid, the hydroxyl 
group is converted to a chloride atom and the carboxylate groups were protected as 
methyl esters, 13, before halide exchange to provide the iodo compound, 14. Controlled 
reduction of a single ester to the hydroxyl group (15) was followed by a Sonogashira 
cross-coupling reaction with 4-ethynylanisole to form the extended chromophore 
system, 16. The final step in the chromophore synthesis is mesylation to give the 
intermediate, 17. 
 
Scheme 4.1 - Synthesis of the extended chromophore, 17 
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Synthesising the tripicolylamine was conducted in a single step from commercially 
available starting materials, following a previously published method (Scheme 4.2). 
205
 
A modified purification step was utilised with an alumina column being found to be 
more effective than a silica column.  
Scheme 4.2 - Synthesis of the tripicolylamine arm, 18 
Stepwise alkylation of 3 with 17 gave first 19, followed by addition of the 
tripicolylamine arm, 18, to yield 20 (Scheme 4.3). Hydrolysis of the peripheral ester 
groups was undertaken using basic conditions and subsequent complexation gave 
[Eu.L
6
]. 
 
Scheme 4.3 - Synthesis of [Eu.L
6
] 
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It was not found possible to purify the complex itself either by column chromatography 
or HPLC. However, purification of the ligand was achieved using HPLC and the 
complex was dialysed to remove any unwanted salt, which is an inevitable by-product 
in this complexation reaction. Complexation was monitored using both mass 
spectrometry and emission spectroscopy. Complete consumption of the ligand was 
confirmed by the absence of any residual ligand fluorescence. 
4.2 Luminescence Studies on [Eu.L
6
] 
Following successful synthesis of [Eu.L
6
], a titration was set up in purite water with 0.1 
M NaCl and 0.1 M MES at pH 5.9. Incremental additions of glyphosate were followed 
through changes in europium emission, following excitation at 365 nm. Although this is 
not the maximum absorbance of this complex (λmax = 340 nm), 365 nm is a 
commercially available LED laser and there is still adequate absorbance at this 
wavelength to achieve a sufficiently intense signal. Some initial titrations were 
performed without time-gated methods for more efficient collection of data. 
4.2.1 Buffer Solution 
In a buffer solution, there should be no binding competition from unwanted species and 
the pH is controlled, so glyphosate binding to the complex should be easily followed 
through the change in emission and spectral form. It is hypothesised that in the presence 
of glyphosate, the pyridine carboxylate on the chromophore would be displaced from 
the metal centre to allow glyphosate to bind through the phosphate oxygen. A 
significant change in spectral form is expected which should be easy to track through 
the use of a variety of wavelength ratios. 
The first titration was performed without time-gating. The complex was excited at its 
absorbance maximum, i.e. 340 nm. Initial testing was extremely promising; a ‘switch-
on’ effect was observed and multiple ratios could potentially be used to monitor the 
binding of glyphosate to the complex. Two bands in the hypersensitive ΔJ = 2 manifold, 
604-614 nm and 614-633 nm became the chosen ratio to following the emission of the 
europium complex with increasing concentrations of glyphosate. 
 124 
 
560 580 600 620 640 660 680 700 720 740 760
0
2
4
6
8
10
12
14
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0 1 2 3 4 5
[Glyphosate] / mM
I 6
0
4
-6
1
4
/I
6
1
4
-6
3
3
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength / nm
 
Figure 4.1 - The change in the emission intensity of [Eu.L
6
] (black) (7 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with incremental additions of glyphosate, up to 5 mM (red) with no stirring after addition. 
(Inset) The intensity ratio of 604-614 nm / 614-633 nm as a function of increasing glyphosate 
Upon repeating these titrations, discrepancies between what should be the same 
titrations were found, after using different instruments. After initial testing on a 
fluorolog where each scan takes approximately 10 seconds per scan, they were repeated 
on a time-gated instrument which takes close to 5 minutes per spectrum. They were 
found to have different logK values of 3.09 and 4.11 respectively. The differences 
between the two titrations were time and wavelength. Having changed the excitation 
wavelength on the fluorolog to 365 nm, a binding constant within error of the original 
was found. It was therefore hypothesised to be due to time. 
An experiment which followed the change in spectral form after the addition of a small 
increment of glyphosate over time was performed. It was found that after stirring for 10 
minutes, there was no further change in spectral form. Therefore, all subsequent 
titrations with [Eu.L
6
] were performed after stirring for ten minutes. 
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Figure 4.2 - Changes in the emission intensity of [Eu.L
6] (black) (6 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 
295 K) with incremental additions of glyphosate, up to 0.5 mM (red). (Inset) The intensity ratio of 604-
614 nm / 614-633 nm as a function of increasing glyphosate 
The apparent logK value of the addition of glyphosate to [Eu.L
6
] with ten minutes 
stirring after each increment gave an apparent logK value of 5.36 (±0.02), significantly 
larger than found without stirring. There is a strong change in emission intensity and the 
spectral form is visually different upon addition of glyphosate, particularly in the 
hypersensitive ΔJ = 2 manifold. The linear range is also well within the MRLs of 
glyphosate, so potentially could be used as a probe. 
The logK value was calculated using Equation 5.2 and the value in parenthesis is the 
statistical error of the fit to the data. Errors in these titrations are similar to those in the 
previous chapter. The experiments were carried out in a buffered solution throughout to 
minimise any change in pH which could affect the binding of glyphosate and other 
species such as phosphate. It was also carried out in a temperature controlled room, but 
there would be some slightly fluctuations throughout the titration and even comparing 
two separate titrations. Although these errors have been minimised, they could still have 
some influence on the logK values calculated. Titrations were repeated to minimise 
random error. 
The lifetimes were recorded at the start and end of the titration in both H2O and D2O to 
allow a q value to be calculated. 
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Table 4.1 - The lifetimes of [Eu.L
6
] with and without glyphosate in H2O and D2O, as well as the 
equivalent q values 
 Lifetime in H2O (τ1) 
(ms) 
Lifetime in D2O 
(τ1) (ms) 
q 
[Eu.L
6
] 0.55 0.73 0.2 
[Eu.L
6
] + glyphosate 0.79 1.36 0.3 
 
In both cases, the q value is approximately zero showing that there is no water in the 
inner sphere, which would be expected as the coordination number around the europium 
ion is already predicted to be nine. 
The positive results obtained, with the high binding constant for glyphosate, the 
selectivity of the complex also needed to be probed. A number of relevant compounds 
will be tested, which will investigate both selectivity and the binding mode of 
glyphosate to the complex. 
 
Figure 4.3 - The structures of four compounds which will be investigated 
 As discussed in previous sections, phosphate is expected to be the main competitor due 
to glyphosate binding through the phosphate group. 
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Figure 4.4  - Changes in the emission intensity of [Eu.L
6
] (black) (6 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 
295 K) with incremental additions of phosphate, up to 0.5 mM (red). (Inset) The intensity ratio of 604-614 
nm / 614-633 nm as a function of increasing phosphate concentration 
Unfortunately, the complex did bind to phosphate, suggesting that monitoring 
phosphate levels in subsequent media is required. A change in spectral form is 
observed, analogous to that of glyphosate binding, suggestive of a similar binding 
mode. However, the logK value in buffer solution is 4.35 (±0.01), almost one order of 
magnitude smaller than found with glyphosate, in addition to a smaller intensity ratio. 
The herbicide glufosinate was also tested as the presence of the phosphinate group 
could potentially allow it to bind to [Eu.L
6
] in such a way that would mimic the change 
in spectral form found with phosphate and glyphosate. 
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Figure 4.5 - Changes in the emission intensity of [Eu.L
6
] (black) (7 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 
295 K) with increasing concentration of glufosinate, up to 0.25 mM (red). (Inset) The intensity ratio of 
604-614 nm / 614-633 nm as a function of increasing glufosinate concentration 
For this compound, a decrease in emission intensity was observed, which has not been 
witnessed for this complex thus far. Furthermore, there is no distinct change in spectral 
form, highlighted by the lack of correlation in the intensity ratio of 604-614 nm / 614-
633 nm with increasing glufosinate concentration. The range of the ratio change was 
only 0.425-0.460, which is small in comparison to that observed upon addition of 
glyphosate. Therefore, it is likely that glufosinate does not bind to the complex through 
the phosphinate group and is unlikely to interfere if it were present in ‘real-world’ 
samples. 
Glyphosate can decompose into the derivative, AMPA, which has been detected in 
some soil samples that also contain the herbicide. It retains the phosphate group and 
consequently its presence may interfere with glyphosate binding. 
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Figure 4.6 - Changes in the emission intensity of [Eu.L
6
] (7 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
with increasing concentration of AMPA, up to 3 mM (red). (Inset) The intensity ratio of 604-614 nm / 
614-633 nm as a function of increasing AMPA concentration 
Following addition of AMPA, an increase in emission intensity was observed. There 
was also a change in spectral form, particularly in the hypersensitive ΔJ = 2 band, with 
the two bands merging into one and the growth of the shoulder band. Following the 
change in this transition, with increasing concentrations of AMPA, a binding curve 
could be produced and fitted to obtain an apparent logK value of 3.30 (±0.01). This is 
almost exactly two log units smaller than that obtained with glyphosate. The suggestion 
is that the binding involves the carboxylate group, which may hydrogen bond to the 
complex. This is a significant contribution to the binding, so studies analysing the 
carboxylate group could be carried out to establish how much this contributes to 
binding. 
Many of the competitive studies focus on the phosphate moiety, but glyphosate can be 
considered as a glycine residue with a phosphate tag. Therefore, a titration of glycine 
with [Eu.L
6
] was undertaken to determine if any significant interactions exist between 
the europium centre and glycine.  
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Figure 4.7 - The emission of [Eu.L
6
] (7 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) with (red) and 
without (black) 0.5 mM glycine 
As revealed in Figure 4.7 the addition of glycine changed neither the emission intensity 
nor the spectral form. This lack of change confirms the hypothesis that glyphosate binds 
through the phosphonate group and any interactions with the rest of the molecule are 
significantly less important.  
Methylation of the central amine on glyphosate is simply achieved by refluxing with 
formic acid and formaldehyde. Titrations performed with this compound can give more 
information about the importance of a secondary amine in comparison to a tertiary 
amine. 
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Figure 4.8 - Changes in the emission intensity of [Eu.L
6
] (7 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
with increasing concentration of N-methyl glyphosate, up to 0.7 mM (red). (Inset) The intensity ratio of 
604-614 nm / 614-633 nm as a function of increasing N-methyl glyphosate concentration 
Upon addition of N-methyl glyphosate, an increase in emission intensity and change in 
spectral form can be observed. Following the change in the intensity ratio of 604-614 
nm / 614-633 nm with increasing glyphosate concentration, a binding constant was 
estimated using non-linear regression analysis to obtain an apparent logK value of 3.93 
(±0.02). This value is smaller than that obtained with glyphosate and phosphate. It 
suggests that the binding of glyphosate to [Eu.L
6
] either involved two hydrogen bonds 
with both hydrogens on the central amine on glyphosate, or the addition of the methyl 
group causes a steric effect which stops N-methyl glyphosate binding to the crowded 
complex.  
4.2.2 Titrations in Different Media 
Following the promising results of the competitive studies, work in more competitive 
media was carried out. The first study used local tap water, although there is no 
detection limit imposed in the EU, the US EPA have advised an MRL. Glyphosate has 
been known to decompose in chlorinated water, but it has been detected in some 
samples, albeit very rarely.
207
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Figure 4.9 - Changes in the emission intensity of [Eu.L
6
] in tap water (black) (18 μM, 0.1 M NaCl, 0.1 M 
MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.5 mM (red). (Inset) The 
intensity ratio of 604-614 nm / 614-633 nm as a function of increasing glyphosate concentration 
Indeed, there was an increase in emission intensity and change in spectral form 
observed that was similar to that found in buffer solution. Following the intensity ratio 
used throughout the studies on this complex, an increase similar to that for glyphosate 
was observed, suggesting that glyphosate decomposition into phosphate occurs on a 
timescale greater than the length of the titration. An apparent logK value of 5.52 (±0.05) 
was calculated, not dissimilar to that in buffer solution. However, the final ratio is not as 
high as that observed in glyphosate. 
Therefore, another experiment was conducted to assess the possibility of glyphosate 
decomposition in tap water throughout the initial titration. An emission spectrum was 
taken of the complex itself, immediately upon addition of 0.5 mM of glyphosate, after 
equilibration, and then after 48 h.  
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Figure 4.10 - The emission spectrum of [Eu.L
6
] (black) (12 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
in tap water after addition of glyphosate (0.1 M) after 0 h (red), 0.5 h (blue) and 48 h (green) 
It is evident that the decay with the complex does not occur after 48 h and the 
possibility of glyphosate decay on the timescale of the titration can be discounted. 
However, the spectral response measured in tap water is not as smooth as that found in 
buffer solution, suggesting that the small amount of phosphate present in tap water 
might be interfering.
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Using the same river water as the sample in Section 3.4, with 0.1 M NaCl and 0.1 M 
MES to ensure the pH was maintained at 5.9, a glyphosate solution was again titrated 
into a solution containing [Eu.L
6
].  
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Figure 4.11 - The change in emission intensity of [Eu.L
6
] in river water (black) (6 μM, 0.1 M NaCl, 0.1 M 
MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.08 mM (red). (Inset) The ratio 
of 604-614 nm / 614-633 nm with increasing glyphosate concentration 
Following the addition of glyphosate, a significant increase in emission intensity and a 
change in spectral form were observed. The change could be tracked using the intensity 
ratio 604-614 nm / 614-633 nm. From Figure 4.11 it can be clearly seen that the two 
bands in the ΔJ = 2 manifold invert in emission intensity. The binding constant was 
estimated using non-linear regression analysis to obtain an apparent logK value of 4.92 
(±0.02), lower than the binding constant observed in buffer. It is therefore likely that 
additional species in the river water interact with the complex. However, as the increase 
in emission intensity is maintained and the ratio gives a smooth curve, this probe is still 
appropriate for use with river water samples. This complex would be suitable for the 
detection of glyphosate in samples where the concentration is close to the limit, 
particularly as in the USA, the EPA MRL for drinking water is 0.7 μg/mL (4 μM). 
Another medium in which glyphosate has been found is in urine. This could be 
concentrations remain below potentially dangerous levels. 
The urine was collected from a healthy 24 year old male for initial investigations, to test 
if the complex could be a viable probe in this medium.  
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Figure 4.12 - Changes in the emission intensity of [Eu.L
6
] in urine (black) (7 μM, 0.1 M NaCl, 0.1 M 
MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.2 mM (red). (Inset) The 
intensity ratio of 604-614 nm / 614-633 nm as a function of increasing glyphosate concentration 
Before addition of glyphosate, the spectral form in urine was observed to be very 
different from that in buffer. This implied an unknown species was already bound.  
Upon addition of glyphosate there is minimal change in both emission intensity and 
spectral form. This is suggestive that the species bound to the complex in urine binds 
more strongly than glyphosate, and hence, no real change in the emission spectrum was 
observed. This was confirmed by the lack of change in the intensity ratios which can be 
used to track any binding event. There could be a number of compounds in urine which 
cause this behaviour, but these initial results confirm that this probe cannot be used in 
this medium. 
The next background solution to be tested was oat extract. The MRL set by the EU is 
0.1 mM and therefore detection around this point is important. Oat extract was made 
using a similar method to the wheat grain extract but with an important difference. 
Sainsbury’s Scottish oats were obtained and soaked in water. However, upon addition 
of water to soak the oat, a thick suspension was formed, akin to porridge. A practical 
issue arose when trying to remove the oats. The best method involved centrifugation to 
remove the majority of the oats, followed by membrane filtration to remove any 
remaining solid traces of oat.  
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Figure 4.13 - Changes in the emission intensity of [Eu.L
6
] in oat extract (black) (5 μM, 0.1 M NaCl, 0.1 
M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.2 mM (red). (Inset) The 
intensity ratio of 604-614 nm / 614-633 nm as a function of increasing glyphosate concentration 
The spectral form at the beginning of the titration resembled that seen with the urine 
sample, rather than buffer solution. The changes in spectral form were only small. 
However, by plotting the intensity ratio 604-614 nm / 614-638 nm as a function of 
glyphosate concentration, a clear, smooth curve was obtained. The binding constant was 
estimated using non-linear regression analysis, giving an apparent logK value of 4.77 
(±0.01), similar to the value found in river water.  
Next, a wheat grain extract was prepared in an analogous method to that described in 
Section 3.6, with an MRL of 59 μM set by the EU.  
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Figure 4.14 - Changes in the emission intensity of [Eu.L
6
] in grain extract (black) (7 μM, 0.1 M NaCl, 0.1 
M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 0.12 mM (red). (Inset) The 
intensity ratio of 604-614 nm / 614-633 nm as a function of increasing glyphosate concentration 
The initial emission spectrum taken in grain extract with no glyphosate present was not 
dissimilar to that in buffer, suggesting that the species bound to the complex in oat 
extract was not found in grains. Upon addition of glyphosate, an increase in emission 
intensity of approximately three fold was found, with an observable change in spectral 
form, as expected for this complex. Following the intensity ratio of 604-614 nm / 614-
633 nm, a curve was extracted. The binding constant was estimated using non-linear 
regression analysis, and an apparent logK value of 4.42 (±0.02) was obtained, similar to 
the values for oats and river water.  
In summary, the results with this complex are encouraging; not only can the complex 
bind glyphosate selectively in a variety of media, but the levels in which glyphosate can 
be detected falls in the range of MRL values set in grains and oats by both US EPA and 
EU. Furthermore, as the complex is an effective probe in these media, it is possible that 
the complex would be able to function in a wide range of food stuffs.  
Although it is not completely selective for glyphosate over phosphate or AMPA, the 
complex does not bind to glufosinate or glycine showing it does have some degree of 
selectivity. The ratio of logK values for glyphosate over phosphate is 5.36/4.35 = 1.23 
and for glyphosate over AMPA is 5.36/3.30 = 1.62.  
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Table 4.2 - The logK values of [Eu.L
6
] of different analytes and glyphosate in different media (295 K, pH 
5.9, 0.1 M NaCl, 0.1 M MES)
h,i
 
 
Glyphosate 
Phosphate AMPA Purite 
water 
River 
water 
Oat 
extract 
Grain 
Extract 
Tap 
water 
[Eu.L
6
] 
5.36 
(±0.02) 
4.92 
(±0.02) 
4.77 
(±0.01) 
4.42 
(±0.02) 
5.52 
(±0.05) 
4.35 
(±0.01) 
3.30 
(±0.01) 
 
4.2.3 Testing [Eu.L
6
] with Zinc 
As the tripicolylamine arm was originally used as zinc sensor, and the ADP/ATP probe 
also functions in the presence zinc ions, a study to examine the effect of zinc on the 
binding of glyphosate was undertaken. It is possible that the presence of added zinc may 
increase the logK value for the association of glyphosate with [Eu.L
6
]. 
4.2.3.1 DFT Experiments 
Density Functional Theory (DFT) is a computational method that among other uses, can 
identify and allow theoretical comparisons of putative low energy structures of 
compounds. Dr. Mark Fox (Durham University) modelled the [Eu.L
6
] complex with 
glyphosate in the presence and absence of zinc. The alkynyl substituent in the 
chromophore was removed and Y was used in place of Eu for simplicity.  
                                                 
h
 The complex was also tested in urine but a binding constant could not be calculated 
i
 Errors given represent statistical error on the fit 
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Figure 4.15 - The DFT of [Y.L
6
] with glyphosate in the absence of zinc, using the hydrid-DFT B3LYP and 
the 3-21G* basis set 
Glyphosate was bound to the metal centre of the complex through the phosphate 
oxygen. Furthermore, a network of stabilising intramolecular hydrogen bonds were also 
defined. The optimised model geometry for {[Y.L
6
]*glyphosate} revealed a N-H…O 
interaction with a H…O distance of 1.47 angstroms and two N-H…N interactions with 
H…N distances of 1.84 and 1.88 angstroms. The phosphate oxygen hydrogen bonds to 
the protonated central amine. Furthermore, each NH in the protonated amine group in 
glyphosate can act as an H-bond donor to the pyridine N atom; at pH 5.9 it is expected 
to be protonated. These stabilising secondary interactions help to explain the differences 
in logK values compared with AMPA and phosphate, where such secondary hydrogen 
binding interactions cannot occur. 
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Figure 4.16 - The DFT of [Y.L
6
] with zinc and glyphosate, using the hydrid-DFT B3LYP and the 3-21G* 
basis set 
In the presence of zinc, the tripicolylamine arm encapsulates the zinc ion and changes 
how glyphosate binds. It binds to the metal centre in the same manner, through the 
phosphate oxygen. However, it is no longer stabilised through a number of hydrogen 
bonds. Instead, the remaining deprotonated phosphate oxygen binds to the zinc ion 
generating a phosphate bridge between the two metal ions. Such an interaction with zinc 
should be sufficiently strong to compensate for the loss of free energy associated with 
hydrogen bonding. 
4.2.3.2 Binding with Zinc 
A titration was performed involving the incremental additions of a zinc chloride 
solution to [Eu.L
6
] in 0.1 M NaCl, 0.1 M MES buffer solution. Although this titration 
had been carried out at pH 7.4,
206
 the titration at 5.9 was thought to be necessary as the 
change of pH could have an effect both on the free energy of binding of glyphosate, and 
of the zinc ion. 
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Figure 4.17 - Changes in the emission spectrum of [Eu.L
6
] (black) (6 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of zinc chloride, up to 10 equivalents (red) 
Upon addition of excess of zinc, a change in spectral form was observed, particularly 
noticeable in the ΔJ = 2 manifold. The intensity ratio of 604-614 nm / 614-633 nm was 
used to track this change, and a smooth binding curve was obtained. However, a simple 
1:1 binding curve was not able to fit this. This was not unexpected as previous studies, 
although done at pH 7.4, had also found this and used a 2:1 binding curve, suggesting 
two complexes, in particular two tripicolylamine moieties, encapsulate the zinc metal 
ion. 
4.2.3.3 Glyphosate Binding in the Presence of Zinc 
From the DFT study it is possible that in the presence of zinc, a different logK value for 
glyphosate could be obtained. Experiments in which one or two equivalents of zinc 
were added to the complex solution were prepared, before glyphosate was titrated in.  
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Figure 4.18 - Changes in the emission spectrum of [Eu.L
6
] with one equivalent of zinc chloride (black) (6 
μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K), with increasing glyphosate concentration, up to 0.1 mM 
(red). (Inset) The intensity ratio of 604-614 nm / 614-633 nm with incremental additions of glyphosate 
In the presence of one equivalent of zinc, addition of glyphosate led to an increase in 
emission of almost four-fold. There was also a distinct change in spectral form in almost 
all transitions. These changes were very similar to those observed in the absence of zinc. 
The ratio which has previously been used in glyphosate titrations for [Eu.L
6
] was again 
utilised, and a 1:1 bind curve was fitted to the data. From this analysis, a logK value of 
5.33 (±0.05) was obtained, which is within error of the logK value achieved in the 
absence of zinc.  
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Figure 4.19 - Changes in the emission spectrum of [Eu.L
6
] with two equivalents of zinc chloride (black) 
(6 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K), with increasing concentration of glyphosate, up to 0.08 
mM (red). (Inset) The intensity ratio of 604-614 nm / 614-633 nm with incremental additions of 
glyphosate 
In the presence of two equivalents of zinc, a logK value of 5.31 (±0.02) was estimated, 
i.e., within error of both one equivalent of zinc, and in the absence of zinc. An 
interesting note in these titrations are that the overall increase in emission intensity is 
much smaller compared to that of one equivalent, which is in turn smaller than that 
observed with no zinc. The reasons behind these traits are unknown. However, what 
these titrations state is that zinc does not increase the apparent binding constant for 
glyphosate to [Eu.L
6
]. Therefore, all further work does not include the addition of zinc 
chloride. 
4.3 Modifying the Tripicolylamine Arm 
The next step in this series of experiments would be to test spiked grains, but 
improvement on the binding ability of glyphosate and selectivity, without the need to 
stir for ten minutes before recording would be preferable. Building on [Eu.L
6
], there are 
a number of ways the complex could be adapted to improve binding. 
The first step is to look at the tripicolylamine. As this moiety was designed to bind zinc, 
it was thought that this arm was not important in the binding of glyphosate, particularly 
as zinc was observed not to improve on the logK value. Therefore, with this in mind, the 
removal of one and two of these picolyl groups was tested. 
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Figure 4.20 - The structure of [Eu.L
7
] (left) and [Eu.L
8
] (right)
j
 
The synthesis of these complexes followed the Scheme 4.3 up to 19. The arm for 
[Eu.L
7
] was synthesised by reacting 2,6-bis(chloromethyl)pyridine with diethylamine. 
This arm was then introduced onto the ring, followed by deprotection of the esters 
groups, and complexation. The remaining pendant arm for [Eu.L
8
] was synthesised 
similarly, using N-(pyridin-2-ylmethyl)ethanamine in place of diethylamine, followed 
by alkylation, deprotection and complexation in an analogous fashion to Scheme 4.3. 
The same titrations as those described for [Eu.L
6
] in buffer solutions were performed on 
[Eu.L
7
], to test what effect the picolyl groups have on the binding of glyphosate. 
The europium emission lifetimes were also recorded at the beginning and end of each 
titration in H2O and D2O so that a q value could be calculated. 
Table 4.3 The lifetimes and q value of [Eu.L
7
] and [Eu.L
8
] in H2O and D2O at the beginning and end of 
the glyphosate titrations 
 Lifetime in H2O (τ1) 
(ms) 
Lifetime in D2O (τ1) 
(ms) 
q 
[Eu.L
7
] 0.61 0.80 0.2 
[Eu.L
7
] + glyphosate 0.65 1.16 0.5 
[Eu.L
8
] 0.44 0.64 0.5 
[Eu.L
8
] + glyphosate 0.99 1.28 0.0 
                                                 
j
 Both synthesised by S. Shuvaev 
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The q values for both complexes with and without glyphosate are all close to zero. Such 
behaviour is not wholly unexpected as [Eu.L
6
] also shows q values around zero, and the 
binding around the europium centre has not changed, as the initial complex is nine 
coordinate.  
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Figure 4.21 - Changes in the emission spectrum of [Eu.L
7
] (black) (7 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of glyphosate, up to 5 mM (red). (Inset) The intensity ratio of 
ΔJ = 4 / ΔJ = 2 as a function of increasing glyphosate concentration 
An increase in emission intensity and a distinct change in spectral form was observed 
upon addition of glyphosate to [Eu.L
7
]. The change in spectral form is similar to that of 
[Eu.L
6
], although not as marked. The binding could also be tracked using the intensity 
ratio of the two bands in the ΔJ = 2 transition, using 602-615 nm / 615-638 nm. What 
was somewhat unexpected was the large decrease in logK compared to [Eu.L
6
]. From 
the fit of the binding a curve, using non-linear regression analysis an estimated value of 
3.11 (±0.01) was obtained, which corresponds to a K value a factor of 100 smaller than 
the tripicolylamine equivalent. Clearly the exchange of two picoylyamine arms for two 
ethyl groups has a deleterious effect on the binding of glyphosate.  
Further experiments were performed to give more information about the binding. For 
example, the binding of phosphate will give an indication if the picoylyamine groups 
interact in any way with the phosphate group itself.   
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Figure 4.22 - Changes in the emission spectrum of [Eu.L
7
] (black) (7 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of phosphate, up to 5 mM (red). (Inset) The intensity ratio of ΔJ 
= 2 / ΔJ = 4 as a function of increasing phosphate concentration 
Upon addition of hydrogen phosphate, there is little evidence of binding; only a slight 
decrease in emission intensity was observed but no discernible change in spectral form. 
This is highlighted in the intensity ratio at 605-636 nm / 675-712 nm, or the ΔJ = 2 / ΔJ 
= 4 manifolds. The change in ratio is small, between the values 0.74 to 0.80, particularly 
when compared to the change in ratio upon addition of glyphosate which increases up to 
1.10. Another point to note, is that this is the change upon addition of 5 mM of 
phosphate, compared to the 0.3-0.5 mM used in glyphosate titrations. Due to the lack of 
distinct change in ratio with increasing phosphate concentration, it was not possible to 
fit this to a binding curve to obtain a logK value. These results suggest that at pH 5.9 
this complex does not bind phosphate in a significant manner. 
However, AMPA is slightly different to phosphate, with a relevant pKa of 5.36.
209
 
Hence, at pH 5.9, the second phosphonate oxygen is deprotonated, as in glyphosate, and 
therefore it may compete in binding to [Eu.L
7
].    
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Figure 4.23 - Changes in the emission of [Eu.L
7
] (black) (10 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 
K) with increasing concentration of AMPA, up to 5 mM (red). (Inset) The intensity ratio of ΔJ = 2 / ΔJ = 
4 as a function of increasing AMPA concentration 
When AMPA is added to a sample of [Eu.L
7
] there is an increase in emission intensity 
and a change in spectral form. The change is form was analogous to that seen with 
glyphosate, as one would expect. It therefore affords a ratio which can be used to track 
the binding event, which is assumed to be similar in nature to that of glyphosate. 
Following the variation of the intensity ratio 605-636 nm / 675-712 nm an apparent 
logK value of 3.35 (±0.02) was found. This value is slightly larger than found for 
glyphosate; this complex is not selective for the herbicide over its metabolite. Inspection 
of the fit however, suggests that this value is not perfect, so although it may not bind 
AMPA better than glyphosate, it is sufficiently close that it will not be possible to detect 
glyphosate in its presence. Further evidence of the similar overall response comes from 
looking at the range of ratios which vary from 0.75 to 1.10, very similar to the range 
obtained upon addition of glyphosate. This titration also suggests that the carboxylate 
groups are involved in binding to the picolyl groups in [Eu.L
6
], which is why AMPA 
and glyphosate behave similarly in this system. As hydrogen phosphate itself does not 
behave in the same manner, it suggests that either the comparative pKas of 
AMPA/glyphosate vs phosphate plays a crucial role, or that the nitrogen on the analyte 
plays an important role in binding to the complexes. 
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The complex was tested with glufosinate, which showed no change in spectral form or 
emission intensity, suggesting that it interacts minimally with glufosinate. Glufosinate 
should therefore not be considered as a competitor for glyphosate with this complex. 
N-methyl glyphosate was also tested, which had little effect on the emission spectrum of 
[Eu.L
7
]. It therefore suggests that the addition of the methyl group disrupts the 
hydrogen bonding as seen in the DFT models (Section 4.2.3.1), and may also make the 
analyte too sterically hindered to bind to the metal centre effectively. 
[Eu.L
7
] was then tested in different media to see how this would affect the binding 
capabilities. The first medium to be tested was urine, in which thus far, no complex had 
been successfully found to work.  
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Figure 4.24 - Changes in the emission spectrum of [Eu.L
7
] in urine (black) (5 μM, 0.1 M NaCl, 0.1 M 
MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 10 mM (red). (Inset) The 
intensity ratio of 605-615 nm / 615-638 nm as a function of increasing glyphosate concentration 
Surprisingly, a change in spectral form and a remarkable increase in emission intensity 
were observed in urine. What was even more interesting was the fact that the ratio led to 
a relatively smooth increase upon incremental additions of glyphosate. An apparent 
logK value of 3.21 (±0.05) was found, very close to the binding constant found for 
glyphosate in buffer solution. However, an important point to note is that the binding 
curve in Figure 4.24 is upon addition of 10 mM of glyphosate in total. Most other 
titrations with glyphosate with this complex usually involve addition up to 0.5 - 1.0 
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mM. Although this has given by far the best response thus far, the range of 
concentrations in which glyphosate is likely to be present in urine, is lower than the 
detection limit with this complex. 
The next medium to be tested was aqueous grain extract. For complex [Eu.L
6
], a 
response could be tracked in this background, and it is therefore, a similar result should 
be seen with [Eu.L
7
]. 
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Figure 4.25 - Changes in the emission of [Eu.L
7
] (black) in grain extract (6 μM, 0.1 M NaCl, 0.1 M MES, 
pH 5.9, 295 K) with increasing concentration of glyphosate, up to 5 mM (red). (Inset) The intensity ratio 
of ΔJ = 2 / ΔJ = 4 as a function of increasing glyphosate concentration 
As found in urine, there was both an increase in emission intensity and a change in 
spectral form. The spectral form at the start of this titration in grain extract is similar to 
that in buffer solution, which may not be expected on comparison with [Eu.L
6
] in the 
same medium. The change in spectral form was tracked using the intensity ratio of 605-
636 nm / 675-712 nm as a function of increasing glyphosate concentration, to give an 
estimated logK value of 3.11 (±0.01). This is identical to the value in buffer solution 
suggesting this complex is not affected by other species in grain extract, which is a very 
useful trait. However, the glyphosate added to get this response is ten times more than 
that used with [Eu.L
6
]. This sensitivity issue means that unless the sample volume is 
pre-concentrated prior to analysis, the concentration this complex can detect is not close 
to any MRL. 
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Oats were then tested to check if a similar situation is found in this background, to see 
the effect this medium has on [Eu.L
7
]. 
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Figure 4.26 - Changes in the emission spectrum of [Eu.L
7
] in oat extract (black) (6 μM, 0.1 M NaCl, 0.1 
M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 6 mM (red). (Inset) The 
intensity ratio of ΔJ = 2 / ΔJ = 4 as a function of increasing glyphosate concentration 
The spectral form at the beginning of the titration is again not dissimilar to that found in 
buffer solution, suggesting that the complex doesn’t bind anything in oat extract to a 
significant degree. Furthermore, upon addition of glyphosate, there was an increase in 
emission intensity and the same change in spectral form as previously seen for this 
complex. Following the intensity ratio of ΔJ = 2 / ΔJ = 4 as a function of glyphosate 
concentration, an apparent logK value of 3.18 (±0.01) was estimated. This is slightly 
higher than achieved in buffer solution, again suggesting that the complex is somewhat 
unaffected by the media it is in. However, it retains the same sensitivity issues observed 
in grain extract. 
It is evident that the two ethyl groups have a dramatic impact on the efficacy of the 
complex to bind glyphosate. The lack of apparent binding at the beginning of titrations 
or any interference from complex media such as grain or oat extract may be related to 
the fact that binding to the complex seems to be less efficient. The lower logK values 
compared to [Eu.L
6
] suggests that it may still have the potential to bind to the 
compounds in grain and oat, but the concentrations of these species is not sufficiently 
high enough to cause a change in spectral form.  
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The next complex examined looked at comparing whether both of these picolyl groups 
are necessary for the binding of glyphosate, or if one is sufficient. 
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Figure 4.27 - Changes in the emission spectrum of [Eu.L
8
] (black) (18 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of glyphosate, up to 5 mM (red). (Inset) The intensity ratio of 
604-635 nm / 677-712 nm as a function of increasing glyphosate concentration 
From initial observations, it is clear that upon addition of glyphosate to [Eu.L
8
], in 0.1 
M MES and 0.1 M NaCl, there is an increase in emission intensity and change in 
spectral form, as is expected from related titrations. The intensity ratio of ΔJ = 2 / ΔJ = 
4 (604-635 nm / 677-712 nm) can be used to follow the binding event, to yield an 
apparent logK value of 3.16 (±0.01), similar to that found for [Eu.L
7
]. The 
comparatively poor sensitivity compared to [Eu.L
6
] suggests that both picolyl groups 
are necessary for efficient binding to glyphosate. 
Upon addition of phosphate to a buffer solution of [Eu.L
8
], similar results compared to 
[Eu.L
7
] were obtained, albeit with a greater change in spectral form and emission 
intensity. However, this increase is not smooth and appears to be two binding events so 
a logK value cannot be extracted. Phosphate clearly interacts with the complex but, at 
relevant concentrations in most media, the change in the ratio is not large. This 
behaviour suggests that both picolyl groups interact with phosphate and encourage its 
binding to the complex, but will not be a major competitor for glyphosate detection with 
this complex.  
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Figure 4.28 - Changes in the emission spectrum of [Eu.L
8
] (black) (9 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of AMPA, up to 5 mM (red). (Inset) The intensity ratio of 604-
635 nm / 677-712 nm as a function of increasing AMPA concentration 
As might be expected, the complex does bind to AMPA, with a change in spectral form 
and emission intensity similar to that seen with glyphosate (Figure 4.28). Again looking 
at the intensity ratio of ΔJ = 2 / ΔJ = 4 bands, the binding event can be followed with 
increasingly concentrations of AMPA, to give an apparent logK value of 3.16 (±0.01). 
This value is significant, as there is no selectivity between AMPA and glyphosate for 
either [Eu.L
7
] or [Eu.L
8
]. It therefore hypothesised that the increase in glyphosate 
binding and its selectivity over AMPA is related to the interactions of the carboxylate 
group of glyphosate and both picolyl groups. As the binding constant is so similar to 
that obtained for [Eu.L
7
] as well as [Eu.L
6
] it is consistent with the hypothesis that that 
AMPA does not interact with the picolyl groups. Moreover, the fact that glyphosate has 
a higher binding constant for [Eu.L
6
] means that the carboxylate groups must interact 
favourably with both picolyl groups in the ternary adduct.  
Although AMPA binds to [Eu.L
8
], glufosinate is not a competitor for glyphosate with 
this complex. There was a minor decrease in emission intensity and the change in 
spectral form is minimal upon addition of glufosinate highlighted by the lack of trend in 
intensity ratios with increasing concentrations.  
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To further probe the binding of glyphosate to the complex, titrations with N-methyl 
glyphosate could highlight the interactions of the central nitrogen atom on glyphosate 
with the complex. 
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Figure 4.29 - Changes in the emission spectrum of [Eu.L
8
]
 
(black) (8 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing concentration of N-methyl glyphosate, up to 2.5 mM (red). (Inset) The 
intensity ratio of 604-635 nm / 677-712 nm as a function of increasing methyl glyphosate concentration 
The spectral change observed upon addition of N-methyl glyphosate is very similar to 
that of phosphate, albeit with a greater increase in emission intensity. The ratio of the 
two hypersensitive bands shows an increase, but not a smooth one from which a logK 
value could be extracted. This behaviour suggests that the two hydrogens on the amine 
on glyphosate must be involved in stabilising hydrogen bond interactions (as H-bond 
donors) to the two picolyl nitrogen acceptors, as seen in the DFT structure, otherwise a 
binding response similar to that of phosphate would be observed 
This complex was then tested in different media to observe how it interacts with 
potentially competitive species that exist in them. The medium tested first was urine. 
 154 
 
580 600 620 640 660 680 700 720
0
1
2
3
4
5
6
1.00
1.04
1.08
1.12
1.16
0 1 2 3 4 5
[Glyphosate] / mM
I 6
1
4
-6
3
5
/I
6
7
7
-7
1
2
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength/ nm  
Figure 4.30 - Changes in the emission spectrum of [Eu.L
8
] (black) in urine (9 μM, 0.1 M NaCl, 0.1 M 
MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to5 mM (red). (Inset) The intensity 
ratio of 604-635 nm / 677-712 nm as a function of increasing glyphosate concentration 
Again, an increase in emission intensity and change in spectral form was observed. 
However, the increase is not as distinctive as it was with [Eu.L
7
]. This was affirmed by 
looking at the ratio of ΔJ = 2 / ΔJ = 4. A binding constant could be estimated using non-
linear regression analysis to give an apparent logK value of 2.89 (±0.01), lower than that 
found in buffer and for [Eu.L
7
] in urine. Furthermore, there is a lot of ‘scatter’ at the 
beginning of the titration, so even if there was an unnaturally high concentration of 
glyphosate in urine, the confidence in the value calculated working from this binding 
constant would be low. This scatter is likely due to a species in urine which bound to 
the [Eu.L
8
] and is replaced by glyphosate. 
Grain extract was then tested, which was predicted to give similar results to that 
observed with [Eu.L
7
]. 
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Figure 4.31 - Changes in the emission spectrum of [Eu.L
8
] (black) in grain extract (18 μM, 0.1 M NaCl, 
0.1 M MES, pH 5.9, 295 K) with increasing concentration of glyphosate, up to 5 mM (red). (Inset) The 
intensity ratio of 604-635 nm / 677-712 nm as a function of increasing glyphosate concentration 
A change in spectral form was observed upon addition of glyphosate in grain extract, 
and the emission intensity greatly increased (Figure 4.31). The change in spectral form 
allowed a binding curve to be fitted using non-linear regression analysis of the emission 
ratio of ΔJ = 2 / ΔJ = 4, to give an apparent logK value of 3.34 (±0.01). This binding 
constant is larger than the value found in buffer solution, suggesting that this complex is 
less sensitive to other species in grain extract compared to [Eu.L
6
]. It is also slightly 
larger than the value found for [Eu.L
7
] in grain, indicating that this complex in 
marginally better behaved, but not with sufficiently avidity to allow its use in grains 
with levels of glyphosate close to MRLs in grains as set by the EU. 
A titration in oat extract is expected to give very similar results to that found in grain 
extract, as the complex thus far has behaved in a very similar manner to that of [Eu.L
7
]. 
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Figure 4.32 - Changes in the emission of [Eu.L
8
] (black) in oat extract (9 μM, 0.1 M NaCl, 0.1 M MES, 
pH 5.9, 295 K) with increasing concentration of glyphosate, up to 5 mM (red). (Inset) The intensity ratio 
of 604-635 nm / 677-712 nm as a function of increasing glyphosate concentration 
The changes in emission intensity and the spectral form were almost identical to those 
seen in buffer solution, with an apparent logK value of 3.57 (±0.04) estimated. This 
value is greater than that found in buffer solution, which was 3.16 (±0.01). However, to 
achieve these changes, a high concentration of glyphosate is needs to be added to the 
titration, and therefore, this complex would not be useful at detecting at or close to 
expected levels of glyphosate in oat. Looking at the inset graph in Figure 4.32, there is 
little to no noise at the beginning of the titration, which is uncommon for complexes in 
this medium. This may be due structural difference of the complexes means it no longer 
binds strongly to these species in these backgrounds so they are not in sufficiently high 
enough concentration to allow a notable change in spectral form, or for a competitive 
displacement process.  
4.4 Further Modification of the Tripicolylamine Arm Utilising 1,2,3 -
triazole 
Following the observation of the importance of the two picolyl groups, another way the 
complex can be altered structurally is through the insertion of a 1,2,3-triazole, replacing 
the pyridine ring closest to the heart of the complex.  
 157 
 
 
Figure 4.33 - The synthetic route to [Eu.L
9
]
k
  
The synthesis followed Scheme 2.1 up to the preparation of compound 3. The mesylate, 
21, is formed through reaction of 2-azidoethanol with mesyl chloride, which is alkylated 
onto cyclen (22). The pendant arm is synthesis through ‘click chemistry’ with N,N-
                                                 
k
 Synthesised by S. Shuvaev 
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bis(pyridin-2-ylmethyl)prop-2-yn-1-amine, to form the triazole moiety (23). The 
chromophore, 17, is alkylated onto the final amine on the cyclen ring, 24, before 
deprotection and complexation to give [Eu.L
9
]. The lifetime of the complex was 
recorded in H2O and D2O at the beginning and the end of the titration with glyphosate. 
Table 4.4 - The lifetimes and q values of [Eu.L
9
] with and without glyphosate 
 Lifetime in 
H2O (τ1) (ms) 
Lifetime in 
D2O (τ1) (ms) 
q 
[Eu.L
9
] 0.61 0.80 0.2 
[Eu.L
9
] + glyphosate 0.65 1.16 0.5 
 
In both cases, the q values were close to zero, suggesting no inner sphere water is 
bound. This is perhaps not unexpected as the complex is already 9-coordinate and 
therefore there would be no space for the water, as seen with previous complexes in this 
chapter. 
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Figure 4.34 - Changes in the emission spectrum of [Eu.L
9
] (black) (21μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing glyphosate concentration, up to 0.3 mM (red). (Inset) The intensity ratio of 
602-615 nm / 615-638 nm as a function of increasing glyphosate concentration 
The complex bound glyphosate with an increase in emission intensity and a change in 
spectral form, similar to those observed in [Eu.L
6
]. The binding event could be followed 
through a variety of ratios, and the one chosen for this complex was 602-615 nm / 615-
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638 nm. Fitting this intensity ratio to a 1:1 binding curve using non-linear regression 
analysis gave an apparent logK value of 4.92 (±0.01). This value is in between the logK 
value calculated for [Eu.L
6
], and [Eu.L
7
] and [Eu.L
8
]. This information is consistent 
with notion that the tripicolylamine arm plays a key role in the binding of glyphosate, 
but the tertiary aliphatic amine that binds directly to the metal centre is less important 
than the remaining two pyridine groups. Furthermore, experiments which looked at the 
rate in which glyphosate binds were undertaken. The binding of glyphosate was seen 
instantaneously in the change in spectral form. Therefore, although this complex had a 
slightly less favourable logK value, the lack of needing to wait for equilibration gives 
[Eu.L
9
] an advantage. 
Following the confirmation of the detection of glyphosate, separate studies were carried 
out, with phosphate, AMPA and glufosinate. 
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Figure 4.35 - The emission spectrum of [Eu.L
9
] (black) (12 μM, 0.1 M NaCl, 0.1 M MES, pH 5.9, 295 K) 
with 0.5 mM of phosphate (red). (Inset) The intensity ratio of 602-615 nm / 615-638 nm as a function of 
increasing phosphate concentration 
[Eu.L
9
] was the first complex tested which was not affected by the addition of 
phosphate. There was no change in spectral form or emission intensity, and the ratio 
used previously in the detection of glyphosate showed no correlation with phosphate 
concentration. This is the first complex in this study which the decision to maintain the 
pH at 5.9 has been effective, as phosphate does not bind, unless the pH is changed to 8.0 
which deprotonates the second phosphate oxygen. This is another very desirable quality 
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of this complex as it is expected that inorganic phosphate would be one of the main 
competitors.  
However, AMPA has bound in this set of compounds, each with a logK value of around 
three. Following the most promising result with phosphate, the complex was titrated 
with AMPA. 
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Figure 4.36 - Changes in the emission spectrum of [Eu.L
9
] (black) (8 μM, 0.1 M NaCl, 0.1 M MES, pH 
5.9, 295 K) with increasing AMPA concentrations, up to 3 mM (red). (Inset) The intensity ratio of 602-
615 nm / 615-638 nm as a function of increasing AMPA concentration 
Following addition of AMPA, a change in spectral form and emission intensity was 
found. Following the ratio of the two bands in the ΔJ = 2 manifold, an apparent logK 
value of 3.20 (±0.01) was obtained, which again is similar to the previous three 
complexes. This is significantly smaller than the value obtained with glyphosate, but 
still has the potential to interfere with the ratio used in glyphosate binding. 
As expected, glufosinate does not bind to the complex in the same way as glyphosate, as 
highlighted by the lack of overall change in spectral form and a lack of distinct change 
in emission intensity. Again, glufosinate is not a competitor for glyphosate in this 
system. The same can also be said for N-methyl glyphosate, which also showed no 
change in spectral form or emission intensity. 
The complex was then tested in more complex media. The first was urine, in which the 
complex [Eu.L
6
] was unsuccessful in positively detecting glyphosate. The change in 
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spectral form for [Eu.L
9
] showed only a vague correlation, which was not sufficient to 
determine a binding constant. The increase in emission intensity was also small 
indicating that this complex does not work well in urine, perhaps having already bound 
to a species that exists in urine which competes with glyphosate in binding to [Eu.L
9
]. 
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Figure 4.37 - Changes in the emission spectrum of [Eu.L
9
] in oat extract (black) (9 μM, 0.1 M NaCl, 0.1 
M MES, pH 5.9, 295 K) with increasing glyphosate concentration, up to 0.2 mM (red). (Inset) The 
intensity ratio of 602-615 nm /615-638 nm as a function of increasing glyphosate concentration 
At the beginning of the titration in aqueous oat extract solution, the spectral form was 
notably different compared to that at the start of the titration in aqueous buffer. This 
behaviour suggests that there is a species in oats which binds to the complex to causes 
this change in spectral form. Upon addition of glyphosate, an increase in emission 
intensity was observed, although this change is not as large as others observed upon 
addition of glyphosate with [Eu.L
9
]. Furthermore, only a slight change in the spectral 
form was noted in the ΔJ = 2 manifold, and this can be tracked using the ratio 602-615 
nm / 615-638 nm. When plotted as a function against increasing glyphosate 
concentration, it yields a binding curve which can be fitted using non-linear regression 
analysis to give an apparently logK value of 4.88 (±0.02). This is marginally smaller 
than the logK value achieved in buffer solution, i.e., this medium does little to affect the 
binding of glyphosate. Another point to note is the lack of noise at low concentrations 
of glyphosate as seen inset in Figure 4.37. It suggests that whichever species causes the 
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change in spectral form compared to buffer solution does little to affect the binding of 
glyphosate. 
After positive results in oat extract, the complex was then tested in grain extract. Again 
looking back at [Eu.L
6
], it may be expected that the complex will have a similar binding 
constant to that found in oats. 
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Figure 4.38 - Changes in the emission spectrum of [Eu.L
9
] in grain extract (black) (10 μM, 0.1 M NaCl, 
0.1 M MES, pH 5.9, 295 K) with increasing glyphosate concentration, up to 2 mM (red). (Inset) The 
intensity ratio of 602-615 nm / 615-638 nm as a function of increasing glyphosate concentration 
A large increase in emission intensity was evident, with distinct and definite changes in 
almost all transitions. The binding event was tracked following the changes in the ΔJ = 
2 manifold, with the intensity ratio of 602-615 nm / 615-638 nm giving an apparent 
logK value of 3.54 (±0.01). This is small compared to the logK value of [Eu.L
6
] as well 
as this complex in buffered water and in oats.  
This behaviour suggests that something that is present in wheat grain solution, which is 
not present in oat extract, interferes with the binding of glyphosate to decrease the logK 
value by almost 100 fold. As the initial spectral form is similar to that observed in 
buffer solution, it suggests that the species which interferes does not bind to the 
complex in a similar manner to glyphosate. Therefore, this complex would be suitable 
for the detection of glyphosate in oats, but not grains. As such, if a sensor which could 
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be used in a wide range of media was desired, this complex may not be the best choice, 
although further tests should be done in a number of different samples to confirm this. 
Thus far, four complexes have been tested to see if they bind to glyphosate, as well as a 
number of other competitors. The complexes have also been tested to investigate if they 
are capable of detecting glyphosate in a range of media. 
Table 4.5 - The logK values of the complexes with analytes and glyphosate in a range of media (295 K, 
pH 5.9, 0.1 M NaCl, 0.1 M MES)
l
 
 
Glyphosate 
Phosphate AMPA Purite 
Water 
Urine 
Oat 
Extract 
Grain 
extract 
[Eu.L
6
] 
5.36 
(±0.02) 
- 
4.77 
(±0.01) 
4.42 
(±0.02) 
4.35 
(±0.01) 
3.30 
(±0.01) 
[Eu.L
7
] 
3.11 
(±0.01) 
3.21 
(±0.05) 
3.18 
(±0.01) 
3.11 
(±0.01) 
- 
3.35 
(±0.02) 
[Eu.L
8
] 
3.16 
(±0.01) 
2.89 
(±0.01) 
3.57 
(±0.04) 
3.34 
(±0.01) 
- 
3.16 
(±0.01) 
[Eu.L
9
] 
4.92 
(±0.01) 
- 
4.88 
(±0.02) 
3.54 
(±0.01) 
- 
3.20 
(±0.01) 
 
                                                 
l
 Errors given represent statistical error on the fit 
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Figure 4.39 - The structures of [Eu.L
6-9
] 
The complex, [Eu.L
6
] gives the highest logK value for glyphosate. However, phosphate 
and AMPA also bind to the complex, albeit slightly more weakly. The reason why 
phosphate only binds to [Eu.L
6
], and seemingly no other complexes may be due to the 
poorer binding abilities of [Eu.L
7-8
] in particular. A slight response can be seen with 
these complexes, but nothing of any significance. The electrostatic interaction of 
phosphate is smaller than that of glyphosate or AMPA, due to the titrations being 
performed at 5.9 may also contribute to the lack of binding.  Furthermore, the complex 
performs well in both oat and wheat extract, but not in urine. The two complexes which 
do give well-defined curves in urine, do so with too low an affinity to detect glyphosate 
in the concentration range at which the herbicide has been found in this medium.  
4.5 Changing the Charge 
The final complex synthesised also includes the tripicolylamine moiety, as this entity is 
clearly important in the binding event of glyphosate. The last alteration was to modify 
the chromophore itself. By removing the carboxylate group at the 6-position of the 
pyridine group, the coordination environment around the europium centre was varied, as 
well as changing the overall charge of the complex.  
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Figure 4.40
m
 - The structure of [Eu.L
10
]
+ 
Synthesis of the conjugated chromophore began by coupling commercially available (4-
bromopyridin-2-yl)methanol and 4-ethynylanisole in THF.
210
 The alcohol was then 
converted into the mesylate ester using mesyl chloride, before an alkylation reaction 
which formed the C-N bond to the 12-N4 cyclen ring, following the analogous synthesis 
in Scheme 4.3.   
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Figure 4.41 - Changes in the  emission spectrum of [Eu.L
10
]
+
 (black) (20 μM, 0.1 M NaCl, 0.1 M MES, 
pH 5.9, 295 K)  with increasing concentration of glyphosate, up to 0.5 mM (red). (Inset) The intensity 
ratio of 612 nm /616 nm as a function of increasing glyphosate concentration 
                                                 
m
 Synthesised by S. Shuvaev 
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A minor increase in emission intensity was observed with little change in spectral form. 
Finding an intensity ratio to track proved difficult, but 612 nm / 616 nm was used which 
showed that with increasing glyphosate concentration, there is a decrease in the 
intensity ratio. This decrease is not smooth, with a lot of scatter, to the extent that fitting 
a binding curve is impossible.  
Furthermore, a month after the synthesis of the complex, a different spectral form was 
observed when dissolved in buffer, and mass spectrometry confirmed that the complex 
had started to decompose. Following these poor results, no further experiments were 
undertaken with this complex.  
4.6 pKa Experiments 
When trying to rationalise the difference in binding between these complexes and 
glyphosate, one key factor to consider is the pKa values of the complexes themselves. 
The pKa of a pyridine N atom is expected to approximately 5.3 which is close to the pH 
in which the titrations were performed (5.9).
211
 It is necessary, therefore, to consider the 
protonation state of the sp
2
 and sp
3
 nitrogen atoms that lie close to the europium centre. 
Hence, studies of the complexes were carried out in which the pKa values for four of the 
complexes were determined in 0.1 M NaCl. For [Eu.L
9
], as the triazole is closest to the 
europium centre it is expected to have a pKa of approximately 1.  
Table 4.6 - The pKa of complexes [Eu.L
6-9
] (295 K, 0.1 M NaCl)
n
 
 Pyridine pKa Amine pKa 
[Eu.L
6
] 5.67 (±0.04) 11.97 (±0.02) 
[Eu.L
7
] 7.60 (±0.06) 11.26 (±0.02) 
[Eu.L
8
] 6.99 (±0.05) 11.36 (±0.02) 
[Eu.L
9
] < 2.5 11.11 (±0.02) 
 
The lower pKa value for [Eu.L
9
] could not be determined, having started the pKa 
titration at pH 3.5. This is expected due to the low pKa values of triazole moieties. The 
pKa value of [Eu.L
6
], which has the highest affinity for glyphosate, was 5.67 (±0.04) 
and therefore, is around 80% deprotonated under the pH conditions of the titrations, 
which were held at 5.9.  
                                                 
n
 Errors given represent statistical error on the fit 
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The pKa’s were determined in H2O at 295 K and the data reported was pH vs the 
intensity ratio 604-614 nm / 614-633 nm.  The curved were fitted using non-linear least-
square iterative analysis by Boltzmann using OriginPro 2015 software, producing 
approximate pKa values. The values stated in parenthesis were statistical errors from the 
fit to the data. Other errors could arise from the pH meter which has an error of ±0.02, 
or in temperature and therefore the experiments were carried out in a temperature 
controlled room.  
However, upon modification of the tripicolylamine arm, by successively replacing the 
picolyl groups with ethyl groups, the pKa value of the pyridine N atom closest to the 
europium centre was raised to 6.99 (±0.05) for the complex with one ethyl group and 
7.60 (±0.06) with two.  Hence, in each of these cases, the pyridine N atom will be > 90 
and 97% protonated at pH 5.9, strongly affecting the binding capabilities of the 
complex.  
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Figure 4.42 - The variation of the europium emission intensity ratio (604-614 nm / 614-633 nm) with pH 
for [Eu.L
6
] and [Eu.L
8
] (7 μM, 0.1 M NaCl, 295 K, λex = 340 nm), showing the fit to the experimental 
data points 
Considering the DFT figures (Section 4.2.3.1), the protonation of the pyridine N atom 
means it cannot act as a hydrogen bond acceptor to the protonated amine in glyphosate. 
The pKa of the central sp
3
 hybridised nitrogen atom was expected to be much higher and 
found to be between 11 and 12 in each case, as expected for this type of aliphatic amine 
group, when close to another protonated ammonium centre that can form a stabilising 
hydrogen bond. Around this pH, the change in spectral form is dramatic, suggesting a 
change in coordination. This could be due to the central aliphatic nitrogen atom 
coordinating to the complex, perhaps replacing the carboxylate group. By raising the pH 
of the titration, it might be argued that these ‘ethyl’ complexes may bind more strongly 
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to glyphosate. However, under higher pH conditions, phosphate is a major competitor, 
as its pKa value is around 7.2. 
4.7 Spiked Grain Experiments 
The complex which gave the best overall binding results was [Eu.L
6
] and it was chosen 
to assess its performance in a further series of experiments. Following the successful 
detection of glyphosate in grain extract, a logical step was to use spiked grains with 
measured amounts of glyphosate and check the known concentration versus the values 
measured using the europium emission complex. Wheat grain was initially chosen, 
rather than oat or urine; the complex did not function well in urine, and handling oat 
extract proved more difficult, but gave similar results. 
The wheat grains were spiked using stock solutions of glyphosate which had been 
diluted down to appropriate concentrations at which this complex would be used. Ten 
grains were then selected and 0.01 mL of a glyphosate solution was added and left for 
24 h in a closed system. The grains absorbed the glyphosate infused water, and the 
grains were subsequently freeze-dried and then soaked for 24 h. The water was removed 
by lyophilisation and remade up to a standard 2 mL in a solution of complex of known 
concentration and 0.1 M MES plus 0.1 M NaCl. A stock solution of the complex was 
made up for these experiments to minimise the risk that difference could arise from 
minor fluctuations in complex concentration or pH.  
After an initial emission spectrum was measured, further increments of a standard 
solution of glyphosate were added to the complex solution, to ensure that a change in 
spectral form ensued. The variation in emission intensity was plotted on the calibration 
curve in grain extract. 
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Figure 4.43 - The calibration curve (solid line) of [Eu.L
6
](7 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9)  
with increasing glyphosate concentrations, with spiked grain at different concentrations at 60 μM 
(purple), 30 μM (blue), 15 μM (green), 7.5 μM (red) 
What is initially clear from Figure 4.43 is that upon addition of more glyphosate, the 
curve that is produced in each case (colour coded) do not faithfully follow the initial 
calibration curve (shown as a solid line), with perhaps the exception of 7.5 μM (Figure 
4.43, red). Some remain fairly close, but others notably, such as 60 μM (Figure 4.43, 
purple), do not stay very close to what might have been expected.  
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Figure 4.44 - The calibration curve (solid line) of [Eu.L
6
](7 μM, 0.1 M NaCl, 0.1 M MES, 295 K, pH 5.9) 
with increasing glyphosate concentrations between 0-0.06 mM, with spiked grain at different 
concentrations at 60 μM (purple), 30 μM (dark blue), 15 μM (green), 7.5 μM (red) 
However, over the range from zero to 60 micromolar added glyphosate, there is a 
pseudo-linear section with a 35% modulation of the intensity ratio that could be 
regarded as a ‘working’ calibration curve.  
Table 4.7 - The concentration of glyphosate in the spike grains, the calculated values from [Eu.L
6
] 
calibration curve with the percentage recovered 
Spiked grain 
[Glyphosate] 
added / μM 
Calculated 
[Glyphosate] / μM 
Percentage 
recovered 
1 60.0 50.5 84% 
2 30.0 39.2 132% 
3 15.0 15.6 104% 
4 7.5 3.9 52% 
 
For the 1
st
 spike grain, an 84% percentage recovery is not unexpected, as the 
concentration of glyphosate in the grain itself is unknown, as it is impossible to know 
whether the grain took up all of the glyphosate when spiking the grains. However, both 
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grains ‘2’ and ‘3’ gave a percentage recovery of over 100%. The same logic therefore 
cannot be applied to these. Grain set ‘3’ was only 104% which could potentially be 
within error, taking into account errors in initial glyphosate curve, the errors  in this 
reading, as well as errors associated with the solution itself. A percentage recovery of 
132% on the other hand cannot be justified in the same manner, and is anomalous. 
Grains ‘4’ give a much lower percentage recovery of approximately 50% which is 
worryingly low. It suggests either the grains did not soak in all the glyphosate, or the 
complex is not very good at detecting glyphosate at this level. 
Furthermore, the data points in Figure 4.43 mostly occur above the calibration curve 
determined in grain extract. Therefore, the spiked grain data set was fitted using non-
linear regression analysis, to calculate a new binding constant in grain extract. 
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Figure 4.45 - Data from the spiked grains fitted using non-linear regression analysis 
Although there is some scatter from the various examples, a binding curve could be 
fitted to this data in Figure 4.45 to give an apparent logK value of 4.97 (±0.01). This is 
slightly higher than found for the original calibration curve (logK = 4.42 (±0.02)), 
suggesting that the complex binds to glyphosate in grain extract slightly more strongly 
than originally surmised. However, owing to the difference between the calibration 
curve originally calculated, and that found using the ‘spiked grain’ data, it suggests that 
there is still some error in the readings which need to be addressed. Some data points 
have been removed from those presented above as they appeared anomalous. 
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A reasonable explanation for the overall behaviour is that grain extract is a very 
complex medium. Each grain may vary in concentrations of species which can bind to 
the complex, or interact with it in some way. For example, how close the grain is to 
germination could affect the concentration of a number of different compounds.  
The easiest way to work around this problem is to do these tests on a greater sample size 
of grains. Clearly, ten grains are not sufficient to get an average background reading, 
but for this project, the limit was the number of grains available. For future studies, 
collecting a greater number of grains and concentrating experiments specifically on this 
complex will increase the number of grains possible to use in each experiment. 
4.8 Conclusion and Further Work 
A series of five complexes was synthesised, based on a complex that has previously 
been shown to detect ATP and ADP. The tripicolylamine moiety was shown to be a 
critical structural feature, as any alteration of it resulted in a lower logK value. 
However, the alteration of one of the pyridines for a triazole group resulted in a 
complex that did not bind to phosphate at 5.9 and did not require an equilibration 
period, after addition of glyphosate. The complex [Eu.L
9
] also bound strongly to 
AMPA, resulting in interference of the glyphosate reading. Furthermore, it was not as 
effective as [Eu.L
6
] in oat and grain extract. It was also found that the carboxylate group 
on the pyridine of the chromophore was necessary for good binding behaviour.  
Following the pKa experiments, it would be interesting to determine the effect of the pH 
of the titrations on the binding capabilities of the complexes. This could be done 
through repetition of the titrations of [Eu.L
7-8
] with glyphosate at a higher pH, above the 
pKas of both complexes. Although this would likely make phosphate a much more 
important competitor, it would give an indication as to how much binding occurs 
through the picolyl groups themselves, or if glyphosate binding is effected by the level 
of protonation in the complex itself. 
Overall, complex [Eu.L
6
] was found to be the best complex for binding glyphosate 
selectively in a range of media, and no structural alteration of this complex was found to 
improve the logK value. It is a ‘switch-on’ sensor, with a number of emission intensity 
ratios which can be used to track the binding event. 
After ascertaining the best complex, further experiments in grain extract were conducted 
in which the grains were spiked with a known concentration of glyphosate. However, 
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[Eu.L
6
] did not perform consistently, with percentage recoveries ranging from 50-
134%.  
To improve on these results, repeats with a greater number of grains in the sample are 
required. Furthermore, tests with the Dionex column could be used as a control, to see 
how much the complex does take up when it is spiked with the glyphosate. 
Changes on the chromophore structure may also be possible, for example, the effect of 
changing a carboxylate for a phosphinate. Furthermore, it is also possible to change the 
methoxy group on top of the chromophore to a wide range of other substituents. 
Changing the size of this group or the electronic nature of it affects the absorption 
wavelength, so care must be taken, but could also potentially avert some of the non-
specific binding issues with aromatic species in the extracts. 
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5. Experimental Details 
5.1 General Experimental 
5.1.1 Materials 
Commercially available reagents and solvents were used without further purification, 
from Sigma Aldrich, Fischer Scientific or Fluorochem. The exception to this was the 
recrystallisation of N-bromosuccinimide (NBS). NBS (10 g) was dissolved in water 
(100 mL) and heated to just below boiling until a clear solution was formed. It was then 
placed in an ice bath for 3 h. The white solid that precipitated out was collected by 
filtration and dried under vacuum. m.p. 176-178 ˚C (lit.212 174 ˚C). 
5.1.2 LC analysis 
The river water and ‘spiked’ glyphosate samples were run through a Dionex LC column 
at 308 K. The column was an IonPac AS18 (2mm) with an ASRS 300 (2mm) 
suppressor. The ECD detector was an ICS series ECD and the UV/vis detector was an 
ICS series VWD. The eluent used throughout was aqueous KOH (30 mM) at a flow rate 
of 0.32 mL/min. This was run by the Durham University Geography Department. 
5.1.3 HPLC analysis 
Preparative HPLC was performed at 298 K using a Shimadzu system consisting of a 
Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid Chromatograph (LC-
20AP), a Prominence UV/Vis Detector (SPD-20A) and a Communications Bus Module 
(CBM-20A). An XBridge C18 OBD 19 x 100 mm, i.d. 5 µM column was used, with a 
flow rate of 17 mL/min. Fractions were collected by hand. The solvent system was H2O 
and MeOH + 0.1% formic acid or H2O and MeCN (gradient elution see Table 5.1, 
Table 5.2 and Table 5.3 ). The UV detector was set at 336 nm and fraction collection 
was performed manually. 
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Table 5.1 - HPLC conditions for Method A 
Step Time / min Flow / mL min
-1
 
%MeOH 
(+0.1% FA) 
%H2O (+0.1%) 
FA 
0 0 17 10 90 
1 0.7 17 10 90 
2 11 17 95 5 
3 14 17 95 5 
4 14.5 17 10 90 
5 16.5 17 10 90 
 
Table 5.2 - HPLC conditions for Method B 
Step Time / min Flow / mL min
-1
 %MeCN  %H2O 
0 0 17 10 90 
1 3 17 10 90 
2 13 17 50 50 
3 15 17 50 50 
4 18 17 10 90 
5 20 17 10 90 
 
Table 5.3 - HPLC conditions for Method C 
Step Time / min 
Flow / mL min
-
1
 
%MeCN  %H2O 
0 0 17 10 90 
1 3 17 10 90 
2 13 17 100 0 
3 15 17 100 0 
4 18 17 10 90 
5 20 17 10 90 
 176 
 
Chiral HPLC was carried out at 290 K on a Perkin Elmer Series 200 system consisting 
of a Perkin Elmer series 200 pump, Perkin Elmer 200 auto-sampler and Perkin Elmer 
series 200 UV/vis detector. A CHIRALPAK-IC 250 × 4.6 mm column was used, with a 
flow rate of 1 mL/min for analytic, and 250 x 10 mm, 5μm semi-prepatory column with 
a flow rate of 4.4 mL/min. A solvent system of hexane:DCM:etheanol (65:30:5) with 
0.1 % DEA was used. The UV detector was set at 260 nm. Fraction collection was 
performed manually. 
5.1.4 Analytical Methods 
NMR spectra were recorded on Varian Mercury-400 (
1
H 399.945 MHz and 
13
C 100.566 
MHz) at 298 K or an Appleby VNMRS-600 (
1
H 599.832 MHz and 
13
C 150.828 MHz) 
for 2D experiments. Spectra were recorded in commercially available deuterated 
solvents from Apollo Scientific and Cambridge Isotope Laboratories. 
13
C and 
1
H 
chemical shift values are quoted in ppm relative to trimethylsilane and all coupling 
constants are given in Hz. Abbreviations when quoting NMR data are as follows: 
singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br).  
Electrospray mass spectra were obtained on a TQD mass spectrometer equipped with an 
Acquity UPLC, an electrospray ion source and an Acquity photodiode array detector 
(Waters Ltd, UK).  Methanol or acetonitrile were used as the carrier solvent. For LC-
MS analyses a 2.1 x 100 mm 1.7 micron Acquity UPLC BEH C18 column was used. 
LC-MS analyses were performed on a Waters system comprising a 3100 Mass Detector 
and a 2998 Photodiode array detector.  
Accurate masses were recorded on a QTOF Premier mass spectrometer equipped with 
an Acquity UPLC, a lock-mass electrospray ion source and an Acquity photodiode array 
detector (Waters Ltd, UK). Methanol was used as the carrier solvent. 
Thin layer chromatography was carried out on neutral aluminium silica plates (Merck 
5554) or neutral aluminium oxide plates (Merck 5550) and visualised under UV 
irradiation (254 or 365 nm). Preparative column chromatography was performed using 
silica gel (Merck Silica Gel 60, 230-400 mesh) or neutral aluminium oxide (Merck 90, 
70-320 mesh). 
Melting points were recorded using Sanyo Gallenkamp melting point apparatus and are 
uncorrected. 
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5.1.5 Optical Techniques 
All samples for optical analyses were contained in quartz cuvettes with a path length of 
1 cm and a polished base. Measurements were recorded at 295 K.    
UV/Vis absorbance spectra were recorded on an ATI Unicam UV/Vis spectrometer 
(Model UV2) using Vision version 3.33 software. Samples were measured relative to a 
reference of pure solvent. Emission spectra were recorded on an ISA Joblin-Yvon Spex 
Fluorolog-3 luminescence spectrometer, or Horiba-Jobin Yvon Fluoromax-3 
luminescence spectrometer equipped with an iHR320 module, which selects either a 
HORIBA FL-1073 (Hammatsu R928P) photomultiplier tube or a HORIBA Synapse 
BIDD CCD for detection of emitted light, using FluorEssence software (based on 
Origin® software). Increments of 2 nm were used, with slit widths of 1.5 nm for both 
excitation and emission. 
Lifetime measurements were carried out on a Perkin Elmer LS55 spectrometer using FL 
Winlab software version 4.00.02. The complexes were excited at λmax, emission 
monitoring at 612.5 or 614 nm, during a fixed gate time of 0.1 ms, after a delay time. 
The lifetimes were taken between 0.1 and 3 ms or 6 ms delay times, dependant on the 
solvent. The excitation and emission slits were set to 10 nm. The observed decays were 
plotting in Origin® using Equation 5.1. 
 𝐼 = 𝐴0 + 𝐴1𝑒
−𝑘𝑡 (5.1) 
The measured excited state lifetime, τ, is the inverse of the radiative decay rate constant, 
k. 
CPL spectra were recorded on a custom built spectrometer consisting of a laser driven 
light source (Energetiq EQ-99 LDLS, spectral range 170 to 2100 nm) coupled to an 
Acton SP2150 monochromator (600 g/nm, 300 nm Blaze) that allows excitation 
wavelengths to be selected with a 6 nm FWHM band-pass. The collection of the emitted 
light was facilitated (90º angle set up, 1 cm path length quartz cuvette) by a Lock-In 
Amplifier (Hinds Instruments Signaloc 2100) and Photoelastic Modulator (Hinds 
Instruments PEM-90). The differentiated light was focused onto an Acton SP2150 
monochromator (1200 g/nm, 500 nm Blaze) equipped with a high sensitivity cooled 
Photo Multiplier Tube (H10723-20 Extended red-multialkali). Spectra were recorded 
using a 5 spectral average sequence in the range of 570-720 nm with 1 nm spectral 
intervals and 500 μs integration time. 
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All data fitting and plotting were performed using Origin® software. Binding constants 
were calculated by fitting to Equation 5.2. The numbers given in parenthesis following 
the binding constants are error in the fit of line to the data. 
 
[𝑋] =
𝐹 − 𝐹0
𝐹1 − 𝐹0
⁄
𝐾 +
[𝐸𝑢] × (
𝐹 − 𝐹0
𝐹1 − 𝐹0
) − [𝐸𝑢] × (
𝐹 − 𝐹0
𝐹1 − 𝐹0
)
2
1 −
𝐹 − 𝐹0
𝐹1 − 𝐹0
 
(5.2) 
Where [X] is the total concentration of the selected analyte in solution, [Eu] is the total 
concentration of the complex, F is either intensity ratio of selected emission transitions 
or IL - IR values, F0 is the initial ratio and F1 is the final ratio. K is the binding constant, 
derived in Equation 5.3, where [EuX] is the concentration of the analyte-coordination 
complex, [Xf] is the concentration of free analyte and [Euf] is the concentration of free 
complex. 
 
𝐾 =
[𝐸𝑢𝑋]
[𝑋𝑓][𝐸𝑢𝑓]
 
(5.3) 
Time gated experiments were carried out in a custom built time-gated 
spectrophotometer. It comprised of a 365 nm 330 mW pulsed LED with 2 ms per pulse 
in a 10 Hz cycle sequence. This was connected to a cuvette holder and an Acton 2155 
scanning monochromator with a 1200 blaze grating, tuned between 400 and 750 nm, 
and a Hamamatsu 7155 red corrected PMT. This was operated using custom written 
Labview software. 
5.1.6 DFT Computations 
The model geometries for [Y.L
6
]*Gly and [Y.L
6
]*Zn
2+
*Gly adducts in this study were 
fully optimised without symmetry constraints using the hybrid-DFT B3LYP 
functional
213,214 
and the 3-21G* basis set
215–220
 for all atoms with the Gaussian 09 
package.
221
 The 4-methoxyphenylethynyl group in ligand L
6
 was replaced with a 
hydrogen atom in the model geometries to reduce computational efforts. The 
paramagnetic Eu(III) complexes are very difficult to model computationally so Y(III) 
has been used instead of Eu(III) in calculations elsewhere.
222–225 
Optimised geometries 
of Y(III) complexes with the B3LYP/3-21G* functional/basis set have been 
demonstrated previously to be suitable models for Eu(III) complexes.
85,90
 The 
Gaussian09 default polarisation continuum solvent model (IEFPCM)
226
 was applied to 
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all calculations using water as solvent. The figures of optimised model geometries were 
generated using Mercury software.
227
 
5.1.7 Grain/Oat Extracts 
Ten grains were selected and soaked in 2 mL of purite water for 24 hr. The water was 
then filtered and lyophilised. The residue was taken up in 2 mL of purite water with 
complex (7 μM) in 0.1 M NaCl, 0.1 M MES at pH 5.9. 
To spike the grains, ten cordiale grains were taken and a 0.01 mL of a glyphosate 
solution (0.15-1.2 mM) was added and the container sealed for 24 hr to allow the grains 
to soak up the glyphosate. After lyophilised to remove any water, the grains were 
soaked for 24 hr in 2 mL of purite water. The solution was filtered and lyophilised 
again, before the residue was taken up in 2 mL of the complex (7 μM) solution with 0.1 
M NaCl, 0.1 M MES at pH 5.9.  
5.2 Synthetic Procedures  
1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester, 1
228
 
 
1,4,7,10-Tetraazacyclododecane (2.5 g, 14.5 mmol) and disodium hydrogen phosphate 
(7.0 g, 49.3 mmol) were dissolved in a solution of distilled water:dioxane (35 mL, 
25:10). The pH was adjusted to 2.5 with addition of HCl. Benzyl chloroformate (5.0 
mL, 35.0 mmol) in dioxane (10 mL) was added dropwise over 2 h, and the solution was 
stirred at room temperature for 18 h. The solvent was evaporated under reduced 
pressure and the residue re-dissolved in water (100 mL). The pH was adjusted to 7.0 
using conc. KOH. The aqueous phase was then washed with diethyl ether (2 x 100 mL) 
and then extracted with DCM (2 x 100 mL). The DCM layers were combined, dried 
with magnesium sulfate and the solvent evaporated under reduced pressure to give a 
clear oil. The oil was crystallised from DCM and diethyl ether to give a white powder 
(1.54 g, 24%). m.p. 116-118 °C (lit.
229
 113-116 °C). 
1
H NMR (400 MHz, CDCl3) δH 
(ppm): 7.35 (10H, m, Ar), 5.18 (4H, s, CH2-Ar), 3.39-4.01 (8H, s, br, cyclen), 2.75-3.25 
(8H, m, br, cyclen), 1.65 (2H, s, br, NH). LCMS (ESI
+
) m/z: 441 [M+H]
+
.  
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4,10-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-1,7- 
dicarboxylic acid dibenzyl ester, 2
228
 
 
1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester (1.50 g, 3.41 
mmol), tert-butyl bromoacetate (1.13 mL, 7.67 mmol) and Cs2CO3 (3.34 g, 10.24 
mmol) were dissolved in anhydrous acetonitrile (25 mL). The mixture was heated under 
reflux for 18 h. The mixture was filtered and the solvent removed under reduced 
pressure to yield a yellow oil, that was purified using column chromatography (silica, 
100% DCM → 2% MeOH) to yield a light yellow oil (1.73 g, 76%). 1H NMR (400 
MHz, CDCl3) δH (ppm): 7.33 (10H, m, Ar), 5.12 (4H, s, CH2-Ar), 3.14-3.58 (16H, m, 
br, cyclen), 2.88 (4H, s, CH2CO), 1.42 (18H, s, br, 
t
Bu). LCMS (ESI
+
) m/z: 689 
[M+H]
+
. 
1,7-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, 3
228
 
 
4,10-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-1,7- dicarboxylic 
acid dibenzyl ester (2.00 g, 2.99 mmol) was dissolved in absolute ethanol (20 mL) with 
a catalytic amount of Pd(OH)2/C (10%). The mixture was agitated in a Parr 
hydrogenation apparatus for 24 h under 40 bar of hydrogen. The catalyst was filtered 
and the solvent removed under reduced pressure to yield a white solid (1.05 g, 2.63 
mmol, 88%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 3.30 (4H, s, CH2CO), 2.79 (8H, s, 
br, cyclen), 2.58 (8H, s, br, cyclen), 1.44 (18H, s, 
t
Bu). LCMS (ESI
+
) m/z: 401 [M+H]
+
. 
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6-Methyl-2-phenoxynictonic acid, 4
51
 
 
Sodium metal (840 mg, 36.5mmol) was slowly dissolved in dry methanol (20 mL). 2-
Chloro-6-methylnicotinic acid (2.5 g, 14.6 mmol) and phenol (6.52 g, 69.4 mmol) were 
added to the solution and stirred for 15 min. The solvent was removed and the 
remaining liquid was refluxed at 180 ˚C for 18 h. The resultant mixture was cooled to 
room temperature and dissolved in water (20 mL) which was washed with diethyl ether 
(3 × 20 mL). The pH of the aqueous layer was adjusted to 4.0 and a white precipitate 
formed. The solvent was removed under reduced pressure to yield a white solid (2.47 g, 
74 %). m.p. 154-156 ˚C (lit.230 155-156 ˚C). 1H NMR (400 MHz, CDCl3) δH (ppm): 
8.40 (1H, d, 
3
JH-H = 8.0 Hz, H
4
), 7.45 (2H, t, 
3
JH-H = 8.0 Hz, H
3
), 7.30 (1H, t, 
3
JH-H = 8.0 
Hz, H
4’
), 7.21 (2H, d, 
3
JH-H = 8.0 Hz, H
2’
), 7.05 (1H, d, 
3
JH-H = 8.0 Hz, H
5
), 3.01 3H, s, 
CH3). LCMS (ESI
+
) m/z: 234 [M+H]
+
. 
2-Methyl-1-azaxanthone, 5
51
 
 
6-Methyl-2-phenoxynicotinic acid (2.47 g, 10.9 mmol) was added to polyphosphoric 
acid (80 g) and stirred at 120 °C for 18 h under argon. The mixture was then allowed to 
cool to room temperature before being poured onto ice water and stirred until the ice 
melted. The pH was adjusted to 12.0 with potassium hydroxide pellets and then 
extracted with DCM (3 × 100 mL). The organic layers were combined, and dried over 
K2CO3 before the solvent was removed under reduced pressure which yielded a yellow 
solid (1.14 g, 50%). m.p. 134-136 ˚C (lit.231 (136-138 ˚C). 1H NMR (400 MHz, CDCl3) 
δH (ppm): 8.56 (1H, d, 
3
JH-H = 8.0 Hz, H
4
), 8.28 (1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 2.0 Hz, 
H
6
), 7.75 (1H, ddd 
3
JH-H = 8.5, 7.0 Hz, 
4
JH-H = 2.0 Hz, H
8
), 7.58 (1H, d, 
3
JH-H = 8.5 Hz, 
4
JH-H = 1.0 Hz, H
9
), 7.40 (1H, ddd, 
3
JH-H = 8.0, 7.0 Hz, 
4
JH-H = 1.0 Hz, H
7
), 7.28 (1H, d, 
3
JH-H = 8.0 Hz, H
3
), 2.69 (3H, s, H
1
). LCMS (ESI
+
) m/z: 212 [M+H]
+
, 234 [M+Na]
+
. 
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2-Bromomethyl-1-azaxanthone, 6
51
 
 
2-Methyl-1-azaxanthone (1.00 g, 4.74 mmol), was dissolved in carbon tetrachloride (25 
mL) and heated with a 60 W tungsten lamp. N-bromosuccinimide (0.843 g, 4.74 mmol) 
and dibenzyl peroxide (15 mg, 0.05 mmol) were added and the solution was stirred 
under argon for 3 days, monitoring the reaction using TLC and 
1
H NMR. The reaction 
was then allowed to cool to room temperature, filtered and the solvent removed under 
vacuum. The resulting solid was purified by column chromatography, with 1:1 
DCM:toluene which yielded a white solid (0.4 g, 30%). 
Alternative procedure:
232
  
Diethylphosphite (1.11 mL, 8.59 mmol) and diisopropylamine (1.40 mL, 10.03 mmol) 
were added at 0 °C to a stirred solution of 2-dibromomethyl-1-azaxanthone (0.67 g, 
1.82 mmol) in dry THF (30 mL) under argon. After 10 minutes the reaction was halted 
and poured onto iced water (50 mL), then extracted with chloroform (3 x 50 mL). The 
organic layer was backwashed with NaHCO3(aq) (50 mL) and water (50 mL) before it 
was dried and the solvent removed under pressure to give a white solid. The organic 
layer was purified by column chromatography (silica, 100% DCM → 3% MeOH) 
which yielded a white powder (0.407 g, 77%). 
m.p. 164-166 ˚C (lit.51 169-170 ˚C). 1H NMR (400 MHz, CDCl3) δH (ppm): 8.72 (1H, d, 
3
JH-H = 8.0 Hz, H
4
), 8.33 (1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 1.5 Hz, H
8
), 7.80 (1H, ddd, 
3
JH-H = 8.0, 7.0 Hz, 
4
JH-H = 1.5 Hz, H
10
), 7.64 (1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 1.0 Hz, 
H
11
), 7.57 (1H, d, 
3
JH-H = 8.0 Hz, H
3
), 7.46 (1H, ddd, 
3
JH-H = 8.0, 7.0 Hz, 
4
JH-H = 1.0 Hz, 
H
9
), 4.62 (2H, s, H
1
). 
13
C NMR (100 MHz, CDCl3) δC (ppm): 177.1 (C
6
), 162.1 (C
2
), 
159.8, (C
13
), 157.8 (C
12
), 138.8, (C
4
), 135.9 (C
10
), 126.8 (C
7
), 125.0 (C
9
), 121.7 (C
8
), 
120.9 (C
3
), 118.6 (C
11
), 116.1 (C
5
), 32.3 (C
1
). LCMS (ESI
+
) m/z: 298 [M+H]
+
. Rf 0.29 
(DCM, silica), Rf 0.51 (DCM:Toluene, silica).  
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1,7-Bis-(tert-butoxycarbonylmethyl)-4,10-bis[2-methyl-1-azaxanthone]-1,4,7,10- 
tetraazacyclododecane, 7
61
 
 
1,7-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (107 mg, 0.27 
mmol), 2-bromomethyl-1-azanthanthone (170 mg, 0.59 mmol) and Cs2CO3 (192 mg, 
0.59 mmol) were dissolved in anhydrous acetonitrile (5 mL) and heated under reflux for 
48 h under argon at 65 °C. The reaction was monitored by LCMS to ensure all the 
brominated material had been consumed. The mixture was allowed to cool to room 
temperature and gravity filtered before the solvent was removed under reduced pressure. 
The residue was dissolved in DCM (5 mL) and washed with water (3 x 5 mL) to remove 
caesium salts. The organic layer was dried and the solvent removed under reduced 
pressure to yield an orange oil (142 mg, 65%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 
8.75 (2H, d, 
3
JH-H = 8.0 Hz, H
3
), 8.32 (2H, d, 
3
JH-H = 8.0 Hz, H
2
), 7.80 (2H, t, 
3
JH-H = 8.0 
Hz, H
4
), 7.63 (2H, d, 
3
JH-H = 8.0 Hz, H
1
), 7.55 (2H, d, 
3
JH-H = 8.0 Hz, H
6
), 7.45 (2H, t, 
3
JH-H = 8.0 Hz, H
5
), 4.09 (4H, s, CH2), 1.57-3.52 (20H, m, cyclen, CH2CO), 1.47 (18H, 
s, 
t
Bu). LCMS (ESI
+
) m/z: 819 [M+H]
+
. 
[Eu.L
1
(OH2)]
+61
 
 
Trifluoroacetic acid (1 mL) was added to a solution of 1,7-bis-(tert-
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (14 mg, 0.017 mmol) in DCM 
(0.5 mL). The reaction mixture was stirred at room temperature for 60 h. The solvent 
was removed under reduced pressure, and the residue re-dissolved in DCM three times 
to ensure complete removal of the acid and tert-butyl alcohol, finally affording a pale 
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brown solid that was used in the following step without further purification. LCMS 
(ESI
+
) m/z: 707 [M+H]
+
.  
The solid residue was dissolved in methanol:water (1 mL:2 mL, 3 mL). Eu(OAc)3 
(0.019 g, 0.057 mmol) was added and the pH was adjusted to 5.5 by addition of aqueous 
ammonia. The mixture was heated under reflux at 90 °C for 18 h. The reaction was 
cooled to room temperature, and then the pH was raised to 10.0 with aqueous ammonia. 
The solution was stirred for a further 1 h before filtering. The pH was adjusted to 5.5 
with glacial acetic acid. The solvent was evaporated and lyophilised to yield a white 
solid which was purified by reverse phase HPLC (Method A, tR = 6.8 min) to give a 
colourless solid (7 mg, 44%). HRMS (ESI
+
) m/z: 871.1771 [M+H]
+
 (C38H38
159
EuN6O9 
requires 871.1743). τH2O: 0.50 ms; τD2O: 1.69 ms; λabs(H2O): 336 nm. 
(S)-Ethyl-N-bromoethanoyl-alanate, 8
233
 
 
S-Alanine ethyl ester (1.5 g, 9.77 mmol), triethylamine (2.79 mL, 20mmol) and 
bromoacetyl bromide (0.85 mL, 9.77 mmol) were dissolved in chloroform and stirred at 
-30 °C in a dry ice/acetone bath for 3 h. The reaction was then warmed to room 
temperature and left to stir overnight. The mixture was washed with HCl (6 M, 15 mL) 
and water (4 x 10 mL). The organic layer was dried and the solvent removed under 
vacuum. The colourless oil was recrystallized with DCM and 40/60 pet. ether to give a 
white crystalline solid (1.10 g, 47%). m.p. 30-32 ˚C (lit.233 30-31 ˚C). 1H NMR (400 
MHz, CDCl3) δH (ppm): 7.10 (1H, s, br, NH), 4.51 (1H, q, 
3
JH-H = 7.0 Hz, CH-CH3, 
4.18 (2H, q, 
3
JH-H = 7.0 Hz, O-CH2), 3.85 (2H, s, br, Br-CH2), 1.41 (3H, d, 
3
JH-H = 7.0 
Hz, CH-CH3), 1.28 (3H, t, 
3
JH-H = 7.0 Hz, O-CH2-CH3). LCMS (ESI
+
) m/z: 238 
[M+H]
+
. 
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(SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(ethoxycarbonyl-2-
ethylcarbamoylmethyl)-1,4,7,10-tetraazacyclododecane, 9
233
 
 
1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester (1.02 g, 2.3 
mmol) and (S)-ethyl-N-bromoethanoyl-alanate (1.10 g, 4.6 mmol) were dissolved in 
anhydrous acetonitrile (25 mL) and potassium carbonate (2.25 g, 16 mmol) was added. 
The reaction mixture was heated to 60 °C and left to stir for 5 days, monitoring via 
LCMS to ensure all the alkyl halide was consumed. The mixture was filtered and the 
solvent removed under reduced pressure to yield an orange oil which was purified by 
column chromatography (alumina, DCM:MeOH, 98:2) to give a yellow oil (1.20 g, 
69%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 7.33 (10H, m, br, Ar), 5.09 (4H, s, H
6
), 
4.51 (2H, br, H
3
), 4.14 (4H, q, 
3
JH-H = 7.0 Hz, H
2
), 3.73 (4H, s, br, H
5
), 2.67-3.31 (18H, 
m, br, cyclen), 1.38 (6H, br, H
4
), 1.25 (6H, t, 
3
JH-H = 7.0 Hz, H
1
). LCMS (ESI
+
) m/z: 755 
[M+H]
+
, 777 [M+Na]
+
. 
(SS)-1,7-Bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-1,4,7,10-
tetraazacyclododecane, 10
233
 
 
(SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-
1,4,7,10-tetraazacyclododecane was dissolved in absolute ethanol (20 mL) with a 
catalytic amount of Pd(OH)2/C (10%). The mixture was hydrogenated using a Parr 
hydrogenator (40 bar) overnight. The catalyst was filtered and the solvent removed to 
give a yellow oil which was used without further purification, (0.46 g, 60%). 
1
H NMR 
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(400 MHz, CDCl3) δH (ppm): 8.38 (2H, s, br, H
1
), 4.55 (2H, m, H
3
), 4.16 (4H, q, 
3
JH-H = 
7.0 Hz, H
5
), 3.22 (4H, m, H
2
), 2.45-2.95 (18H, m, br, cyclen), 1.36 (6H, d, 
3
JH-H = 7.0 
Hz, H
4
), 1.26 (6H, t, 
3
JH-H = 7.0 Hz, H
6
). LCMS (ESI
+
) m/z: 488 [M+H]
+
. 
(SS)-1,7-Bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-
2methyl]-1,4,7,10-tetraazacyclododecane, 11
52
 
 
A mixture of (SS)-1,7-Bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-1,4,7,10-
tetraazacyclododecane (301 mg, 0.619 mmol), and 2-bromomethyl-1-azaxanthone (179 
mg, 0.619 mmol) was stirred in dry acetonitrile (10 mL) with sodium bicarbonate (50 
mg, 0.619 mmol) at 70 ˚C for 18 h. The reaction was monitored using LCMS to confirm 
all the brominated starting material had been consumed. The solvent was removed 
under reduced pressure, the solid was re-dissolved in DCM (50 mL) and the sodium 
salts were filtered off. The solvent was removed and the solid was purified by a column 
chromatography (alumina, 100% DCM → 1% MeOH) to give an off-white solid (85 
mg, 20%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 8.68 (1H, d, 
3
JH-H = 8.0 Hz, H
4
), 8.25 
(1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 2.0 Hz, H
6
), 7.81 (1H, ddd, 
3
JH-H = 8.0, 7.0 Hz, 
4
JH-H = 
2.0 Hz, H
7
), 7.62 (1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 1.0 Hz, H
9
), 7.46 (1H, ddd, 
3
JH-H = 
8.0, 7.0 Hz, 
4
JH-H = 1.0 Hz, H
8
), 7.41 (1H, d, 
3
JH-H = 8.0 Hz, H
3
), 4.35 (2H, q, 
3
JH-H = 
7.0 Hz, H
16
), 4.11 (4H, q, 
3
JH-H = 7.0 Hz, H
19
), 3.93 (2H, s, H
10
), 2.80-3.40 (20H, m, 
cyclen, H
13
), 1.24 (6H, d, 
3
JH-H = 7.0 Hz, H
17
), 1.19 (6H, t, 
3
JH-H = 7.0 Hz, H
20
). LCMS 
(ESI
+
) m/z: 695 [M+H]
+
. 
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(SS)-1,7-Bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-
2methyl]-10methyl-1,4,7,10-tetraazacyclododecane, 12
52
 
 
(SS)-1,7-Bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-2-methyl]-
1,4,7,10-tetraazacyclododecane (85 mg, 0.12 mmol) was added to a solution of formic 
acid (2 mL) and formaldehyde (2 mL, 38% solution) and left to stir under reflux for 18 
h. The solvent was removed under reduced pressure and the residue was re-dissolved in 
DCM:MeOH (10 mL, 10:1). The solid was filtered and the organic solvent was 
removed to yield a yellow solid (26 mg, 30%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 
8.70 (1H, d, 
3
JH-H = 8.0 Hz, H
4
), 8.27 (1H, dd, 
3
JH-H = 8.0, 
4
JH-H = 2.0 Hz, H
6
), 7.75 (1H, 
ddd, 
3
JH-H = 8.0, 7.0 Hz, 
4
JH-H = 2.0 Hz, H
7
), 7.61 (2H, m, H
3,9
), 7.44 (2H, t, 
3
JH-H = 7.0 
Hz, H
8
), 4.33 (2H, q, 
3
JH-H = 7.0 Hz, H
16
), 4.11 (2H, m, H
10
), 4.07 (2H, q, 
3
JH-H = 7.0 
Hz, H
19
), 2.90-3.20 (20H, m, cyclen, H
13
), 2.79 (3H, s, H
21
), 1.41 (6H, d, 
3
JH-H = 7.0 Hz, 
H
17
), 1.23 (6H, t, 
3
JH-H = 7.0 Hz, H
20
). LCMS (ESI
+
) m/z: 710 [M+H]
+
. 
(SS)-1,7-Bis(carboxy-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-2-methyl]-10-
methyl-1,4,7,10-tetraazacyclododecane, L
2 52
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A solution of NaOD (5 mL, 0.1M) in D2O was freshly made and (SS)-1,7-
bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-2-methyl]-10-methyl-
1,4,7,10-tetraazacyclododecane (26 mg) was added. The reaction was monitored by 
1
H 
NMR. After 18 h, the pH was adjusted to 6.0 and the solvent was removed under 
reduced pressure and the resultant mixture was purified by HPLC (Method B, tR = 9.2 
min) to yield a yellow solid (4 mg, 17 %). 
1
H NMR (400 MHz, D2O) δH (ppm): 8.51 
(1H, d, 
3
JH-H = 8.0 Hz, H
4
), 8.16 (1H, dd, 
3
JH-H = 8.0 Hz, 
4
JH-H = 1.5 Hz, H
6
), 8.00 (1H, 
ddd, 
3
JH-H = 8.0, 7.0 Hz, 
3
JH-H = 1.5 Hz, H
7
), 7.62 (1H, t, 
3
JH-H = 7.5, H
9
), 7.50 (1H, d, 
3
JH-H = 8.0 Hz, H
8
) 7.27 (1H, d, 
3
JH-H = 8.0 Hz, H
3
), 4.34 (2H, q, 
3
JH-H = 7.0 Hz, H
16
), 
1.65-2.15 (25H, m, cyclen, H
10, 13, 21
), 1.07 (6H, d, 
3
JH-H = 7.0 Hz, H
17
). LCMS (ESI
+
) 
m/z: 807 [M+H]
+
. 
[Eu.L
2
(OH2)]
+ 52
 
 
(SS)-1,7-Bis(carboxy-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-2-methyl]-10-
methyl-1,4,7,10-tetraazacyclododecane (4 mg, 6 μM) and Eu(OAc)3 (2 mg, 6 μM) was 
dissolved in 50:50 H2O:MeOH (1 mL) and was boiled under reflux for 4 days. The pH 
was adjusted to 10 and a white solid was removed with a centrifuge. The pH was 
adjusted to neutral and the solution was lyophilised to yield a yellow solid (2 mg, 41%). 
LCMS (ESI
+
) m/z: 805 [M-OAc]
+. τH2O: 0.57 ms; τD2O: 1.42 ms; λabs(H2O): 336 nm. 
Dimethyl 4-chloropyridine-2,6-dicarboxylate, 13
234
 CAS: 5371-70-0 
 
 189 
 
Chelidamic acid (1 g, 5.5 mmol) was dissolved in thionyl chloride (5.6 mL, 0.7 mol) 
and a few drops of DMF were added. The solution was stirred at 100 ˚C under argon for 
48 h. The thionyl chloride was removed and the residue re-dissolved in dry DCM (3 
mL). The solution was cooled to 0 ˚C before anhydrous MeOH (4 mL) was added 
dropwise. The solution was subsequently warmed to room temperature and the solvent 
removed under reduced pressure. The residue was washed with NaHCO3 (20 mL) and 
extracted in to DCM (3 x 30 mL). The organic layers were combined and washed 
successively with water (50 mL), then brine (50 mL). The organic layer was dried with 
MgSO4, filtered and the solvent removed yielding a yellow solid, (0.8 g, 74%). m.p. 
145-147 °C (lit.
235
 139-140 °C). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 8.30 (2H, s, py-
H), 4.04 (6H, s, O-CH3). 
13
C NMR (100 MHz, CDCl3) δC (ppm): 164.3 (C=O), 149.6 
(py-C), 147.0 (py-C), 128.5 (py-C), 53.7 (O-CH3). HRMS (ESI
+
) m/z: 230.0231 
[M+H]
+
 (C9H9NO4Cl requires 230.0220). Rf (5% MeOH, silica) 0.61. 
Dimethyl 4-iodopyridine-2,6-dicarboxylate, 14
234
 CAS: 112776-84-8 221 
 
Dimethyl 4-chloropyridine-2,6-dicarboxylate (0.99 g, 3.4 mmol) was dissolved in dry 
acetonitrile (50 mL). Sodium iodide (6.49 g, 43.3 mmol) was then added and the 
mixture was sonicated for 30 min. Acetyl chloride (1 mL, 14.0 mmol) was subsequently 
added and the solution sonicated again, for 45 min. The solvent was removed and the 
residue re-dissolved in DCM (30 mL). The organic layer was extracted with Na2CO3(aq) 
(25 mL), and the aqueous layer was re-extracted into DCM (2 x 30 mL). The organic 
layers were combined and washed with NaS2O4.H2O (50 mL), dried over MgSO4, 
filtered and the solvent removed under reduced pressure. The orange solid was purified 
using column chromatography (silica, 100% DCM → 1% MeOH) to yield a white solid, 
(1.15 g, 82%). m.p. 184-185 ˚C (lit.90 179-180 °C). 1H NMR (400 MHz, CDCl3) δH 
(ppm): 8.66 (2H, s, py-H), 4.01 (6H, s, O-CH3). 
13
C NMR (100 MHz, CDCl3) δc (ppm): 
164.0 (C=O), 148.4 (py-C), 137.3 (py-C), 107.13 (py-C), 53.6 (O-CH3). HRMS (ESI
+
) 
m/z: 321.9658 [M+H]
+
 (C9H9NO4I required 321.9576). Rf (5% MeOH, silica) 0.77. 
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Methyl 6-(hydroxymethyl)-4-iodopicolinate, 15
234
 CAS: 1247012-08-3 224  
 
Dimethyl 4-iodopyridine-2,6-dicarboxylate was dissolved in DCM (6 mL) and MeOH 
(4 mL), and cooled to 0 °C. NaBH4 was subsequently added and stirred for 1.5 hr. The 
reaction was quenched with HCl (4 mL, 1 M) and the volatile solvents removed under 
reduced pressure. The remaining aqueous solution was washed with ethyl acetate (3 x 
30 mL). The organic layers were combined, dried with MgSO4, filtered and the solvent 
removed yielding a yellow oil. This was purified using flash column chromatography 
(silica, 100% DCM → 1% MeOH) to give a white solid, (0.83 g, 79%). m.p. 139-140 
˚C (lit.90 140-141 °C). 1H NMR: (400 MHz, CDCl3) 8.39 (1H, s, py-H
3
), 7.98 (1H, s, 
py-H
5
), 4.83 (2H, s, CH2-OH), 4.00 (3H, s, O-CH3).
 13
C NMR (100 MHz, CDCl3) δc 
(ppm): 164.3 (C=O), 161.1 (py-C
6
), 147.3 (py-C
2
) 133.4 (py-C
5
), 133.25 (py-C
3
), 107.2 
(py-C
4
), 64.2 (CH2-OH), 53.4 (CH3). HRMS (ESI
+
) m/z: 293.9593 [M+H]
+
 (C8H9NO3I 
requires 293.9627). Rf (5% MeOH, silica) 0.30. 
Methyl 6-(hydroxymethyl)-4-((4-methoxyphenyl)ethynyl)picolinate, 16
222
 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate (0.50 g, 1.7 mmol) was dissolved in dry 
THF (10 mL) and the solution degassed by three freeze-pump-thaw cycles. 4-
Ethynylanisole (327μL, 2.5 mmol) and trimethylamine (1.19 g, 8.5 mmol) were added 
and the solution was degassed once more. 
[Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (110 mg) and CuI (60 mg) 
were added and the mixture was stirred at 65 °C overnight. The solvent was removed 
under reduced pressure and purified by HPLC (Method C, tR = 10.7 min), to yield a 
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white solid, (0.24 g, 47%). 
1
H NMR (400 MHz, CDCl3) δH (ppm) : 8.11 (1H, s, py-H
3
), 
7.62 (1H, s, py-H
5
), 7.53 (2H, d, 
3
JH-H = 8.5 Hz, H
4
), 6.93 (2H, d, 
3
JH-H = 8.5 Hz, H
3
), 
4.89 (2H, s, CH2-OH), 4.04 (3H, s, COOCH3), 3.87 (3H, s, H
1
). 
13
C NMR (100 MHz, 
CDCl3) δC (ppm): 165.1 (C=O), 160.8 (C
2
), 160.5 (py-C
6
), 147.0 (py-C
2
), 134.4 (C
4
), 
133.9 (C
5
), 125.9 (py-C
3
), 125.6 (py-C
5
), 114.4 (C
3
), 113.7 (py-C
4
), 96.4 (C
6
), 85.3 (C
7
), 
64.7 (CH2-OH), 55.5 (O-CH3), 53.3 (COOCH3). HRMS (ESI
+
) m/z: 298.1084 [M+H]
+
 
(C17H16NO4 requires 298.1079). 
1-(6-(Chloromethyl)pyridin-2-yl)-N,N-bis(pyridin-2- 
ylmethyl)methanamine, 18
205
 
 
2,6 Bis(chloromethyl)pyridine (0.50 g, 2.8 mmol) and NaHCO3 (0.24 g, 2.8 mmol) were 
dissolved in MeCN (20 mL). Di-picoylamine (0.56, 2.8 mmol) in MeCN (5 mL) was 
added dropwise and the resultant solution was stirred at room temperature overnight 
under argon. The mixture was then filtered and the solvent removed under reduced 
pressure to yield an orange solid. The compound was purified via flash column 
chromatography (alumina, 100% DCM) to yield a yellow solid, (0.5 g, 53%). m.p. 108-
109 ˚C (lit.236 98 °C). 1H NMR (400 MHz, CDCl3) δH (ppm) : 8.53 (2H, m, H
12
), 7.65 
(3H, m, H
4, 13
), 7.57 (2H, d, 
3
JH-H = 8.0 Hz, H
10
), 7.52 (1H, d, 
3
JH-H = 8.0 Hz, H
5
), 7.31 
(1H, d, 
3
JH-H = 7.5 Hz, H
3
), 7.14 (2H, ddd, 
3
JH-H = 8.0, 5.0 Hz, 
4
JH-H = 1.0 Hz, H
11
), 4.63 
(2H, s, H
1
), 3.93 (4H, s, H
8
), 3.92 (2H, s, H
7
).
13
C NMR (100 MHz, CDCl3) δC (ppm): 
159.0 (C
6
), 158.9 (C
9
), 156.0 (C
2
), 149.1 (C
12
), 137.6 (C
4
), 136.7 (C
13
), 123.3 (C
10
), 
122.4 (C
5
), 122.3 (C
11
), 121.2 (C
3
), 60.1 (C
8
), 59.9 (C
7
), 46.9 (C
1
). Rf (Alumina, DCM) 
0.31. HRMS (ESI
+
) m/z: 339.1385 [M+H]
+
 (C19H20ClN4 requires 399.1376). 
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Di-tert-butyl 2,2'-(4-((6-(methoxycarbonyl)-4-((4-methoxyphenyl)ethynyl)pyridine 
-2-yl)methyl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetate, 19
206
 
 
Methyl 6-(hydroxymethyl)-4-((4-methoxyphenyl)ethynyl)picolinate (0.24 g, 0.64 
mmol) was dissolved in THF (10 mL). Trimethylamine (0.26 mL, 1.8 mmol) was added 
and the solution was cooled to 0 °C. Mesyl chloride (65 μL, 0.84 mmol) was added and 
the solution was allowed to warm to room temperature and stirred for 2 h, checking the 
progress of the reaction by TLC. Once the starting material was no longer visible, the 
solvent was removed and the residue was dissolved in DCM (30 mL). This solution was 
washed with water (30 mL) and the aqueous layer re-extracted with DCM (2 x 30 mL). 
The organic layers were combined, dried over potassium carbonate, filtered and the 
solvent removed to yield the mesylate ester as a viscous yellow glass that was used 
without purification in the subsequent alkylation reaction.  
1,7-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (1.11 g, 2.7 mmol) 
was stirred with K2CO3 (1.53 g, 11 mmol) in dry acetonitrile (20 mL) for 20 min under 
argon at room temperature and subsequently cooled to 0 °C. The mesylate was 
dissolved in dry MeCN (10 mL) and added dropwise to the cooled solution. The 
solution was then allowed to warm to room temperature and stirred under argon for 18 
h. The solvent was removed under reduced pressure to yield a yellow solid (250 mg, 
18%) which was purified using HPLC (Method C tR = 9.1 min). 
1
H NMR (400 MHz, 
CDCl3) δH (ppm): 8.05 (1H, d, 
4
JH-H = 1.0 Hz , H
13
), 7.52 (1H, d, 
4
JH-H = 1.0 Hz, H
9
), 
7.50 (2H, d, 
3
JH-H = 9.0 Hz, H
4
), 6.92 (2H, d, 
3
JH-H = 9.0 Hz, H
3
), 4.01 (3H, s, H
12
), 3.84 
(3H, s, H
1
), 3.79 (2H, s, H
15
), 3.23 (4H, s, H
16
), 1.42 (18H, s, H
19
). 
13
C NMR (100 MHz, 
CDCl3) δC (ppm): 170.4 (C
17
), 165.6 (C
11
), 160.8 (C
2
), 158.6 (C
14
), 147.7 (C
10
), 134.2 
(C
8
), 133.7 (C
4
), 128.5 (C
13
), 125.8 (C
9
), 114.3 (C
3
), 113.3 (C
5
), 96.9 (C
6
), 84.8 (C
7
), 
81.6 (C
18
), 58.4 (C
15
), 56.5 (cyclen), 55.4 (C
1
), 55.3 (cyclen), 53.3 (C
12
), 51.2 (cyclen), 
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50.3 (cyclen), 46.1 (C
16
), 28.3 (C
19
). HRMS (ESI
+
) m/z: 680.4023 [M+H]
+
 (C37H54N5O7 
requires 680.3698). 
Di-tert-butyl 2,2'-(4-((6-((bis(pyridin-2-ylmethyl)amino)methyl)pyridin-2-
yl)methyl)-10-((6-(methoxycarbonyl)-4-((4-methoxyphenyl)ethynyl)pyridin-2-
yl)methyl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetate, 20
206
 
 
Di-tert-butyl 2,2'-(4-((6-(methoxycarbonyl)-4-((4-methoxyphenyl)ethynyl)pyridine-2-
yl)methyl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetate (30 mg, 44 μmol) was 
dissolved in dry acetronitrile (10 mL). KI (20 mg, 0.12 mM), K2CO3 (50 mg, 0.36 
mmol), and 1-(6-(chloromethyl)pyridin-2-yl)-N,N-bis(pyridin-2-ylmethyl)methanamine 
(31 mg, 91 μmol) were added and the solution was left to stir at 65 °C under argon for 
18 h. The solvent was removed under reduced pressure and the resultant solid was 
purified through HPLC (Method C, tR = 10.4 min), yielding a white solid (20 mg, 47%). 
1
H NMR (400 MHz, CDCl3) δH (ppm): 8.53 (2H, d, 
3
JH-H = 5.0 Hz, H
32
), 8.07 (1H, d, 
4
JH-H = 1.0 Hz, H
9
), 7.71 (3H, m, H
23, 30
), 7.57 (4H, m, H
24, 29, 13
), 7.48 (2H, d, 
3
JH-H = 9.0 
Hz, H
4
), 7.37 (1H, d, 
3
JH-H = 8.0 Hz, H
22
), 7.20 (2H, ddd, 
3
JH-H = 8.0, 5.0 Hz, 
4
JH-H = 1.0 
Hz, H
31
), 6.89 (2H, d, 
3
JH-H =  9.0 Hz, H
3
), 4.62 (2H, s, H
20
), 4.22 (2H, s, H
15
), 3.95 (3H, 
s, H
12
), 3.89 (4H, s, H
27
), 3.88 (2H, s, H
26
), 3.83 (3H, s, H
1
), 3.40 (6H, br, s, cyclen-H), 
3.11 (2H, s, H
16
), 2.94 (6H, s, cyclen-H), 1.40 (18H, s, H
19
).  
13
C NMR (100 MHz, 
CDCl3) δC (ppm): 169.7 (C
17
), 165.0 (C
11
), 160.7 (C
2
), 159.2 (C
25
), 158.4 (C
28
), 157.1 
(C
14
), 148.4 (C
32
), 147.8 (C
10
) 137.7 (C
23
), 137.3 (C
30
), 134.2 (C
8
) 133.7 (C
4
), 128.9 
(C
13
), 126.1 (C
9
), 124.2 (C
22
), 123.3 (C
29
), 122.8 (C
24
), 122.6 (C
31
), 114.3 (C
3
), 113.4 
(C
5
), 96.8 (C
6
), 84.8 (C
7
), 82.0 (C
18
), 60.2 (C
26
), 59.7 (C
27
), 59.2 (C
15
), 56.9 (cyclen), 
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56.8 (C
20
), 55.4 (C
1
), 53.0 (cyclen), 52.9 (C
12
), 51.4 (cyclen), 50.4 (cyclen), 49.3 (C
16
), 
28.1 (C
19
). HRMS (ESI
+
) m/z: 982.5576 [M+H]
+
 (C56H72N9O7 requires 982.5555) 
[Eu.L
6
]
206
 
 
Di-tert-butyl 2,2'-(4-((6-((bis(pyridin-2-ylmethyl)amino)methyl)pyridin-2-yl)methyl)-
10-((6-(methoxycarbonyl)-4-((4-methoxyphenyl)ethynyl)pyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate  (30 mg, 0.03 mmol) was dissolved in 
NaOH(aq) (0.5 M, 6 mL) and stirred at 60 for 2 h, with the reaction being monitored via 
LCMS. The solution was neutralised with 1 M HCl (12 mL). EuCl3 (30 mg, 0.12 mmol) 
was added and stirred at room temperature for a further 2 h. The solution was altered to 
pH 10.0 with ammonia solution. Eu(OH)3 was centrifuged out, the remaining solution 
was neutralised and the solvent removed under reduced pressure. The resultant solid 
was dialysed to remove the salt yielding a white solid, (10 mg, 21%). HRMS (ESI
+
) 
m/z: 1006.3148 [M+H]
+
 (C47H50
159
EuN9O7 requires 1006.3130). τH2O: 0.55 ms; 
τD2O:0.73 ms; λabs(H2O): 340 nm. 
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